Second Report on Human Biomonitoring of Environmental Chemicals in Canada - Tables 8.1.1 to 8.19.9

F = Data is too unreliable to be published.

x = Suppressed to meet the confidentiality requirements of the Statistics Act.

E = Use data with caution.

Table 8.1.1: Antimony -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a1 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a1 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a1 footnotes

Table a1 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a1 footnote a referrer

Table a1 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a1 footnote b referrer

Total, 6-79 years
1 5492 22.40 0.042
(0.040 - 0.045)
<LOD 0.043
(0.040 - 0.045)
0.079
(0.074 - 0.083)
0.18
(0.17 - 0.19)
2 5738 19.90 0.048
(0.046 - 0.050)
<LOD 0.045
(0.043 - 0.048)
0.087
(0.081 - 0.092)
0.19
(0.16 - 0.22)
Males, 6-79 years
1 2662 15.63 0.051
(0.048 - 0.054)
<LOD 0.051
(0.047 - 0.055)
0.092
(0.084 - 0.099)
0.19
(0.17 - 0.22)
2 2746 15.51 0.054
(0.051 - 0.058)
<LOD 0.052
(0.047 - 0.057)
0.098
(0.089 - 0.11)
0.23E
(0.14 - 0.31)
Females, 6-79 years
1 2830 28.76 0.035
(0.032 - 0.038)
<LOD 0.035
(0.032 - 0.039)
0.068
(0.064 - 0.071)
0.16
(0.14 - 0.19)
2 2992 23.93 0.042
(0.040 - 0.045)
<LOD 0.039
(0.035 - 0.042)
0.077
(0.069 - 0.086)
0.16
(0.14 - 0.18)
 
Table 8.1.2: Antimony -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a2 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a2 footnotes

Table a2 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a2 footnote a referrer

Table a2 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a2 footnote b referrer

Total, 3-79 years
1Table a2 footnote b . . . . . . .
2 6311 20.00 0.048
(0.046 - 0.050)
<LOD 0.045
(0.043 - 0.048)
0.087
(0.081 - 0.092)
0.19
(0.16 - 0.22)
3-5 years
1Table a2 footnote b . . . . . . .
2 573 20.94 0.052
(0.046 - 0.059)
<LOD 0.051
(0.040 - 0.063)
0.087
(0.073 - 0.10)
0.18
(0.12 - 0.24)
6-11 years
1 1034 17.99 0.048
(0.044 - 0.054)
<LOD 0.051
(0.047 - 0.055)
0.084
(0.076 - 0.091)
0.18
(0.14 - 0.21)
2 1062 13.56 0.057
(0.051 - 0.063)
<LOD 0.056
(0.049 - 0.064)
0.090
(0.078 - 0.10)
0.18
(0.13 - 0.23)
12-19 years
1 983 12.92 0.059
(0.053 - 0.065)
<LOD 0.065
(0.058 - 0.073)
0.098
(0.090 - 0.11)
0.19
(0.16 - 0.23)
2 1041 14.22 0.061
(0.054 - 0.069)
<LOD 0.066
(0.059 - 0.072)
0.10
(0.092 - 0.11)
0.20
(0.17 - 0.24)
20-39 years
1 1169 25.66 0.042
(0.038 - 0.047)
<LOD 0.043
(0.038 - 0.048)
0.081
(0.074 - 0.089)
0.19
(0.15 - 0.23)
2 1321 21.73 0.050
(0.045 - 0.056)
<LOD 0.046
(0.042 - 0.051)
0.089
(0.079 - 0.10)
0.20E
(0.083 - 0.31)
40-59 years
1 1223 27.80 0.040
(0.037 - 0.042)
<LOD 0.040
(0.037 - 0.043)
0.074
(0.070 - 0.078)
0.18
(0.15 - 0.20)
2 1228 23.62 0.045
(0.041 - 0.049)
<LOD 0.041
(0.034 - 0.049)
0.082
(0.074 - 0.091)
0.22
(0.18 - 0.25)
60-79 years
1 1083 25.58 0.036
(0.034 - 0.038)
<LOD 0.035
(0.033 - 0.038)
0.066
(0.060 - 0.072)
0.14
(0.11 - 0.16)
2 1086 25.14 0.040
(0.037 - 0.044)
<LOD 0.037
(0.034 - 0.040)
0.073
(0.065 - 0.081)
0.16
(0.13 - 0.19)
 
Table 8.1.3: Antimony -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a3 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a3 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a3 footnotes

Table a3 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a3 footnote a referrer

Table a3 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a3 footnote b referrer

Table a3 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a3 footnote c referrer

Males, Total 3-79 years
1Table a3 footnote c . . . . . . .
2 3036 15.55 0.055
(0.051 - 0.058)
<LOD 0.052
(0.047 - 0.057)
0.097
(0.089 - 0.11)
0.23
(0.15 - 0.30)
Males, 6-11 years
1 524 14.12 0.052
(0.043 - 0.063)
<LOD 0.053
(0.046 - 0.060)
0.088
(0.073 - 0.10)
0.18
(0.13 - 0.23)
2 532 11.65 0.056
(0.048 - 0.065)
<LODE
(<LOD - 0.022)
0.054
(0.044 - 0.064)
0.080
(0.063 - 0.098)
0.17E
(0.079 - 0.25)
Males, 12-19 years
1 505 8.51 0.065
(0.058 - 0.074)
0.021E
(<LOD - 0.029)
0.068
(0.059 - 0.078)
0.099
(0.089 - 0.11)
0.20
(0.14 - 0.27)
2 542 11.81 0.068
(0.058 - 0.079)
F 0.071
(0.057 - 0.085)
0.11
(0.089 - 0.14)
0.21
(0.14 - 0.29)
Males, 20-39 years
1 514 18.68 0.049
(0.042 - 0.057)
<LOD 0.051
(0.041 - 0.060)
0.093
(0.079 - 0.11)
0.19
(0.14 - 0.24)
2 551 16.15 0.059
(0.051 - 0.068)
<LOD 0.056
(0.045 - 0.067)
0.10
(0.083 - 0.13)
0.33E
(0.14 - 0.52)
Males, 40-59 years
1 578 18.34 0.051
(0.047 - 0.055)
<LOD 0.048
(0.044 - 0.053)
0.094
(0.083 - 0.11)
0.20
(0.15 - 0.26)
2 616 16.88 0.052
(0.045 - 0.061)
<LOD 0.050
(0.040 - 0.059)
0.097
(0.079 - 0.11)
0.24E
(0.15 - 0.34)
Males, 60-79 years
1 541 17.93 0.046
(0.041 - 0.051)
<LOD 0.045
(0.039 - 0.051)
0.079
(0.070 - 0.088)
0.16
(0.12 - 0.20)
2 505 21.19 0.045
(0.040 - 0.050)
<LOD 0.042
(0.038 - 0.046)
0.088
(0.076 - 0.10)
0.16
(0.13 - 0.18)
Females, Total 3-79 years
1Table a3 footnote c . . . . . . .
2 3275 24.12 0.042
(0.040 - 0.045)
<LOD 0.039
(0.036 - 0.042)
0.077
(0.069 - 0.085)
0.16
(0.14 - 0.19)
Females, 6-11 years
1 510 21.96 0.045
(0.041 - 0.049)
<LOD 0.049
(0.044 - 0.054)
0.079
(0.072 - 0.086)
0.17
(0.13 - 0.21)
2 530 15.47 0.057
(0.052 - 0.064)
<LOD 0.060
(0.050 - 0.069)
0.095
(0.080 - 0.11)
0.19E
(0.12 - 0.25)
Females, 12-19 years
1 478 17.57 0.052
(0.047 - 0.058)
<LOD 0.059
(0.051 - 0.067)
0.094
(0.077 - 0.11)
0.19
(0.15 - 0.24)
2 499 16.83 0.055
(0.047 - 0.063)
<LOD 0.064
(0.055 - 0.073)
0.094
(0.088 - 0.10)
0.18
(0.15 - 0.20)
Females, 20-39 years
1 655 31.15 0.037
(0.033 - 0.041)
<LOD 0.036
(0.031 - 0.042)
0.071
(0.063 - 0.080)
0.18E
(0.11 - 0.25)
2 770 25.71 0.043
(0.038 - 0.049)
<LOD 0.041
(0.035 - 0.046)
0.081
(0.064 - 0.097)
0.15
(0.12 - 0.18)
Females, 40-59 years
1 645 36.28 0.031
(0.027 - 0.036)
<LOD 0.030
(0.024 - 0.035)
0.058
(0.049 - 0.067)
0.15
(0.13 - 0.17)
2 612 30.39 0.039
(0.035 - 0.043)
<LOD 0.034
(0.029 - 0.038)
0.068
(0.051 - 0.085)
0.16
(0.12 - 0.20)
Females, 60-79 years
1 542 33.21 0.029
(0.026 - 0.032)
<LOD 0.028
(0.024 - 0.031)
0.049
(0.042 - 0.056)
0.12
(0.098 - 0.14)
2 581 28.57 0.036
(0.032 - 0.041)
<LOD 0.033
(0.028 - 0.038)
0.064
(0.051 - 0.078)
0.16
(0.11 - 0.22)
 
Table 8.1.4: Antimony (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 6-79 years Table a4 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a4 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a4 footnotes

Table a4 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a4 footnote a referrer

Table a4 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a4 footnote b referrer

Total, 6-79 years
1 5479 22.45 0.053
(0.051 - 0.056)
<LOD 0.050
(0.048 - 0.053)
0.074
(0.070 - 0.078)
0.16
(0.14 - 0.18)
2 5719 19.97 0.045
(0.042 - 0.047)
<LOD 0.043
(0.041 - 0.045)
0.067
(0.064 - 0.070)
0.15
(0.13 - 0.18)
Males, 6-79 years
1 2653 15.68 0.052
(0.049 - 0.055)
<LOD 0.049
(0.046 - 0.052)
0.074
(0.068 - 0.079)
0.15
(0.12 - 0.19)
2 2739 15.55 0.043
(0.041 - 0.046)
<LOD 0.042
(0.038 - 0.045)
0.065
(0.062 - 0.069)
0.15
(0.12 - 0.18)
Females, 6-79 years
1 2826 28.80 0.055
(0.052 - 0.059)
<LOD 0.052
(0.049 - 0.055)
0.075
(0.069 - 0.080)
0.16
(0.13 - 0.19)
2 2980 24.03 0.046
(0.043 - 0.050)
<LOD 0.044
(0.042 - 0.047)
0.068
(0.062 - 0.075)
0.16
(0.13 - 0.20)
 
Table 8.1.5: Antimony (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a5 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a5 footnotes

Table a5 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a5 footnote a referrer

Table a5 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a5 footnote b referrer

Total, 3-79 years
1Table a5 footnote b . . . . . . .
2 6291 20.06 0.046
(0.043 - 0.048)
<LOD 0.044
(0.042 - 0.046)
0.069
(0.065 - 0.073)
0.16
(0.14 - 0.19)
3-5 years
1Table a5 footnote b . . . . . . .
2 572 20.98 0.089
(0.079 - 0.10)
<LOD 0.085
(0.073 - 0.097)
0.13
(0.12 - 0.14)
0.32E
(0.18 - 0.47)
6-11 years
1 1031 18.04 0.077
(0.072 - 0.082)
<LOD 0.074
(0.069 - 0.078)
0.10
(0.095 - 0.11)
0.21
(0.16 - 0.27)
2 1058 13.61 0.064
(0.058 - 0.071)
<LOD 0.060
(0.053 - 0.067)
0.090
(0.079 - 0.10)
0.19E
(0.12 - 0.26)
12-19 years
1 982 12.93 0.052
(0.049 - 0.056)
<LOD 0.049
(0.045 - 0.053)
0.070
(0.064 - 0.075)
0.12
(0.094 - 0.14)
2 1039 14.24 0.045
(0.042 - 0.050)
<LOD 0.045
(0.042 - 0.048)
0.066
(0.060 - 0.073)
0.12
(0.094 - 0.14)
20-39 years
1 1165 25.75 0.050
(0.046 - 0.054)
<LOD 0.047
(0.045 - 0.049)
0.070
(0.064 - 0.076)
0.16
(0.13 - 0.20)
2 1319 21.76 0.041
(0.038 - 0.046)
<LOD 0.039
(0.037 - 0.040)
0.061
(0.055 - 0.068)
0.16E
(0.088 - 0.24)
40-59 years
1 1218 27.91 0.054
(0.050 - 0.057)
<LOD 0.051
(0.048 - 0.054)
0.073
(0.067 - 0.079)
0.16
(0.14 - 0.19)
2 1223 23.71 0.043
(0.040 - 0.046)
<LOD 0.042
(0.040 - 0.045)
0.065
(0.059 - 0.070)
0.15
(0.12 - 0.18)
60-79 years
1 1083 25.58 0.053
(0.050 - 0.056)
<LOD 0.050
(0.047 - 0.053)
0.074
(0.070 - 0.079)
0.14
(0.12 - 0.16)
2 1080 25.28 0.047
(0.044 - 0.051)
<LOD 0.047
(0.044 - 0.050)
0.071
(0.064 - 0.077)
0.16
(0.13 - 0.18)
 
Table 8.1.6: Antimony (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a6 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a6 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a6 footnotes

Table a6 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a6 footnote a referrer

Table a6 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a6 footnote b referrer

Table a6 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a6 footnote c referrer

Males, Total 3-79 years
1Table a6 footnote c . . . . . . .
2 3028 15.59 0.044
(0.042 - 0.047)
<LOD 0.043
(0.040 - 0.046)
0.067
(0.063 - 0.071)
0.15
(0.11 - 0.19)
Males, 6-11 years
1 522 14.18 0.081
(0.075 - 0.087)
<LOD 0.077
(0.071 - 0.083)
0.11
(0.096 - 0.11)
0.23E
(0.11 - 0.36)
2 530 11.70 0.061
(0.052 - 0.071)
<LOD
(<LOD - 0.039)
0.059
(0.051 - 0.067)
0.085
(0.072 - 0.099)
0.15E
(0.092 - 0.21)
Males, 12-19 years
1 504 8.53 0.056
(0.052 - 0.060)
0.030
(<LOD - 0.033)
0.055
(0.051 - 0.060)
0.073
(0.068 - 0.079)
0.12
(0.096 - 0.14)
2 541 11.83 0.046
(0.040 - 0.052)
<LOD
(<LOD - 0.029)
0.045
(0.040 - 0.050)
0.068
(0.057 - 0.079)
0.13
(0.099 - 0.17)
Males, 20-39 years
1 512 18.75 0.046
(0.042 - 0.052)
<LOD 0.041
(0.035 - 0.048)
0.066
(0.056 - 0.076)
0.16
(0.12 - 0.21)
2 550 16.18 0.041
(0.035 - 0.048)
<LOD 0.037
(0.032 - 0.042)
0.063
(0.051 - 0.074)
0.16E
(0.067 - 0.25)
Males, 40-59 years
1 574 18.47 0.052
(0.048 - 0.055)
<LOD 0.051
(0.046 - 0.055)
0.072
(0.065 - 0.079)
0.16
(0.11 - 0.21)
2 615 16.91 0.042
(0.038 - 0.045)
<LOD 0.039
(0.035 - 0.044)
0.063
(0.055 - 0.071)
0.15
(0.13 - 0.17)
Males, 60-79 years
1 541 17.93 0.050
(0.046 - 0.054)
<LOD 0.046
(0.042 - 0.050)
0.066
(0.060 - 0.072)
0.14
(0.11 - 0.16)
2 503 21.27 0.043
(0.041 - 0.047)
<LOD 0.045
(0.041 - 0.049)
0.065
(0.060 - 0.069)
0.13
(0.096 - 0.17)
Females, Total 3-79 years
1Table a6 footnote c . . . . . . .
2 3263 24.21 0.047
(0.043 - 0.051)
<LOD 0.045
(0.042 - 0.048)
0.071
(0.064 - 0.077)
0.17
(0.13 - 0.20)
Females, 6-11 years
1 509 22.00 0.073
(0.067 - 0.078)
<LOD 0.070
(0.065 - 0.075)
0.098
(0.088 - 0.11)
0.19
(0.14 - 0.23)
2 528 15.53 0.068
(0.061 - 0.075)
<LOD 0.061
(0.054 - 0.069)
0.098
(0.081 - 0.12)
0.24E
(0.13 - 0.35)
Females, 12-19 years
1 478 17.57 0.049
(0.044 - 0.053)
<LOD 0.045
(0.042 - 0.049)
0.063
(0.052 - 0.074)
0.12E
(0.047 - 0.19)
2 498 16.87 0.045
(0.042 - 0.048)
<LOD 0.045
(0.040 - 0.049)
0.065
(0.060 - 0.070)
0.11
(0.090 - 0.12)
Females, 20-39 years
1 653 31.24 0.053
(0.049 - 0.058)
<LOD 0.050
(0.047 - 0.053)
0.071
(0.066 - 0.075)
0.16E
(0.088 - 0.24)
2 769 25.75 0.042
(0.037 - 0.048)
<LOD 0.039
(0.036 - 0.043)
0.060
(0.049 - 0.071)
0.16E
(0.082 - 0.24)
Females, 40-59 years
1 644 36.34 0.055
(0.049 - 0.062)
<LOD 0.051
(0.045 - 0.057)
0.074
(0.063 - 0.084)
0.17
(0.13 - 0.20)
2 608 30.59 0.045
(0.040 - 0.050)
<LOD 0.044
(0.041 - 0.047)
0.066
(0.056 - 0.076)
0.16E
(0.092 - 0.24)
Females, 60-79 years
1 542 33.21 0.056
(0.052 - 0.060)
<LOD 0.056
(0.051 - 0.060)
0.079
(0.067 - 0.090)
0.14
(0.12 - 0.17)
2 577 28.77 0.051
(0.046 - 0.057)
<LOD 0.049
(0.043 - 0.055)
0.078
(0.067 - 0.089)
0.17
(0.14 - 0.20)
 
Table 8.2.1.1: Arsenic (total) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a7 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a7 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a7 footnotes

Table a7 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a7 footnote a referrer

Table a7 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a7 footnote b referrer

Total, 6-79 years
1 5492 0.18 12
(9.8 - 14)
3.1
(2.8 - 3.4)
11
(8.7 - 13)
23
(18 - 28)
67
(48 - 86)
2 5738 1.93 9.2
(7.7 - 11)
2.0
(1.7 - 2.4)
7.9
(6.7 - 9.0)
20
(15 - 24)
77
(58 - 96)
Males, 6-79 years
1 2662 0.23 13
(11 - 16)
3.6
(3.2 - 4.0)
12
(8.8 - 15)
25
(18 - 32)
70
(47 - 92)
2 2746 1.71 10
(8.3 - 12)
2.1
(1.8 - 2.5)
9.0
(7.4 - 11)
22
(15 - 28)
80E
(48 - 110)
Females, 6-79 years
1 2830 0.14 11
(9.0 - 12)
2.7
(2.2 - 3.2)
10
(8.6 - 12)
21
(17 - 25)
65
(47 - 84)
2 2992 2.14 8.3
(7.0 - 9.9)
2.0
(1.4 - 2.6)
7.2
(6.2 - 8.2)
18
(13 - 22)
74
(56 - 91)
 
Table 8.2.1.2: Arsenic (total) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a8 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a8 footnotes

Table a8 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a8 footnote a referrer

Table a8 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a8 footnote b referrer

Total, 3-79 years
1Table a8 footnote b . . . . . . .
2 6311 1.96 9.1
(7.7 - 11)
2.0
(1.7 - 2.3)
7.8
(6.7 - 8.9)
19
(15 - 24)
76
(58 - 94)
3-5 years
1Table a8 footnote b . . . . . . .
2 573 2.27 6.6
(5.1 - 8.4)
F 6.3
(4.7 - 8.0)
11
(7.8 - 14)
41
(31 - 51)
6-11 years
1 1034 0.10 9.5
(8.0 - 11)
2.4
(1.8 - 3.0)
9.5
(7.9 - 11)
18
(14 - 22)
51E
(29 - 73)
2 1062 2.26 7.0
(6.3 - 7.8)
2.0
(1.5 - 2.4)
6.8
(6.3 - 7.3)
13
(11 - 14)
44E
(26 - 62)
12-19 years
1 983 0.31 11
(9.1 - 14)
3.3
(2.2 - 4.3)
11
(8.6 - 13)
20
(14 - 26)
54
(35 - 73)
2 1041 2.21 7.2
(5.8 - 8.9)
1.9E
(1.1 - 2.7)
6.4
(5.3 - 7.4)
14
(10 - 17)
52E
(17 - 88)
20-39 years
1 1169 0.09 12
(10 - 14)
3.0
(2.5 - 3.4)
11
(9.5 - 13)
25
(17 - 32)
66
(47 - 85)
2 1321 2.12 9.6
(8.0 - 11)
2.1
(1.7 - 2.5)
8.4
(6.9 - 9.9)
20
(15 - 26)
74
(63 - 85)
40-59 years
1 1223 0.41 12
(10 - 15)
3.1
(2.6 - 3.6)
11
(8.4 - 15)
24
(19 - 30)
72E
(42 - 100)
2 1228 1.55 9.3
(7.3 - 12)
2.1E
(1.1 - 3.0)
8.1
(6.5 - 9.8)
20
(15 - 26)
70
(50 - 91)
60-79 years
1 1083 0 12
(9.2 - 15)
3.5
(2.9 - 4.1)
11
(6.9 - 14)
22
(17 - 28)
72
(49 - 96)
2 1086 1.57 11
(7.8 - 15)
2.1
(1.4 - 2.7)
9.2
(6.3 - 12)
25E
(12 - 38)
120E
(44 - 190)
 
Table 8.2.1.3: Arsenic (total) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a9 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a9 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a9 footnotes

Table a9 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a9 footnote a referrer

Table a9 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a9 footnote b referrer

Table a9 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a9 footnote c referrer

Males, Total 3-79 years
1Table a9 footnote c . . . . . . .
2 3036 1.71 9.9
(8.3 - 12)
2.1
(1.8 - 2.4)
8.9
(7.4 - 10)
21
(15 - 28)
80E
(50 - 110)
Males, 6-11 years
1 524 0.19 9.4
(6.9 - 13)
2.4E
(1.3 - 3.6)
9.5
(7.4 - 12)
17
(11 - 23)
51E
(31 - 70)
2 532 2.07 7.1
(6.1 - 8.2)
2.1
(1.6 - 2.7)
6.8
(6.2 - 7.5)
12
(9.6 - 15)
39E
(18 - 61)
Males, 12-19 years
1 505 0.40 11
(8.8 - 14)
3.6
(2.8 - 4.4)
10
(7.9 - 12)
19
(14 - 24)
F
2 542 2.21 7.1
(5.7 - 8.8)
2.0
(1.4 - 2.6)
6.1
(5.2 - 7.0)
12
(8.0 - 17)
F
Males, 20-39 years
1 514 0.19 13
(11 - 15)
3.5
(2.9 - 4.2)
12
(9.1 - 15)
27
(18 - 37)
65
(47 - 84)
2 551 2.18 11
(8.4 - 14)
2.1
(1.5 - 2.8)
9.6
(6.8 - 12)
24E
(14 - 34)
81E
(32 - 130)
Males, 40-59 years
1 578 0.35 15
(11 - 18)
4.0
(2.8 - 5.2)
14
(9.1 - 18)
29
(21 - 36)
79E
(27 - 130)
2 616 0.65 11
(8.5 - 15)
2.0E
(0.78 - 3.3)
10
(7.9 - 13)
26E
(15 - 37)
80E
(41 - 120)
Males, 60-79 years
1 541 0 14
(10 - 18)
3.8
(2.8 - 4.8)
13
(8.6 - 18)
25
(19 - 32)
75E
(45 - 100)
2 505 1.58 11
(8.3 - 15)
2.4
(1.9 - 2.9)
10
(7.3 - 13)
24E
(15 - 33)
110
(80 - 140)
Females, Total 3-79 years
1Table a9 footnote c . . . . . . .
2 3275 2.20 8.3
(7.0 - 9.8)
2.0
(1.4 - 2.6)
7.2
(6.2 - 8.1)
17
(13 - 22)
74
(56 - 91)
Females, 6-11 years
1 510 0 9.6
(8.1 - 11)
2.2
(1.4 - 2.9)
9.5
(7.4 - 12)
20
(16 - 23)
F
2 530 2.45 6.9
(5.9 - 8.0)
1.4E
(0.80 - 2.0)
6.7
(5.9 - 7.4)
13
(10 - 16)
F
Females, 12-19 years
1 478 0.21 11
(8.6 - 15)
2.7E
(0.75 - 4.7)
11
(8.4 - 14)
22E
(13 - 30)
54
(35 - 73)
2 499 2.20 7.3
(5.6 - 9.4)
F 6.6
(5.4 - 7.9)
14
(9.6 - 18)
F
Females, 20-39 years
1 655 0 11
(9.4 - 13)
2.4
(1.7 - 3.0)
11
(9.6 - 12)
22
(17 - 27)
66E
(36 - 97)
2 770 2.08 8.7
(7.2 - 10)
2.0E
(1.2 - 2.9)
7.4
(6.2 - 8.6)
17
(13 - 22)
73
(52 - 94)
Females, 40-59 years
1 645 0.47 10
(8.6 - 12)
2.8
(2.2 - 3.4)
9.6
(7.7 - 12)
22
(18 - 26)
66E
(42 - 91)
2 612 2.45 7.8
(6.0 - 9.9)
2.1E
(1.0 - 3.1)
7.0
(5.7 - 8.2)
16
(11 - 22)
58E
(34 - 81)
Females, 60-79 years
1 542 0 10
(8.0 - 13)
3.2
(2.3 - 4.1)
9.3
(6.4 - 12)
20
(15 - 25)
70
(46 - 95)
2 581 1.55 10E
(7.2 - 15)
1.5E
(<LOD - 2.4)
7.8
(5.0 - 11)
27E
(9.0 - 45)
F
 
Table 8.2.1.4: Arsenic (total) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 6-79 years Table a10 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a10 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a10 footnotes

Table a10 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a10 footnote a referrer

Table a10 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a10 footnote b referrer

Total, 6-79 years
1 5479 0.18 14
(11 - 18)
4.7
(3.9 - 5.5)
13
(9.6 - 16)
24
(18 - 30)
67
(45 - 89)
2 5719 1.94 8.6
(7.2 - 10)
2.4
(2.1 - 2.8)
7.1
(6.0 - 8.2)
17
(12 - 21)
71
(55 - 87)
Males, 6-79 years
1 2653 0.23 13
(10 - 16)
4.4
(3.6 - 5.2)
11
(8.3 - 13)
22
(17 - 26)
59
(41 - 78)
2 2739 1.72 8.0
(6.7 - 9.6)
2.3
(1.9 - 2.6)
6.8
(5.6 - 8.0)
15
(11 - 19)
66
(46 - 86)
Females, 6-79 years
1 2826 0.14 16
(13 - 20)
5.0
(4.1 - 5.9)
14
(11 - 17)
27
(19 - 35)
78
(53 - 100)
2 2980 2.15 9.2
(7.6 - 11)
2.6
(2.2 - 3.1)
7.3
(6.2 - 8.5)
18
(13 - 23)
78
(52 - 100)
 
Table 8.2.1.5: Arsenic (total) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a11 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a11 footnotes

Table a11 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a11 footnote a referrer

Table a11 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a11 footnote b referrer

Total, 3-79 years
1Table a11 footnote b . . . . . . .
2 6291 1.97 8.6
(7.3 - 10)
2.5
(2.1 - 2.8)
7.2
(6.1 - 8.3)
17
(13 - 21)
71
(56 - 87)
3-5 years
1Table a11 footnote b . . . . . . .
2 572 2.27 11
(8.8 - 14)
3.9E
(<LOD - 5.3)
9.6
(8.4 - 11)
17
(15 - 19)
F
6-11 years
1 1031 0.10 15
(12 - 18)
5.3
(4.5 - 6.1)
13
(9.4 - 16)
24
(19 - 29)
59E
(17 - 100)
2 1058 2.27 7.9
(7.1 - 8.8)
2.9
(2.6 - 3.2)
6.6
(6.1 - 7.1)
13
(10 - 16)
54E
(27 - 80)
12-19 years
1 982 0.31 9.8
(7.6 - 13)
3.7
(3.1 - 4.3)
9.1
(7.0 - 11)
16
(11 - 20)
36E
(21 - 51)
2 1039 2.21 5.3
(4.5 - 6.3)
1.9
(1.5 - 2.3)
4.5
(3.6 - 5.3)
8.1
(6.7 - 9.5)
39E
(16 - 61)
20-39 years
1 1165 0.09 13
(11 - 16)
4.5
(3.8 - 5.3)
12
(9.0 - 15)
23
(17 - 29)
60
(39 - 80)
2 1319 2.12 7.9
(6.6 - 9.4)
2.3
(1.9 - 2.7)
6.6
(5.1 - 8.0)
15
(12 - 19)
56
(42 - 70)
40-59 years
1 1218 0.41 16
(12 - 20)
5.1
(3.7 - 6.5)
14
(10 - 17)
25
(20 - 30)
F
2 1223 1.55 8.9
(7.2 - 11)
2.5
(1.9 - 3.1)
7.6
(6.1 - 9.1)
19
(12 - 25)
71
(52 - 89)
60-79 years
1 1083 0 16
(12 - 22)
5.3
(4.3 - 6.3)
14
(9.2 - 20)
29E
(17 - 42)
87
(58 - 110)
2 1080 1.57 13
(9.4 - 17)
3.3
(2.6 - 4.1)
10
(7.2 - 13)
27E
(15 - 39)
130E
(37 - 220)
 
Table 8.2.1.6: Arsenic (total) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a12 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a12 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a12 footnotes

Table a12 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a12 footnote a referrer

Table a12 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a12 footnote b referrer

Table a12 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a12 footnote c referrer

Males, Total 3-79 years
1Table a12 footnote c . . . . . . .
2 3028 1.72 8.1
(6.8 - 9.6)
2.3
(1.9 - 2.6)
7.0
(5.8 - 8.1)
15
(11 - 19)
66
(47 - 85)
Males, 6-11 years
1 522 0.19 14
(11 - 18)
5.4
(4.5 - 6.3)
12
(7.9 - 16)
23
(16 - 29)
F
2 530 2.08 7.7
(6.8 - 8.8)
2.9
(2.4 - 3.4)
6.4
(5.7 - 7.2)
13
(9.8 - 16)
49E
(26 - 72)
Males, 12-19 years
1 504 0.40 9.4
(7.1 - 12)
3.4
(2.6 - 4.3)
8.9
(7.0 - 11)
15
(10 - 20)
35E
(20 - 50)
2 541 2.22 4.8
(4.0 - 5.7)
1.7
(1.3 - 2.1)
4.1
(3.4 - 4.8)
7.5
(6.4 - 8.6)
37E
(14 - 60)
Males, 20-39 years
1 512 0.20 12
(9.4 - 15)
4.1
(2.9 - 5.2)
10
(7.9 - 13)
21
(15 - 27)
48
(39 - 58)
2 550 2.18 7.3
(5.8 - 9.2)
2.2
(1.8 - 2.6)
6.6
(4.6 - 8.6)
14
(9.9 - 18)
52E
(32 - 72)
Males, 40-59 years
1 574 0.35 14
(11 - 18)
4.6
(3.3 - 6.0)
12
(8.7 - 15)
23
(18 - 29)
F
2 615 0.65 8.9
(7.1 - 11)
2.5
(1.9 - 3.1)
7.7
(5.8 - 9.7)
18E
(9.4 - 27)
74
(48 - 100)
Males, 60-79 years
1 541 0 14
(11 - 19)
5.1
(4.2 - 6.0)
12
(8.2 - 17)
23
(16 - 30)
73E
(44 - 100)
2 503 1.59 11
(8.1 - 14)
3.0
(2.1 - 3.9)
8.8
(6.1 - 11)
22E
(12 - 32)
79
(57 - 100)
Females, Total 3-79 years
1Table a12 footnote c . . . . . . .
2 3263 2.21 9.3
(7.7 - 11)
2.6
(2.2 - 3.1)
7.4
(6.3 - 8.6)
18
(14 - 23)
78
(53 - 100)
Females, 6-11 years
1 509 0 15
(13 - 18)
5.3
(4.1 - 6.5)
13
(10 - 16)
25
(19 - 31)
F
2 528 2.46 8.1
(6.9 - 9.5)
3.0
(2.5 - 3.4)
6.9
(6.3 - 7.4)
13
(9.1 - 17)
67E
(25 - 110)
Females, 12-19 years
1 478 0.21 10
(7.9 - 13)
4.0
(3.3 - 4.8)
9.4
(6.7 - 12)
16
(11 - 21)
39E
(24 - 54)
2 498 2.21 6.0
(4.9 - 7.4)
2.2
(<LOD - 2.7)
5.0
(3.5 - 6.5)
9.0
(5.9 - 12)
40E
(12 - 68)
Females, 20-39 years
1 653 0 15
(12 - 19)
4.8
(4.0 - 5.6)
14
(11 - 17)
26
(18 - 35)
79E
(42 - 120)
2 769 2.08 8.4
(7.2 - 9.9)
2.5
(2.0 - 3.1)
6.6
(5.2 - 7.9)
16
(11 - 21)
76E
(46 - 110)
Females, 40-59 years
1 644 0.47 17
(14 - 22)
5.6
(3.7 - 7.5)
15
(11 - 20)
27
(21 - 33)
85E
(37 - 130)
2 608 2.47 8.9
(6.9 - 12)
2.5
(1.7 - 3.4)
7.5
(6.0 - 9.1)
19
(13 - 24)
71E
(40 - 100)
Females, 60-79 years
1 542 0 19
(14 - 26)
5.7
(4.1 - 7.4)
17E
(9.5 - 24)
37E
(23 - 50)
95E
(57 - 130)
2 577 1.56 15
(11 - 20)
3.6
(<LOD - 4.6)
11
(7.6 - 14)
32E
(15 - 49)
F
 
Table 8.2.2.1: Arsenous acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a13 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a13 footnotes

Table a13 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a13 footnote a referrer

Total, 3-79 years
2 2537 75.60 -- <LOD <LOD 1.2E
(<LOD - 1.8)
4.5E
(2.2 - 6.7)
3-5 years
2 516 84.50 -- <LOD <LOD <LOD 2.3E
(1.3 - 3.2)
6-11 years
2 511 78.86 -- <LOD <LOD <LOD 3.0E
(1.8 - 4.1)
12-19 years
2 510 72.35 -- <LOD <LOD 1.3E
(<LOD - 1.9)
5.2E
(1.5 - 8.9)
20-39 years
2 355 69.86 -- <LOD <LOD 1.4E
(<LOD - 2.2)
F
40-59 years
2 356 70.51 -- <LOD <LOD F 3.4E
(1.8 - 4.9)
60-79 years
2 289 73.01 -- <LOD <LOD F F
           
 
Table 8.2.2.2: Arsenous acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a14 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a14 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a14 footnotes

Table a14 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a14 footnote a referrer

Table a14 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a14 footnote b referrer

Males, Total 3-79 years
2 1271 72.54 -- <LOD <LOD 1.4E
(<LOD - 1.9)
4.8E
(1.6 - 8.0)
Males, 6-11 years
2 260 76.92 -- <LOD <LOD <LOD 3.4E
(1.8 - 5.1)
Males, 12-19 years
2 255 70.98 -- <LOD <LOD 1.3E
(<LOD - 2.1)
5.1E
(2.0 - 8.2)
Males, 20-39 years
2 167 62.87 -- <LOD <LOD F X
Males, 40-59 years
2 193 63.21 -- <LOD <LOD 1.5E
(<LOD - 2.1)
X
Males, 60-79 years
2 141 69.50 -- <LOD <LOD F X
Females, Total 3-79 years
2 1266 78.67 -- <LOD <LOD <LOD 4.0E
(1.8 - 6.2)
Females, 6-11 years
2 251 80.88 -- <LOD <LOD <LOD 2.8E
(1.6 - 4.0)
Females, 12-19 years
2 255 73.73 -- <LOD <LOD 1.3E
(<LOD - 2.1)
F
Females, 20-39 years
2 188 76.06 -- <LOD <LOD <LOD X
Females, 40-59 years
2 163 79.14 -- <LOD <LOD <LOD X
Females, 60-79 years
2 148 76.35 -- <LOD <LOD F X
           
 
Table 8.2.2.3: Arsenous acid (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a15 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a15 footnotes

Table a15 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a15 footnote a referrer

Total, 3-79 years
2 2527 75.90 -- <LOD <LOD 1.6
(<LOD - 1.9)
4.5E
(2.7 - 6.2)
3-5 years
2 515 84.66 -- <LOD <LOD <LOD 4.7E
(3.0 - 6.4)
6-11 years
2 509 79.17 -- <LOD <LOD <LOD 3.8E
(2.2 - 5.3)
12-19 years
2 508 72.64 -- <LOD <LOD 1.1
(<LOD - 1.4)
4.4E
(2.1 - 6.6)
20-39 years
2 353 70.25 -- <LOD <LOD 1.5E
(<LOD - 2.1)
4.3E
(<LOD - 7.1)
40-59 years
2 354 70.90 -- <LOD <LOD <LOD
(<LOD - 2.1)
3.9
(2.8 - 5.0)
60-79 years
2 288 73.26 -- <LOD <LOD 1.9E
(<LOD - 3.0)
F
           
 
Table 8.2.2.4: Arsenous acid (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a16 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a16 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a16 footnotes

Table a16 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a16 footnote a referrer

Table a16 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a16 footnote b referrer

Males, Total 3-79 years
2 1267 72.77 -- <LOD <LOD 1.5
(<LOD - 1.7)
3.7E
(1.4 - 6.0)
Males, 6-11 years
2 259 77.22 -- <LOD <LOD <LOD 3.7
(2.5 - 5.0)
Males, 12-19 years
2 254 71.26 -- <LOD <LOD 1.0E
(<LOD - 1.4)
F
Males, 20-39 years
2 166 63.25 -- <LOD <LOD 1.3E
(<LOD - 1.9)
X
Males, 40-59 years
2 193 63.21 -- <LOD <LOD 1.7
(<LOD - 2.1)
X
Males, 60-79 years
2 141 69.50 -- <LOD <LOD 1.5
(<LOD - 1.9)
X
Females, Total 3-79 years
2 1260 79.05 -- <LOD <LOD <LOD 5.0
(3.3 - 6.6)
Females, 6-11 years
2 250 81.20 -- <LOD <LOD <LOD 4.0E
(1.7 - 6.2)
Females, 12-19 years
2 254 74.02 -- <LOD <LOD 1.4
(<LOD - 1.8)
4.9E
(<LOD - 7.5)
Females, 20-39 years
2 187 76.47 -- <LOD <LOD <LOD X
Females, 40-59 years
2 161 80.12 -- <LOD <LOD <LOD X
Females, 60-79 years
2 147 76.87 -- <LOD <LOD <LOD
(<LOD - 4.3)
X
           
 
Table 8.2.3.1: Arsenic acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a17 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a17 footnotes

Table a17 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a17 footnote a referrer

Total, 3-79 years
2 2538 99.49 -- <LOD <LOD <LOD <LOD
3-5 years
2 516 98.84 -- <LOD <LOD <LOD <LOD
6-11 years
2 511 99.61 -- <LOD <LOD <LOD <LOD
12-19 years
2 510 99.41 -- <LOD <LOD <LOD <LOD
20-39 years
2 355 99.44 -- <LOD <LOD <LOD <LOD
40-59 years
2 357 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 289 100 -- <LOD <LOD <LOD <LOD
           
 
Table 8.2.3.2: Arsenic acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a18 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a18 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a18 footnotes

Table a18 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a18 footnote a referrer

Table a18 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a18 footnote b referrer

Males, Total 3-79 years
2 1271 99.37 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 260 99.23 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 255 99.22 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 167 98.80 -- <LOD <LOD <LOD X
Males, 40-59 years
2 193 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 141 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1267 99.61 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 251 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 255 99.61 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 188 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 164 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 148 100 -- <LOD <LOD <LOD X
 
Table 8.2.3.3: Arsenic acid (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a19 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a19 footnotes

Table a19 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a19 footnote a referrer

Total, 3-79 years
2 2528 99.88 -- <LOD <LOD <LOD <LOD
3-5 years
2 515 99.03 -- <LOD <LOD <LOD <LOD
6-11 years
2 509 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 508 99.80 -- <LOD <LOD <LOD <LOD
20-39 years
2 353 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 355 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 288 100 -- <LOD <LOD <LOD <LOD
 
Table 8.2.3.4: Arsenic acid (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a20 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a20 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a20 footnotes

Table a20 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a20 footnote a referrer

Table a20 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a20 footnote b referrer

Males, Total 3-79 years
2 1267 99.68 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 259 99.61 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 254 99.61 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 166 99.40 -- <LOD <LOD <LOD X
Males, 40-59 years
2 193 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 141 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1261 100 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 250 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 254 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 187 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 162 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 147 100 -- <LOD <LOD <LOD X
 
Table 8.2.4.1: Monomethylarsonic acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a21 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a21 footnotes

Table a21 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a21 footnote a referrer

Total, 3-79 years
2 2538 73.01 -- <LOD <LOD 1.4E
(<LOD - 1.9)
3.0
(2.3 - 3.7)
3-5 years
2 516 77.91 -- <LOD <LOD <LOD 2.5
(2.1 - 2.9)
6-11 years
2 511 76.52 -- <LOD <LOD <LODE
(<LOD - 1.3)
3.0
(2.1 - 3.9)
12-19 years
2 510 62.94 -- <LOD <LOD 1.7
(1.1 - 2.2)
3.2
(2.2 - 4.2)
20-39 years
2 355 70.14 -- <LOD <LOD 1.7
(1.3 - 2.1)
3.3E
(1.8 - 4.7)
40-59 years
2 357 71.43 -- <LOD <LOD 1.3E
(<LOD - 1.8)
2.7
(1.7 - 3.6)
60-79 years
2 289 81.31 -- <LOD <LOD <LOD 2.6E
(1.4 - 3.8)
           
 
Table 8.2.4.2: Monomethylarsonic acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a22 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a22 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a22 footnotes

Table a22 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a22 footnote a referrer

Table a22 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a22 footnote b referrer

Males, Total 3-79 years
2 1271 69.63 -- <LOD <LOD 1.5
(1.2 - 1.9)
3.4
(2.4 - 4.4)
Males, 6-11 years
2 260 80.77 -- <LOD <LOD <LOD 3.4E
(1.7 - 5.0)
Males, 12-19 years
2 255 58.82 -- <LOD <LOD 1.6
(1.1 - 2.2)
3.3E
(2.0 - 4.6)
Males, 20-39 years
2 167 61.68 -- <LOD <LOD 2.0
(1.6 - 2.3)
X
Males, 40-59 years
2 193 62.18 -- <LOD <LOD 1.5E
(<LOD - 2.2)
X
Males, 60-79 years
2 141 77.30 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1267 76.40 -- <LOD <LOD <LOD 2.5
(2.0 - 2.9)
Females, 6-11 years
2 251 72.11 -- <LOD <LOD 1.4
(1.1 - 1.8)
3.0
(2.1 - 3.8)
Females, 12-19 years
2 255 67.06 -- <LOD <LOD 1.7
(1.1 - 2.3)
3.2E
(1.8 - 4.5)
Females, 20-39 years
2 188 77.66 -- <LOD <LOD <LOD X
Females, 40-59 years
2 164 82.32 -- <LOD <LOD <LOD X
Females, 60-79 years
2 148 85.14 -- <LOD <LOD <LOD X
 
Table 8.2.4.1: Monomethylarsonic acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a23 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a23 footnotes

Table a23 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a23 footnote a referrer

Total, 3-79 years
2 2528 73.30 -- <LOD <LOD 1.5
(<LOD - 1.7)
3.4
(2.6 - 4.2)
3-5 years
2 515 78.06 -- <LOD <LOD <LOD 5.0
(3.7 - 6.2)
6-11 years
2 509 76.82 -- <LOD <LOD <LOD
(<LOD - 2.0)
3.3
(2.7 - 3.9)
12-19 years
2 508 63.19 -- <LOD <LOD 1.1
(0.88 - 1.4)
2.6E
(1.5 - 3.7)
20-39 years
2 353 70.54 -- <LOD <LOD 1.4
(1.1 - 1.8)
3.3E
(1.7 - 5.0)
40-59 years
2 355 71.83 -- <LOD <LOD 1.3
(<LOD - 1.6)
3.2
(2.1 - 4.4)
60-79 years
2 288 81.60 -- <LOD <LOD <LOD 3.6
(2.5 - 4.7)
 
Table 8.2.4.4: Monomethylarsonic acid (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a24 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a24 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a24 footnotes

Table a24 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a24 footnote a referrer

Table a24 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a24 footnote b referrer

Males, Total 3-79 years
2 1267 69.85 -- <LOD <LOD 1.3
(1.2 - 1.5)
2.9
(2.0 - 3.8)
Males, 6-11 years
2 259 81.08 -- <LOD <LOD <LOD 3.4
(2.5 - 4.2)
Males, 12-19 years
2 254 59.06 -- <LOD <LOD 1.0
(0.77 - 1.3)
2.2
(1.7 - 2.7)
Males, 20-39 years
2 166 62.05 -- <LOD <LOD 1.3
(0.93 - 1.7)
X
Males, 40-59 years
2 193 62.18 -- <LOD <LOD 1.3
(<LOD - 1.7)
X
Males, 60-79 years
2 141 77.30 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1261 76.76 -- <LOD <LOD <LOD 4.0
(3.2 - 4.9)
Females, 6-11 years
2 250 72.40 -- <LOD <LOD 1.7
(1.5 - 2.0)
3.3
(2.2 - 4.4)
Females, 12-19 years
2 254 67.32 -- <LOD <LOD 1.4
(1.1 - 1.7)
3.5E
(1.7 - 5.3)
Females, 20-39 years
2 187 78.07 -- <LOD <LOD <LOD X
Females, 40-59 years
2 162 83.33 -- <LOD <LOD <LOD X
Females, 60-79 years
2 147 85.71 -- <LOD <LOD <LOD X
 
Table 8.2.5.1: Dimethylarsinic acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a25 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a25 footnotes

Table a25 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a25 footnote a referrer

Total, 3-79 years
2 2538 3.78 6.5
(5.6 - 7.5)
1.9
(1.7 - 2.2)
6.6
(5.6 - 7.5)
11
(9.0 - 14)
30E
(13 - 47)
3-5 years
2 516 3.68 6.8
(5.8 - 7.9)
2.6
(2.2 - 3.1)
6.4
(5.6 - 7.3)
12
(9.6 - 14)
24E
(14 - 34)
6-11 years
2 511 2.74 7.2
(6.5 - 8.1)
2.7
(2.2 - 3.2)
7.6
(6.5 - 8.7)
12
(10 - 13)
26E
(15 - 37)
12-19 years
2 510 2.75 6.7
(5.3 - 8.5)
2.2
(1.4 - 2.9)
6.4
(4.7 - 8.2)
12
(8.2 - 15)
32E
(17 - 47)
20-39 years
2 355 5.63 6.8
(5.4 - 8.5)
1.9
(1.4 - 2.5)
7.2
(5.5 - 8.8)
12
(8.2 - 17)
40E
(20 - 60)
40-59 years
2 357 5.32 5.9
(4.8 - 7.2)
1.7E
(<LOD - 2.5)
5.8
(4.6 - 7.0)
10
(7.7 - 13)
22
(16 - 28)
60-79 years
2 289 3.46 6.7
(5.3 - 8.4)
1.9
(1.5 - 2.4)
6.6
(5.4 - 7.8)
13E
(8.2 - 18)
38E
(13 - 63)
 
Table 8.2.5.2: Dimethylarsinic acid -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a26 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a26 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a26 footnotes

Table a26 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a26 footnote a referrer

Table a26 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a26 footnote b referrer

Males, Total 3-79 years
2 1271 3.15 6.7
(5.7 - 8.0)
2.0
(1.4 - 2.6)
6.7
(5.1 - 8.3)
13
(9.8 - 15)
30E
(15 - 45)
Males, 6-11 years
2 260 3.46 7.3
(6.1 - 8.8)
2.9
(2.4 - 3.5)
8.1
(6.1 - 10)
10
(8.7 - 12)
24E
(11 - 38)
Males, 12-19 years
2 255 1.18 6.6
(5.3 - 8.2)
2.4
(1.6 - 3.2)
6.1
(4.5 - 7.6)
10
(7.0 - 13)
28E
(13 - 43)
Males, 20-39 years
2 167 4.79 7.1E
(4.7 - 11)
F 7.8
(5.0 - 11)
13E
(3.8 - 22)
X
Males, 40-59 years
2 193 3.11 6.1
(4.6 - 8.2)
1.7E
(<LOD - 2.7)
6.1E
(3.2 - 8.9)
12
(8.1 - 16)
X
Males, 60-79 years
2 141 2.84 7.2
(5.2 - 9.9)
2.3E
(1.4 - 3.3)
6.9
(4.6 - 9.2)
13
(8.6 - 18)
X
Females, Total 3-79 years
2 1267 4.42 6.2
(5.3 - 7.3)
1.9
(1.4 - 2.4)
6.4
(5.6 - 7.3)
10
(8.0 - 13)
33E
(14 - 53)
Females, 6-11 years
2 251 1.99 7.1
(6.1 - 8.4)
2.3
(1.5 - 3.1)
7.5
(6.5 - 8.5)
13
(11 - 15)
28E
(16 - 39)
Females, 12-19 years
2 255 4.31 6.9
(5.1 - 9.4)
2.0E
(<LOD - 3.4)
7.3
(5.2 - 9.3)
14
(9.1 - 18)
33E
(18 - 48)
Females, 20-39 years
2 188 6.38 6.4
(4.8 - 8.7)
2.0
(1.5 - 2.5)
6.7
(4.8 - 8.6)
9.9E
(5.8 - 14)
X
Females, 40-59 years
2 164 7.93 5.7
(4.4 - 7.2)
F 5.7
(4.4 - 7.0)
9.5
(7.0 - 12)
X
Females, 60-79 years
2 148 4.05 6.2
(4.6 - 8.5)
1.6E
(1.0 - 2.2)
5.8E
(3.6 - 8.0)
11E
(4.3 - 18)
X
 
Table 8.2.5.3: Dimethylarsinic acid (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a27 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a27 footnotes

Table a27 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a27 footnote a referrer

Total, 3-79 years
2 2528 3.80 6.4
(5.6 - 7.4)
2.7
(2.4 - 3.0)
5.8
(5.0 - 6.5)
10
(8.3 - 12)
29E
(18 - 39)
3-5 years
2 515 3.69 12
(10 - 13)
5.5
(4.8 - 6.1)
10
(8.7 - 12)
16
(13 - 19)
44E
(19 - 68)
6-11 years
2 509 2.75 8.4
(7.5 - 9.3)
4.0
(3.7 - 4.4)
8.0
(7.2 - 8.8)
12
(9.8 - 14)
34E
(20 - 47)
12-19 years
2 508 2.76 5.2
(4.2 - 6.4)
2.1
(1.6 - 2.6)
4.6
(3.5 - 5.6)
7.7
(5.6 - 9.9)
26E
(15 - 36)
20-39 years
2 353 5.67 5.8
(4.6 - 7.2)
2.4
(2.1 - 2.8)
4.9
(3.6 - 6.2)
9.4
(6.5 - 12)
29E
(15 - 44)
40-59 years
2 355 5.35 6.0
(5.3 - 6.8)
2.9
(<LOD - 3.3)
5.6
(5.0 - 6.2)
8.6
(7.1 - 10)
20E
(12 - 29)
60-79 years
2 288 3.47 7.8
(6.3 - 9.8)
2.7
(2.2 - 3.2)
7.6
(5.8 - 9.3)
13
(9.6 - 16)
F
 
Table 8.2.5.4: Dimethylarsinic acid (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a28 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a28 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a28 footnotes

Table a28 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a28 footnote a referrer

Table a28 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a28 footnote b referrer

Males, Total 3-79 years
2 1267 3.16 5.8
(4.9 - 6.7)
2.5
(2.1 - 2.9)
5.3
(4.5 - 6.2)
8.9
(7.4 - 10)
22E
(12 - 32)
Males, 6-11 years
2 259 3.47 8.4
(7.2 - 9.7)
4.3
(3.4 - 5.2)
8.0
(7.2 - 8.8)
12
(8.8 - 15)
27E
(15 - 40)
Males, 12-19 years
2 254 1.18 4.7
(3.8 - 5.8)
2.1
(1.7 - 2.4)
4.0
(3.1 - 4.9)
6.6
(4.9 - 8.2)
24E
(13 - 35)
Males, 20-39 years
2 166 4.82 5.2
(3.6 - 7.3)
1.9E
(<LOD - 2.9)
4.4E
(2.0 - 6.9)
8.8E
(5.5 - 12)
X
Males, 40-59 years
2 193 3.11 5.4
(4.5 - 6.3)
2.8
(<LOD - 3.3)
5.0
(4.1 - 5.8)
7.4
(6.0 - 8.7)
X
Males, 60-79 years
2 141 2.84 6.8
(5.2 - 8.9)
2.6
(1.8 - 3.5)
6.0
(4.0 - 8.0)
10
(8.2 - 12)
X
Females, Total 3-79 years
2 1261 4.44 7.1
(6.1 - 8.4)
2.9
(2.6 - 3.2)
6.3
(5.4 - 7.2)
12
(9.4 - 15)
34E
(21 - 46)
Females, 6-11 years
2 250 2.00 8.4
(7.3 - 9.6)
4.0
(3.4 - 4.5)
7.5
(6.4 - 8.7)
12
(8.9 - 14)
35E
(21 - 49)
Females, 12-19 years
2 254 4.33 5.7
(4.5 - 7.4)
2.3
(<LOD - 3.1)
5.2
(3.9 - 6.5)
8.9
(6.2 - 12)
28E
(15 - 41)
Females, 20-39 years
2 187 6.42 6.5
(5.0 - 8.4)
2.7
(2.3 - 3.2)
5.0
(3.9 - 6.1)
10E
(4.7 - 15)
X
Females, 40-59 years
2 162 8.02 6.8
(5.8 - 7.9)
2.9
(<LOD - 3.6)
6.3
(5.4 - 7.2)
10
(8.1 - 12)
X
Females, 60-79 years
2 147 4.08 8.9
(6.8 - 12)
2.7
(2.0 - 3.4)
8.5E
(5.1 - 12)
15
(9.7 - 20)
X
 
Table 8.2.6.1: Arsenocholine and arsenobetaine -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a29 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a29 footnotes

Table a29 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a29 footnote a referrer

Total, 3-79 years
2 2538 48.50 -- <LOD 3.4E
(<LOD - 5.2)
16E
(8.7 - 23)
110E
(70 - 160)
3-5 years
2 516 59.69 -- <LOD <LOD 6.9E
(2.0 - 12)
82E
(47 - 120)
6-11 years
2 511 58.12 -- <LOD <LOD 6.5E
(3.3 - 9.7)
F
12-19 years
2 510 57.65 -- <LOD <LOD F 89E
(38 - 140)
20-39 years
2 355 38.59 5.3E
(3.4 - 8.4)
<LOD F F F
40-59 years
2 357 30.81 4.3
(3.2 - 5.7)
<LOD 3.5E
(<LOD - 5.9)
12E
(6.1 - 17)
85E
(45 - 130)
60-79 years
2 289 29.41 8.5E
(5.2 - 14)
<LOD 8.5E
(3.4 - 14)
37E
(18 - 55)
180E
(78 - 270)
 
Table 8.2.6.2: Arsenocholine and arsenobetaine -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a30 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a30 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a30 footnotes

Table a30 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a30 footnote a referrer

Table a30 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a30 footnote b referrer

Males, Total 3-79 years
2 1271 46.34 -- <LOD 3.7E
(<LOD - 5.9)
18E
(8.1 - 27)
F
Males, 6-11 years
2 260 59.23 -- <LOD <LOD F 49E
(30 - 68)
Males, 12-19 years
2 255 53.73 -- <LOD <LOD F 88E
(26 - 150)
Males, 20-39 years
2 167 35.33 F <LOD F F X
Males, 40-59 years
2 193 26.94 4.9E
(3.2 - 7.6)
<LOD F F X
Males, 60-79 years
2 141 26.24 9.8E
(5.3 - 18)
<LOD F 35E
(17 - 54)
X
Females, Total 3-79 years
2 1267 50.67 -- <LOD F 14E
(7.7 - 21)
120E
(69 - 170)
Females, 6-11 years
2 251 56.97 -- <LOD <LOD F F
Females, 12-19 years
2 255 61.57 -- <LOD <LOD F F
Females, 20-39 years
2 188 41.49 -- <LOD F F X
Females, 40-59 years
2 164 35.37 3.7
(2.7 - 5.1)
<LOD F 12E
(5.4 - 19)
X
Females, 60-79 years
2 148 32.43 7.5E
(3.8 - 15)
<LOD F F X
 
Table 8.2.6.3: Arsenocholine and arsenobetaine (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a31 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a31 footnotes

Table a31 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a31 footnote a referrer

Total, 3-79 years
2 2528 48.69 -- <LOD 3.6E
(<LOD - 5.7)
17
(11 - 22)
110E
(43 - 170)
3-5 years
2 515 59.81 -- <LOD <LOD 12E
(5.5 - 19)
F
6-11 years
2 509 58.35 -- <LOD <LOD 7.1E
(2.4 - 12)
F
12-19 years
2 508 57.87 -- <LOD <LOD 5.7E
(<LOD - 9.2)
58E
(25 - 92)
20-39 years
2 353 38.81 4.4E
(2.8 - 6.8)
<LOD F 17E
(6.9 - 26)
F
40-59 years
2 355 30.99 4.4
(3.2 - 6.0)
<LOD F 13E
(6.5 - 19)
57E
(21 - 94)
60-79 years
2 288 29.51 10E
(6.1 - 16)
<LOD 11E
(4.3 - 18)
43E
(23 - 63)
200E
(100 - 290)
 
Table 8.2.6.4: Arsenocholine and arsenobetaine (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a32 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a32 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a32 footnotes

Table a32 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a32 footnote a referrer

Table a32 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a32 footnote b referrer

Males, Total 3-79 years
2 1267 46.49 -- <LOD 3.0E
(<LOD - 5.0)
14E
(8.2 - 21)
F
Males, 6-11 years
2 259 59.46 -- <LOD <LOD F 54E
(28 - 81)
Males, 12-19 years
2 254 53.94 -- <LOD <LOD 6.4E
(<LOD - 10)
82E
(31 - 130)
Males, 20-39 years
2 166 35.54 3.5E
(1.7 - 7.0)
<LOD F 17E
(<LOD - 26)
X
Males, 40-59 years
2 193 26.94 4.3E
(2.7 - 6.8)
<LOD F 10E
(<LOD - 16)
X
Males, 60-79 years
2 141 26.24 9.3E
(5.0 - 17)
<LOD F 36E
(20 - 53)
X
Females, Total 3-79 years
2 1261 50.91 -- <LOD 4.1E
(<LOD - 6.9)
18E
(12 - 25)
150E
(48 - 240)
Females, 6-11 years
2 250 57.20 -- <LOD <LOD 9.4E
(<LOD - 14)
F
Females, 12-19 years
2 254 61.81 -- <LOD <LOD F F
Females, 20-39 years
2 187 41.71 -- <LOD 5.0E
(<LOD - 7.9)
F X
Females, 40-59 years
2 162 35.80 4.5E
(2.9 - 6.9)
<LOD <LOD
(<LOD - 7.7)
18E
(10 - 26)
X
Females, 60-79 years
2 147 32.65 11E
(5.7 - 20)
<LOD F 50E
(<LOD - 76)
X
 
Table 8.3.1: Cadmium -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 6-79 years Table a33 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a33 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a33 footnotes

Table a33 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a33 footnote a referrer

Table a33 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a33 footnote b referrer

Total, 6-79 years
1 5319 2.91 0.34
(0.31 - 0.37)
0.091
(0.087 - 0.094)
0.27
(0.25 - 0.29)
0.62
(0.55 - 0.70)
3.6
(3.1 - 4.1)
2 5575 4.27 0.31
(0.28 - 0.34)
0.088
(0.077 - 0.099)
0.27
(0.25 - 0.30)
0.57
(0.51 - 0.63)
2.6
(2.1 - 3.1)
Males, 6-79 years
1 2576 3.34 0.30
(0.27 - 0.34)
0.084
(0.073 - 0.095)
0.22
(0.20 - 0.25)
0.58
(0.43 - 0.72)
3.4
(2.8 - 4.0)
2 2687 4.84 0.28
(0.25 - 0.31)
0.083
(0.071 - 0.094)
0.24
(0.22 - 0.26)
0.54
(0.48 - 0.60)
2.5
(1.9 - 3.0)
Females, 6-79 years
1 2743 2.52 0.38
(0.35 - 0.41)
0.093
(0.091 - 0.095)
0.32
(0.29 - 0.36)
0.65
(0.56 - 0.74)
3.7
(3.1 - 4.3)
2 2888 3.74 0.34
(0.29 - 0.38)
0.095
(0.084 - 0.11)
0.31
(0.28 - 0.34)
0.59
(0.45 - 0.73)
2.7
(2.1 - 3.4)
c Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).
 
Table 8.3.2: Cadmium -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a34 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a34 footnotes

Table a34 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a34 footnote a referrer

Table a34 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a34 footnote b referrer

Total, 3-79 years
1Table a34 footnote b . . . . . . .
2 6070 5.16 0.29
(0.27 - 0.32)
0.083
(0.071 - 0.094)
0.26
(0.24 - 0.29)
0.54
(0.49 - 0.59)
2.6
(2.1 - 3.0)
3-5 years
1Table a34 footnote b . . . . . . .
2 495 15.15 0.075
(0.067 - 0.084)
<LOD 0.076
(0.066 - 0.087)
0.10
(0.096 - 0.11)
0.14E
(0.041 - 0.24)
6-11 years
1 910 9.12 0.091
(0.082 - 0.10)
<LODE
(<LOD - 0.053)
0.092
(0.090 - 0.094)
0.098
(0.084 - 0.11)
0.22
(0.19 - 0.26)
2 961 14.05 0.086
(0.079 - 0.094)
<LOD 0.090
(0.084 - 0.097)
0.11
(0.11 - 0.11)
0.20
(0.18 - 0.23)
12-19 years
1 945 3.92 0.16
(0.13 - 0.20)
0.066
(0.045 - 0.086)
F 0.21
(0.19 - 0.23)
F
2 997 5.72 0.14
(0.12 - 0.16)
0.059
(0.042 - 0.075)
0.11
(0.10 - 0.11)
0.19
(0.17 - 0.21)
0.82E
(0.42 - 1.2)
20-39 years
1 1165 1.55 0.34
(0.30 - 0.38)
0.091
(0.084 - 0.098)
0.24
(0.21 - 0.27)
0.68
(0.43 - 0.92)
3.4
(3.1 - 3.7)
2 1313 2.21 0.29
(0.24 - 0.35)
0.093
(0.062 - 0.12)
0.24
(0.20 - 0.28)
0.53E
(0.33 - 0.74)
2.7
(2.1 - 3.2)
40-59 years
1 1220 0.90 0.48
(0.43 - 0.54)
0.098E
(0.049 - 0.15)
0.36
(0.32 - 0.41)
0.98
(0.73 - 1.2)
4.2
(3.7 - 4.7)
2 1222 0.98 0.42
(0.37 - 0.47)
0.11
(0.10 - 0.11)
0.34
(0.31 - 0.37)
0.78
(0.52 - 1.0)
3.1
(2.4 - 3.8)
60-79 years
1 1079 0.56 0.45
(0.41 - 0.49)
0.19
(0.18 - 0.20)
0.39
(0.37 - 0.41)
0.71
(0.59 - 0.82)
2.7
(2.2 - 3.2)
2 1082 0.46 0.46
(0.41 - 0.51)
0.18
(0.13 - 0.22)
0.40
(0.35 - 0.44)
0.72
(0.63 - 0.81)
2.3
(1.9 - 2.8)
 
Table 8.3.3: Cadmium -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a35 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a35 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a35 footnotes

Table a35 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a35 footnote a referrer

Table a35 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a35 footnote b referrer

Table a35 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a35 footnote c referrer

Males, Total 3-79 years
1Table a35 footnote c . . . . . . .
2 2940 5.78 0.27
(0.24 - 0.30)
0.078
(0.067 - 0.088)
0.23
(0.21 - 0.25)
0.53
(0.46 - 0.60)
2.4
(1.9 - 2.9)
Males, 6-11 years
1 459 9.59 0.088
(0.079 - 0.098)
<LOD 0.091
(0.088 - 0.094)
0.098
(0.074 - 0.12)
0.21
(0.15 - 0.27)
2 488 13.11 0.086
(0.077 - 0.096)
<LOD 0.089
(0.082 - 0.096)
0.11
(0.10 - 0.11)
0.21
(0.15 - 0.26)
Males, 12-19 years
1 489 3.48 0.16
(0.13 - 0.19)
0.058E
(<LOD - 0.080)
0.098E
(0.047 - 0.15)
0.20
(0.18 - 0.22)
F
2 523 7.07 0.15
(0.12 - 0.18)
0.062
(0.044 - 0.081)
0.11
(0.10 - 0.11)
0.20
(0.14 - 0.25)
F
Males, 20-39 years
1 514 2.14 0.32
(0.26 - 0.40)
0.083
(0.061 - 0.11)
0.21
(0.16 - 0.25)
0.77E
(0.41 - 1.1)
3.6
(3.1 - 4.1)
2 552 3.08 0.26
(0.21 - 0.31)
0.081
(0.056 - 0.11)
0.20
(0.14 - 0.26)
0.50E
(0.29 - 0.71)
2.7E
(1.6 - 3.8)
Males, 40-59 years
1 577 1.73 0.40
(0.32 - 0.49)
0.094
(0.090 - 0.098)
0.28
(0.24 - 0.31)
0.85E
(0.36 - 1.4)
3.9
(2.9 - 4.9)
2 617 1.46 0.38
(0.33 - 0.44)
0.10
(0.10 - 0.11)
0.31
(0.26 - 0.35)
0.84E
(0.40 - 1.3)
2.9
(2.2 - 3.5)
Males, 60-79 years
1 537 0.74 0.41
(0.35 - 0.48)
0.18
(0.13 - 0.23)
0.35
(0.31 - 0.39)
0.66
(0.43 - 0.89)
2.7
(1.8 - 3.6)
2 507 0.59 0.42
(0.37 - 0.49)
0.15E
(0.084 - 0.21)
0.37
(0.32 - 0.41)
0.69
(0.59 - 0.78)
2.3
(1.5 - 3.0)
Females, Total 3-79 years
1Table a35 footnote c . . . . . . .
2 3130 4.57 0.32
(0.28 - 0.37)
0.089
(0.076 - 0.10)
0.30
(0.27 - 0.33)
0.57
(0.45 - 0.69)
2.7
(2.1 - 3.4)
Females, 6-11 years
1 451 8.65 0.094
(0.083 - 0.11)
0.040E
(<LOD - 0.068)
0.093
(0.091 - 0.095)
0.099
(0.075 - 0.12)
0.23
(0.19 - 0.26)
2 473 15.01 0.086
(0.077 - 0.096)
<LOD 0.093
(0.083 - 0.10)
0.11
(0.11 - 0.11)
0.20
(0.17 - 0.24)
Females, 12-19 years
1 456 4.39 0.17
(0.14 - 0.21)
0.080
(0.065 - 0.095)
0.18E
(0.095 - 0.26)
0.22
(0.19 - 0.26)
F
2 474 4.22 0.13
(0.12 - 0.15)
0.053E
(<LOD - 0.073)
0.11
(0.10 - 0.11)
0.19
(0.16 - 0.21)
0.68E
(0.31 - 1.1)
Females, 20-39 years
1 651 1.08 0.36
(0.31 - 0.41)
0.093
(0.091 - 0.095)
0.27
(0.22 - 0.32)
0.63
(0.46 - 0.80)
3.2
(2.7 - 3.7)
2 761 1.58 0.33
(0.25 - 0.44)
0.10
(0.068 - 0.14)
0.28
(0.21 - 0.36)
F 2.6E
(1.7 - 3.6)
Females, 40-59 years
1 643 0.16 0.58
(0.51 - 0.66)
0.19
(0.17 - 0.22)
0.43
(0.37 - 0.50)
1.1E
(0.61 - 1.5)
4.4
(4.0 - 4.8)
2 605 0.50 0.47
(0.38 - 0.56)
F 0.38
(0.34 - 0.43)
0.76E
(0.46 - 1.1)
3.3
(2.5 - 4.2)
Females, 60-79 years
1 542 0.37 0.49
(0.44 - 0.56)
0.20
(0.18 - 0.21)
0.42
(0.37 - 0.48)
0.75
(0.64 - 0.86)
2.7
(1.9 - 3.5)
2 575 0.35 0.49
(0.45 - 0.54)
0.20
(0.16 - 0.25)
0.43
(0.39 - 0.47)
0.77
(0.66 - 0.88)
2.6
(2.0 - 3.1)
 
Table 8.3.4: Cadmium -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a36 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a36 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a36 footnotes

Table a36 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a36 footnote a referrer

Table a36 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a36 footnote b referrer

Total, 6-79 years
1 5491 9.71 0.34
(0.31 - 0.38)
<LODE
(<LOD - 0.11)
0.37
(0.34 - 0.41)
0.67
(0.62 - 0.72)
1.6
(1.5 - 1.7)
2 5738 6.12 0.40
(0.36 - 0.44)
0.10
(0.093 - 0.11)
0.42
(0.36 - 0.48)
0.77
(0.68 - 0.85)
1.9
(1.6 - 2.1)
Males, 6-79 years
1 2661 8.27 0.36
(0.33 - 0.39)
0.091
(<LOD - 0.11)
0.39
(0.36 - 0.43)
0.68
(0.63 - 0.74)
1.6
(1.4 - 1.7)
2 2746 5.35 0.39
(0.34 - 0.45)
0.10
(0.087 - 0.12)
0.41
(0.35 - 0.48)
0.76
(0.63 - 0.89)
1.6
(1.3 - 1.9)
Females, 6-79 years
1 2830 11.06 0.33
(0.29 - 0.37)
<LOD 0.36
(0.33 - 0.39)
0.66
(0.60 - 0.72)
1.7
(1.5 - 1.9)
2 2992 6.82 0.40
(0.37 - 0.44)
0.10
(0.094 - 0.11)
0.42
(0.36 - 0.48)
0.77
(0.70 - 0.84)
2.0
(1.6 - 2.4)
 
Table 8.3.5: Cadmium -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a37 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a37 footnotes

Table a37 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a37 footnote a referrer

Table a37 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a37 footnote b referrer

Total, 3-79 years
1Table a37 footnote b . . . . . . .
2 6311 6.56 0.39
(0.35 - 0.44)
0.10
(0.091 - 0.11)
0.41
(0.35 - 0.47)
0.75
(0.66 - 0.84)
1.8
(1.6 - 2.0)
3-5 years
1Table a37 footnote b . . . . . . .
2 573 10.99 0.23
(0.19 - 0.28)
<LOD 0.25
(0.21 - 0.30)
0.40
(0.33 - 0.47)
F
6-11 years
1 1033 14.71 0.22
(0.18 - 0.25)
<LOD 0.25
(0.20 - 0.29)
0.42
(0.37 - 0.46)
0.72
(0.60 - 0.85)
2 1062 9.70 0.25
(0.21 - 0.30)
0.076
(<LOD - 0.095)
0.27
(0.21 - 0.32)
0.43
(0.33 - 0.54)
0.86
(0.64 - 1.1)
12-19 years
1 983 10.48 0.27
(0.23 - 0.31)
<LOD 0.32
(0.28 - 0.36)
0.48
(0.42 - 0.53)
0.89
(0.66 - 1.1)
2 1041 7.59 0.27
(0.22 - 0.32)
0.090
(<LOD - 0.12)
0.30
(0.24 - 0.36)
0.47
(0.38 - 0.56)
0.81
(0.68 - 0.94)
20-39 years
1 1169 13.17 0.27
(0.25 - 0.31)
<LOD 0.31
(0.27 - 0.36)
0.54
(0.49 - 0.59)
1.1
(0.99 - 1.3)
2 1321 7.12 0.34
(0.29 - 0.39)
0.087E
(<LOD - 0.12)
0.36
(0.30 - 0.43)
0.66
(0.53 - 0.79)
1.2
(1.0 - 1.4)
40-59 years
1 1223 7.36 0.42
(0.38 - 0.46)
0.093
(<LOD - 0.10)
0.45
(0.40 - 0.51)
0.81
(0.74 - 0.87)
2.1
(1.7 - 2.4)
2 1228 4.64 0.50
(0.44 - 0.56)
0.11
(0.095 - 0.12)
0.53
(0.44 - 0.62)
0.98
(0.84 - 1.1)
2.5
(2.0 - 3.0)
60-79 years
1 1083 3.14 0.50
(0.44 - 0.56)
0.099
(<LOD - 0.13)
0.51
(0.46 - 0.56)
0.98
(0.89 - 1.1)
2.2
(1.9 - 2.6)
2 1086 1.66 0.54
(0.47 - 0.62)
0.11
(0.091 - 0.13)
0.58
(0.50 - 0.65)
1.0
(0.93 - 1.1)
2.5
(2.0 - 2.9)
 
Table 8.3.6: Cadmium -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a38 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a38 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a38 footnotes

Table a38 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a38 footnote a referrer

Table a38 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a38 footnote b referrer

Table a38 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a38 footnote c referrer

Males, Total 3-79 years
1Table a38 footnote c . . . . . . .
2 3036 5.67 0.39
(0.34 - 0.45)
0.10
(0.085 - 0.12)
0.41
(0.34 - 0.47)
0.74
(0.61 - 0.86)
1.6
(1.3 - 1.8)
Males, 6-11 years
1 523 13.00 0.22
(0.18 - 0.27)
<LOD 0.25
(0.18 - 0.33)
0.42
(0.36 - 0.47)
0.71
(0.59 - 0.83)
2 532 7.52 0.27
(0.21 - 0.35)
0.089
(<LOD - 0.11)
0.29
(0.22 - 0.37)
0.47
(0.30 - 0.63)
0.95
(0.68 - 1.2)
Males, 12-19 years
1 505 8.12 0.27
(0.24 - 0.31)
0.091E
(<LOD - 0.13)
0.31
(0.27 - 0.35)
0.45
(0.39 - 0.51)
0.77
(0.55 - 0.98)
2 542 6.09 0.29
(0.23 - 0.37)
0.10
(0.084 - 0.12)
0.31
(0.24 - 0.39)
0.48
(0.34 - 0.62)
0.85
(0.68 - 1.0)
Males, 20-39 years
1 514 11.87 0.28
(0.24 - 0.32)
<LOD 0.33
(0.28 - 0.38)
0.54
(0.46 - 0.62)
1.1
(0.97 - 1.2)
2 551 6.53 0.32
(0.27 - 0.39)
0.074E
(<LOD - 0.11)
0.35
(0.27 - 0.43)
0.65
(0.47 - 0.83)
1.3E
(0.81 - 1.9)
Males, 40-59 years
1 578 6.57 0.43
(0.38 - 0.49)
0.094
(<LOD - 0.11)
0.48
(0.42 - 0.55)
0.81
(0.71 - 0.92)
1.9
(1.5 - 2.3)
2 616 5.36 0.48
(0.41 - 0.57)
0.11E
(<LOD - 0.16)
0.57
(0.46 - 0.68)
1.0
(0.78 - 1.2)
1.8
(1.2 - 2.4)
Males, 60-79 years
1 541 2.22 0.56
(0.50 - 0.64)
0.15E
(0.094 - 0.21)
0.58
(0.52 - 0.64)
1.0
(0.87 - 1.1)
2.3
(1.7 - 2.8)
2 505 0.99 0.54
(0.44 - 0.66)
0.11E
(<LOD - 0.16)
0.55
(0.42 - 0.67)
1.0
(0.82 - 1.2)
2.4
(1.7 - 3.1)
Females, Total 3-79 years
1Table a38 footnote c . . . . . . .
2 3275 7.39 0.39
(0.36 - 0.43)
0.10
(0.092 - 0.11)
0.41
(0.35 - 0.47)
0.76
(0.69 - 0.83)
2.0
(1.6 - 2.4)
Females, 6-11 years
1 510 16.47 0.21
(0.18 - 0.26)
<LOD 0.24
(0.19 - 0.29)
0.42
(0.36 - 0.47)
0.73
(0.57 - 0.89)
2 530 11.89 0.23
(0.19 - 0.27)
<LOD 0.25
(0.21 - 0.29)
0.40
(0.32 - 0.49)
0.81
(0.57 - 1.1)
Females, 12-19 years
1 478 12.97 0.27
(0.22 - 0.32)
<LOD 0.34
(0.28 - 0.39)
0.52
(0.42 - 0.62)
0.97
(0.68 - 1.3)
2 499 9.22 0.24
(0.20 - 0.29)
0.076E
(<LOD - 0.11)
0.28
(0.22 - 0.34)
0.46
(0.41 - 0.52)
0.77
(0.69 - 0.84)
Females, 20-39 years
1 655 14.20 0.27
(0.23 - 0.32)
<LOD 0.29
(0.23 - 0.35)
0.53
(0.44 - 0.62)
1.3
(0.84 - 1.7)
2 770 7.53 0.35
(0.29 - 0.41)
0.096
(0.071 - 0.12)
0.37
(0.28 - 0.46)
0.71
(0.55 - 0.86)
1.1
(1.0 - 1.3)
Females, 40-59 years
1 645 8.06 0.40
(0.35 - 0.46)
0.092
(<LOD - 0.12)
0.41
(0.33 - 0.48)
0.79
(0.71 - 0.86)
2.3
(1.8 - 2.8)
2 612 3.92 0.51
(0.43 - 0.61)
0.11
(0.094 - 0.12)
0.51
(0.41 - 0.60)
0.95
(0.62 - 1.3)
2.6
(2.3 - 3.0)
Females, 60-79 years
1 542 4.06 0.44
(0.37 - 0.52)
0.095E
(<LOD - 0.13)
0.46
(0.40 - 0.52)
0.90
(0.74 - 1.1)
2.2
(1.8 - 2.6)
2 581 2.24 0.54
(0.49 - 0.60)
0.11
(0.097 - 0.12)
0.59
(0.54 - 0.64)
1.1
(0.98 - 1.2)
2.5
(2.1 - 3.0)
 
Table 8.3.7: Cadmium (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 6-79 years Table a39 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a39 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a39 footnotes

Table a39 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a39 footnote a referrer

Table a39 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a39 footnote b referrer

Total, 6-79 years
1 5478 9.73 0.42
(0.40 - 0.44)
<LOD
(<LOD - 0.18)
0.39
(0.37 - 0.41)
0.68
(0.63 - 0.74)
1.5
(1.4 - 1.7)
2 5719 6.14 0.37
(0.34 - 0.41)
0.14
(0.12 - 0.16)
0.36
(0.32 - 0.40)
0.62
(0.57 - 0.67)
1.4
(1.3 - 1.6)
Males, 6-79 years
1 2652 8.30 0.36
(0.34 - 0.38)
0.15
(<LOD - 0.16)
0.33
(0.31 - 0.35)
0.54
(0.48 - 0.60)
1.2
(1.0 - 1.3)
2 2739 5.37 0.31
(0.28 - 0.35)
0.13
(0.11 - 0.15)
0.31
(0.26 - 0.35)
0.49
(0.42 - 0.55)
1.1
(0.97 - 1.3)
Females, 6-79 years
1 2826 11.08 0.50
(0.47 - 0.53)
<LOD 0.46
(0.42 - 0.50)
0.80
(0.73 - 0.86)
2.0
(1.7 - 2.2)
2 2980 6.85 0.44
(0.40 - 0.48)
0.16
(0.14 - 0.19)
0.43
(0.39 - 0.47)
0.74
(0.68 - 0.80)
1.9
(1.5 - 2.4)
 
Table 8.3.8: Cadmium (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a40 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a40 footnotes

Table a40 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a40 footnote a referrer

Table a40 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a40 footnote b referrer

Total, 3-79 years
1Table a40 footnote b . . . . . . .
2 6291 6.58 0.37
(0.34 - 0.41)
0.14
(0.12 - 0.16)
0.36
(0.32 - 0.40)
0.62
(0.57 - 0.67)
1.4
(1.3 - 1.6)
3-5 years
1Table a40 footnote b . . . . . . .
2 572 11.01 0.39
(0.33 - 0.47)
<LOD 0.42
(0.36 - 0.49)
0.58
(0.50 - 0.66)
F
6-11 years
1 1030 14.76 0.34
(0.31 - 0.38)
<LOD 0.33
(0.30 - 0.37)
0.46
(0.40 - 0.52)
0.86
(0.70 - 1.0)
2 1058 9.74 0.28
(0.24 - 0.33)
0.12
(<LOD - 0.15)
0.28
(0.24 - 0.32)
0.42
(0.34 - 0.51)
0.80
(0.67 - 0.94)
12-19 years
1 982 10.49 0.24
(0.22 - 0.26)
<LOD 0.23
(0.22 - 0.25)
0.31
(0.28 - 0.34)
0.53
(0.40 - 0.65)
2 1039 7.60 0.20
(0.17 - 0.23)
0.099
(<LOD - 0.12)
0.20
(0.18 - 0.23)
0.27
(0.23 - 0.32)
0.46
(0.34 - 0.58)
20-39 years
1 1165 13.22 0.31
(0.29 - 0.33)
<LOD 0.30
(0.28 - 0.32)
0.45
(0.42 - 0.48)
0.83
(0.68 - 0.97)
2 1319 7.13 0.28
(0.24 - 0.32)
0.13
(<LOD - 0.14)
0.27
(0.22 - 0.33)
0.43
(0.37 - 0.49)
0.79
(0.69 - 0.88)
40-59 years
1 1218 7.39 0.54
(0.51 - 0.57)
0.22
(<LOD - 0.25)
0.52
(0.47 - 0.56)
0.86
(0.78 - 0.94)
1.9
(1.6 - 2.2)
2 1223 4.66 0.47
(0.43 - 0.53)
0.19
(0.16 - 0.22)
0.46
(0.41 - 0.50)
0.77
(0.69 - 0.85)
1.9
(1.3 - 2.4)
60-79 years
1 1083 3.14 0.70
(0.64 - 0.76)
0.30
(<LOD - 0.33)
0.68
(0.62 - 0.75)
1.1
(0.94 - 1.2)
2.1
(1.8 - 2.4)
2 1080 1.67 0.64
(0.58 - 0.71)
0.26
(0.22 - 0.29)
0.63
(0.57 - 0.69)
1.0
(0.90 - 1.1)
2.0
(1.7 - 2.3)
 
Table 8.3.9: Cadmium (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a41 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a41 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a41 footnotes

Table a41 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a41 footnote a referrer

Table a41 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a41 footnote b referrer

Table a41 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a41 footnote c referrer

Males, Total 3-79 years
1Table a41 footnote c . . . . . . .
2 3028 5.68 0.32
(0.28 - 0.35)
0.13
(0.11 - 0.15)
0.31
(0.27 - 0.36)
0.49
(0.43 - 0.55)
1.1
(0.97 - 1.3)
Males, 6-11 years
1 521 13.05 0.34
(0.32 - 0.37)
<LOD 0.33
(0.31 - 0.36)
0.46
(0.41 - 0.51)
0.83
(0.68 - 0.97)
2 530 7.55 0.30
(0.24 - 0.37)
0.13E
(<LOD - 0.19)
0.30
(0.24 - 0.36)
0.45
(0.35 - 0.56)
0.86
(0.73 - 0.98)
Males, 12-19 years
1 504 8.13 0.23
(0.21 - 0.25)
0.12
(<LOD - 0.14)
0.22
(0.21 - 0.24)
0.31
(0.26 - 0.35)
0.53E
(0.30 - 0.75)
2 541 6.10 0.20
(0.17 - 0.23)
0.099
(0.078 - 0.12)
0.20
(0.17 - 0.23)
0.27
(0.21 - 0.33)
0.49E
(0.27 - 0.71)
Males, 20-39 years
1 512 11.91 0.26
(0.25 - 0.28)
<LOD 0.25
(0.23 - 0.27)
0.37
(0.34 - 0.40)
0.65
(0.54 - 0.76)
2 550 6.55 0.22
(0.19 - 0.26)
0.099
(<LOD - 0.12)
0.22
(0.18 - 0.26)
0.35
(0.28 - 0.42)
0.62
(0.40 - 0.85)
Males, 40-59 years
1 574 6.62 0.43
(0.39 - 0.48)
0.17
(<LOD - 0.21)
0.42
(0.37 - 0.47)
0.69
(0.59 - 0.80)
1.2
(0.97 - 1.4)
2 615 5.37 0.38
(0.33 - 0.44)
0.17
(<LOD - 0.20)
0.37
(0.29 - 0.45)
0.60
(0.46 - 0.75)
1.2
(0.85 - 1.5)
Males, 60-79 years
1 541 2.22 0.60
(0.53 - 0.68)
0.26
(0.24 - 0.29)
0.56
(0.48 - 0.64)
0.99
(0.75 - 1.2)
1.7
(1.4 - 2.0)
2 503 0.99 0.52
(0.45 - 0.61)
0.23
(<LOD - 0.27)
0.49
(0.41 - 0.58)
0.81
(0.60 - 1.0)
1.6
(1.3 - 1.9)
Females, Total 3-79 years
1Table a41 footnote c . . . . . . .
2 3263 7.42 0.44
(0.40 - 0.48)
0.16
(0.14 - 0.18)
0.43
(0.38 - 0.47)
0.74
(0.67 - 0.80)
1.9
(1.4 - 2.4)
Females, 6-11 years
1 509 16.50 0.34
(0.29 - 0.40)
<LOD 0.33
(0.29 - 0.37)
0.47
(0.38 - 0.55)
0.90
(0.68 - 1.1)
2 528 11.93 0.27
(0.23 - 0.31)
<LOD 0.27
(0.23 - 0.31)
0.40
(0.31 - 0.48)
0.76
(0.58 - 0.95)
Females, 12-19 years
1 478 12.97 0.25
(0.22 - 0.27)
<LOD 0.25
(0.23 - 0.27)
0.31
(0.29 - 0.33)
0.53
(0.39 - 0.67)
2 498 9.24 0.20
(0.17 - 0.23)
0.097
(<LOD - 0.12)
0.21
(0.18 - 0.23)
0.28
(0.24 - 0.31)
0.44
(0.36 - 0.51)
Females, 20-39 years
1 653 14.24 0.37
(0.34 - 0.41)
<LOD 0.35
(0.31 - 0.38)
0.55
(0.49 - 0.61)
1.0
(0.77 - 1.3)
2 769 7.54 0.34
(0.29 - 0.39)
0.14
(0.12 - 0.16)
0.34
(0.26 - 0.43)
0.51
(0.42 - 0.60)
0.85
(0.76 - 0.95)
Females, 40-59 years
1 644 8.07 0.67
(0.64 - 0.71)
0.28
(<LOD - 0.33)
0.65
(0.59 - 0.72)
1.0
(0.94 - 1.1)
2.3
(2.1 - 2.5)
2 608 3.95 0.59
(0.50 - 0.68)
0.25
(0.20 - 0.29)
0.54
(0.44 - 0.64)
0.94
(0.77 - 1.1)
2.4
(1.7 - 3.0)
Females, 60-79 years
1 542 4.06 0.81
(0.75 - 0.87)
0.36
(<LOD - 0.39)
0.79
(0.71 - 0.88)
1.2
(0.97 - 1.4)
2.4
(2.0 - 2.8)
2 577 2.25 0.76
(0.72 - 0.81)
0.31
(0.24 - 0.38)
0.75
(0.68 - 0.82)
1.1
(1.0 - 1.3)
2.6
(1.9 - 3.2)
 
Table 8.4.1: Cesium -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a42 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a42 footnotes

Table a42 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a42 footnote a referrer

Total, 3-79 years
2 6311 0.02 4.6
(4.3 - 4.9)
1.7
(1.6 - 1.9)
4.9
(4.6 - 5.3)
7.3
(6.7 - 7.9)
12
(11 - 14)
3-5 years
2 573 0 5.3
(4.8 - 5.8)
2.6
(2.0 - 3.2)
5.5
(4.9 - 6.1)
7.6
(6.6 - 8.6)
11
(10 - 12)
6-11 years
2 1062 0 4.9
(4.6 - 5.3)
2.4
(2.0 - 2.7)
5.2
(4.7 - 5.7)
7.0
(6.5 - 7.6)
11
(10 - 12)
12-19 years
2 1041 0.1 4.6
(4.2 - 5.1)
1.7
(1.4 - 2.1)
5.0
(4.4 - 5.5)
7.3
(6.5 - 8.0)
11
(9.6 - 12)
20-39 years
2 1321 0 4.4
(4.1 - 4.8)
1.7
(1.3 - 2.0)
4.8
(4.3 - 5.2)
7.2
(6.4 - 8.0)
11
(9.3 - 14)
40-59 years
2 1228 0 4.8
(4.3 - 5.5)
1.7
(1.5 - 1.9)
5.2
(4.5 - 5.8)
7.9
(6.8 - 8.9)
14
(11 - 17)
60-79 years
2 1086 0 4.2
(3.9 - 4.5)
1.7
(1.6 - 1.9)
4.3
(3.8 - 4.8)
6.7
(6.1 - 7.3)
12
(10 - 13)
 
Table 8.4.2: Cesium -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a43 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a43 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a43 footnotes

Table a43 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a43 footnote a referrer

Table a43 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a43 footnote b referrer

Males, Total 3-79 years
2 3036 0 4.9
(4.5 - 5.3)
1.9
(1.7 - 2.2)
5.2
(4.7 - 5.6)
7.6
(6.9 - 8.3)
13
(12 - 14)
Males, 6-11 years
2 532 0 5.1
(4.6 - 5.6)
2.6
(2.3 - 2.9)
5.1
(4.4 - 5.7)
6.9
(6.1 - 7.7)
11
(9.9 - 13)
Males, 12-19 years
2 542 0 4.9
(4.3 - 5.5)
2.1
(1.6 - 2.7)
5.2
(4.5 - 5.8)
7.3
(6.4 - 8.3)
11
(7.9 - 13)
Males, 20-39 years
2 551 0 4.6
(4.2 - 5.1)
1.8
(1.4 - 2.2)
5.1
(4.6 - 5.7)
7.3
(6.4 - 8.2)
12
(9.9 - 15)
Males, 40-59 years
2 616 0 5.2
(4.4 - 6.2)
1.9
(1.4 - 2.3)
5.5
(4.4 - 6.6)
8.4
(6.3 - 11)
14
(11 - 17)
Males, 60-79 years
2 505 0 4.5
(4.1 - 5.0)
1.9
(1.6 - 2.3)
4.7
(4.2 - 5.2)
7.1
(6.4 - 7.7)
12
(9.9 - 14)
Females, Total 3-79 years
2 3275 0.03 4.3
(4.1 - 4.6)
1.6
(1.4 - 1.7)
4.6
(4.3 - 4.9)
7.0
(6.5 - 7.5)
11
(10 - 13)
Females, 6-11 years
2 530 0 4.8
(4.4 - 5.2)
1.9
(1.7 - 2.2)
5.3
(4.8 - 5.7)
7.2
(6.6 - 7.9)
10
(9.2 - 12)
Females, 12-19 years
2 499 0.2 4.3
(3.9 - 4.8)
1.5
(1.2 - 1.8)
4.6
(4.0 - 5.3)
7.2
(6.4 - 8.0)
11
(9.6 - 12)
Females, 20-39 years
2 770 0 4.2
(3.7 - 4.8)
1.5
(1.0 - 2.0)
4.5
(4.0 - 5.1)
7.0
(5.9 - 8.1)
10
(8.9 - 12)
Females, 40-59 years
2 612 0 4.5
(4.0 - 5.0)
1.5
(1.3 - 1.8)
5.0
(4.5 - 5.4)
7.3
(6.3 - 8.2)
13
(8.8 - 16)
Females, 60-79 years
2 581 0 3.9
(3.6 - 4.3)
1.6
(1.3 - 1.8)
3.8
(3.2 - 4.4)
6.2
(5.5 - 7.0)
11
(9.2 - 13)
 
Table 8.4.3: Cesium (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a44 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a44 footnotes

Table a44 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a44 footnote a referrer

Total, 3-79 years
2 6291 0.02 4.4
(4.2 - 4.6)
2.5
(2.4 - 2.6)
4.3
(4.1 - 4.6)
5.8
(5.5 - 6.1)
9.9
(9.0 - 11)
3-5 years
2 572 0 8.9
(8.3 - 9.6)
5.2
(4.5 - 5.8)
8.9
(8.3 - 9.5)
12
(11 - 13)
19
(16 - 22)
6-11 years
2 1058 0 5.6
(5.3 - 5.9)
3.3
(3.1 - 3.5)
5.4
(5.0 - 5.9)
7.3
(6.8 - 7.9)
11
(10 - 12)
12-19 years
2 1039 0.1 3.4
(3.3 - 3.5)
2.1
(2.0 - 2.2)
3.4
(3.3 - 3.6)
4.6
(4.4 - 4.8)
6.5
(5.8 - 7.2)
20-39 years
2 1319 0 3.6
(3.4 - 3.8)
2.3
(2.1 - 2.4)
3.5
(3.2 - 3.7)
4.8
(4.4 - 5.2)
6.7
(5.5 - 7.9)
40-59 years
2 1223 0 4.7
(4.3 - 5.0)
2.7
(2.5 - 2.9)
4.6
(4.2 - 5.0)
6.1
(5.6 - 6.6)
9.8
(7.7 - 12)
60-79 years
2 1080 0 5.0
(4.7 - 5.2)
2.8
(2.5 - 3.0)
5.0
(4.8 - 5.1)
6.5
(6.1 - 6.9)
11
(10 - 12)
 
Table 8.4.4: Cesium (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a45 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a45 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a45 footnotes

Table a45 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a45 footnote a referrer

Table a45 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a45 footnote b referrer

Males, Total 3-79 years
2 3028 0 4.0
(3.8 - 4.2)
2.3
(2.2 - 2.4)
3.8
(3.6 - 4.1)
5.3
(5.0 - 5.6)
9.0
(7.9 - 10)
Males, 6-11 years
2 530 0 5.5
(5.1 - 6.0)
3.2
(2.9 - 3.5)
5.3
(4.8 - 5.9)
7.6
(7.0 - 8.2)
11
(10 - 12)
Males, 12-19 years
2 541 0 3.3
(3.1 - 3.5)
1.9
(1.7 - 2.1)
3.3
(3.0 - 3.5)
4.5
(4.1 - 4.8)
6.9
(5.2 - 8.6)
Males, 20-39 years
2 550 0 3.2
(3.0 - 3.4)
2.1
(1.7 - 2.4)
3.2
(3.0 - 3.4)
4.1
(3.8 - 4.4)
5.6
(5.3 - 5.9)
Males, 40-59 years
2 615 0 4.2
(3.8 - 4.6)
2.6
(2.2 - 2.9)
4.1
(3.7 - 4.6)
5.6
(5.0 - 6.1)
8.2
(6.0 - 10)
Males, 60-79 years
2 503 0 4.4
(4.1 - 4.7)
2.6
(2.4 - 2.8)
4.5
(4.2 - 4.7)
5.6
(5.0 - 6.2)
8.6
(7.1 - 10)
Females, Total 3-79 years
2 3263 0.03 4.8
(4.6 - 5.1)
2.7
(2.5 - 2.9)
4.7
(4.4 - 5.0)
6.3
(5.9 - 6.8)
11
(9.4 - 13)
Females, 6-11 years
2 528 0 5.6
(5.3 - 6.0)
3.6
(3.3 - 3.8)
5.5
(5.0 - 6.1)
7.0
(6.5 - 7.5)
11
(9.7 - 12)
Females, 12-19 years
2 498 0.2 3.6
(3.4 - 3.7)
2.2
(2.0 - 2.4)
3.5
(3.3 - 3.8)
4.7
(4.5 - 4.9)
6.3
(5.7 - 7.0)
Females, 20-39 years
2 769 0 4.1
(3.8 - 4.4)
2.5
(2.2 - 2.8)
4.0
(3.7 - 4.4)
5.2
(4.7 - 5.6)
8.0
(7.0 - 9.0)
Females, 40-59 years
2 608 0 5.2
(4.7 - 5.7)
3.0
(2.8 - 3.2)
5.0
(4.5 - 5.4)
6.7
(5.9 - 7.6)
12
(8.0 - 15)
Females, 60-79 years
2 577 0 5.6
(5.2 - 5.9)
3.1
(2.6 - 3.6)
5.5
(5.2 - 5.8)
7.2
(6.8 - 7.6)
12
(11 - 13)
 
Table 8.5.1: Cobalt -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a46 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a46 footnotes

Table a46 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a46 footnote a referrer

Total, 3-79 years
2 6070 0.02 0.23
(0.21 - 0.24)
0.15
(0.13 - 0.17)
0.22
(0.20 - 0.24)
0.27
(0.25 - 0.29)
0.40
(0.36 - 0.43)
3-5 years
2 495 0 0.26
(0.23 - 0.28)
0.17
(0.13 - 0.21)
0.26
(0.24 - 0.28)
0.31
(0.29 - 0.33)
0.42
(0.32 - 0.52)
6-11 years
2 961 0 0.25
(0.23 - 0.27)
0.18
(0.16 - 0.20)
0.24
(0.22 - 0.26)
0.29
(0.27 - 0.31)
0.37
(0.34 - 0.40)
12-19 years
2 997 0.10 0.23
(0.21 - 0.25)
0.16
(0.14 - 0.18)
0.23
(0.21 - 0.25)
0.27
(0.25 - 0.30)
0.38
(0.34 - 0.41)
20-39 years
2 1313 0 0.22
(0.20 - 0.24)
0.14
(0.12 - 0.16)
0.21
(0.19 - 0.23)
0.27
(0.24 - 0.30)
0.40
(0.35 - 0.44)
40-59 years
2 1222 0 0.22
(0.21 - 0.24)
0.14
(0.12 - 0.16)
0.21
(0.20 - 0.23)
0.26
(0.24 - 0.28)
0.43
(0.34 - 0.52)
60-79 years
2 1082 0 0.22
(0.20 - 0.24)
0.14
(0.12 - 0.16)
0.22
(0.20 - 0.24)
0.26
(0.24 - 0.29)
0.39
(0.35 - 0.42)
 
Table 8.5.2: Cobalt -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a47 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a47 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a47 footnotes

Table a47 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a47 footnote a referrer

Table a47 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a47 footnote b referrer

Males, Total 3-79 years
2 2940 0.03 0.21
(0.19 - 0.23)
0.14
(0.12 - 0.16)
0.21
(0.19 - 0.22)
0.25
(0.23 - 0.27)
0.33
(0.30 - 0.37)
Males, 6-11 years
2 488 0 0.24
(0.23 - 0.27)
0.18
(0.17 - 0.20)
0.24
(0.22 - 0.26)
0.29
(0.26 - 0.31)
0.39
(0.34 - 0.43)
Males, 12-19 years
2 523 0.19 0.22
(0.20 - 0.24)
0.15
(0.13 - 0.17)
0.22
(0.19 - 0.24)
0.26
(0.23 - 0.29)
0.36
(0.32 - 0.40)
Males, 20-39 years
2 552 0 0.20
(0.19 - 0.22)
0.14
(0.12 - 0.17)
0.20
(0.18 - 0.22)
0.24
(0.21 - 0.27)
0.29
(0.27 - 0.32)
Males, 40-59 years
2 617 0 0.20
(0.19 - 0.22)
0.13
(0.11 - 0.15)
0.20
(0.18 - 0.22)
0.24
(0.22 - 0.26)
0.30
(0.27 - 0.33)
Males, 60-79 years
2 507 0 0.21
(0.20 - 0.23)
0.14
(0.12 - 0.16)
0.21
(0.19 - 0.23)
0.26
(0.23 - 0.28)
0.40
(0.33 - 0.47)
Females, Total 3-79 years
2 3130 0 0.24
(0.22 - 0.26)
0.15
(0.14 - 0.17)
0.23
(0.21 - 0.26)
0.29
(0.27 - 0.31)
0.44
(0.38 - 0.50)
Females, 6-11 years
2 473 0 0.25
(0.23 - 0.27)
0.17
(0.14 - 0.20)
0.25
(0.22 - 0.27)
0.30
(0.27 - 0.33)
0.37
(0.34 - 0.39)
Females, 12-19 years
2 474 0 0.25
(0.23 - 0.27)
0.17
(0.15 - 0.19)
0.25
(0.23 - 0.26)
0.29
(0.26 - 0.31)
0.39
(0.34 - 0.44)
Females, 20-39 years
2 761 0 0.24
(0.21 - 0.27)
0.15
(0.13 - 0.17)
0.23
(0.20 - 0.27)
0.30
(0.27 - 0.33)
0.45
(0.36 - 0.53)
Females, 40-59 years
2 605 0 0.24
(0.23 - 0.26)
0.16
(0.14 - 0.18)
0.23
(0.22 - 0.25)
0.29
(0.26 - 0.31)
0.51
(0.41 - 0.62)
Females, 60-79 years
2 575 0 0.23
(0.21 - 0.25)
0.15
(0.13 - 0.16)
0.22
(0.20 - 0.24)
0.28
(0.24 - 0.31)
0.38
(0.35 - 0.42)
 
Table 8.5.3: Cobalt -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a48 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a48 footnotes

Table a48 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a48 footnote a referrer

Total, 3-79 years
2 6304 6.87 0.23
(0.21 - 0.26)
<LOD 0.25
(0.22 - 0.29)
0.44
(0.40 - 0.49)
0.97
(0.86 - 1.1)
3-5 years
2 573 2.79 0.34
(0.30 - 0.39)
0.10
(0.068 - 0.13)
0.37
(0.31 - 0.43)
0.55
(0.48 - 0.63)
1.1E
(0.65 - 1.6)
6-11 years
2 1061 1.60 0.38
(0.35 - 0.41)
0.12
(0.098 - 0.14)
0.40
(0.37 - 0.43)
0.58
(0.53 - 0.64)
1.1
(0.95 - 1.3)
12-19 years
2 1041 3.17 0.36
(0.32 - 0.41)
0.086
(<LOD - 0.11)
0.36
(0.32 - 0.41)
0.62
(0.54 - 0.71)
1.5
(1.2 - 1.9)
20-39 years
2 1320 7.80 0.24
(0.20 - 0.27)
<LOD 0.26
(0.21 - 0.30)
0.45
(0.37 - 0.52)
0.92
(0.75 - 1.1)
40-59 years
2 1224 11.11 0.20
(0.17 - 0.23)
<LOD 0.22
(0.17 - 0.27)
0.41
(0.36 - 0.46)
0.85
(0.72 - 0.97)
60-79 years
2 1085 11.80 0.18
(0.15 - 0.21)
<LOD 0.18
(0.14 - 0.23)
0.32
(0.26 - 0.38)
0.74
(0.51 - 0.98)
 
Table 8.5.4: Cobalt -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table a49 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a49 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a49 footnotes

Table a49 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a49 footnote a referrer

Table a49 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a49 footnote b referrer

Males, Total 3-79 years
2 3035 7.35 0.21
(0.19 - 0.24)
<LOD 0.23
(0.19 - 0.28)
0.41
(0.35 - 0.46)
0.81
(0.71 - 0.91)
Males, 6-11 years
2 532 1.50 0.39
(0.35 - 0.44)
0.13
(0.087 - 0.18)
0.42
(0.37 - 0.46)
0.59
(0.48 - 0.69)
1.0
(0.72 - 1.3)
Males, 12-19 years
2 542 3.51 0.34
(0.29 - 0.40)
0.091E
(<LOD - 0.13)
0.36
(0.30 - 0.42)
0.55
(0.47 - 0.64)
1.2
(0.86 - 1.5)
Males, 20-39 years
2 551 10.34 0.19
(0.16 - 0.23)
<LOD 0.20
(0.16 - 0.25)
0.35
(0.27 - 0.43)
0.69
(0.55 - 0.82)
Males, 40-59 years
2 615 11.87 0.18
(0.15 - 0.22)
<LOD 0.20
(0.14 - 0.26)
0.34
(0.27 - 0.40)
0.60
(0.49 - 0.71)
Males, 60-79 years
2 505 11.09 0.18
(0.16 - 0.21)
<LOD 0.18
(0.14 - 0.23)
0.33
(0.27 - 0.38)
0.70E
(0.45 - 0.96)
Females, Total 3-79 years
2 3269 6.42 0.25
(0.23 - 0.28)
<LOD 0.27
(0.24 - 0.30)
0.52
(0.46 - 0.57)
1.1
(1.0 - 1.3)
Females, 6-11 years
2 529 1.70 0.36
(0.33 - 0.40)
0.11
(0.084 - 0.14)
0.37
(0.33 - 0.41)
0.57
(0.49 - 0.66)
1.2
(1.0 - 1.3)
Females, 12-19 years
2 499 2.81 0.38
(0.32 - 0.45)
0.080E
(<LOD - 0.12)
0.37
(0.31 - 0.44)
0.73
(0.64 - 0.83)
1.8E
(1.1 - 2.6)
Females, 20-39 years
2 769 5.98 0.29
(0.24 - 0.35)
<LODE
(<LOD - 0.078)
0.33
(0.26 - 0.39)
0.58
(0.47 - 0.69)
1.2
(0.97 - 1.3)
Females, 40-59 years
2 609 10.34 0.22
(0.19 - 0.26)
<LOD 0.24
(0.19 - 0.29)
0.50
(0.39 - 0.61)
0.99
(0.64 - 1.4)
Females, 60-79 years
2 580 12.41 0.17
(0.14 - 0.21)
<LOD 0.18
(0.13 - 0.23)
0.31
(0.23 - 0.39)
0.76E
(0.41 - 1.1)
 
Table 8.5.5: Cobalt (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a50 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a50 footnotes

Table a50 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a50 footnote a referrer

Total, 3-79 years
2 6285 6.89 0.22
(0.20 - 0.25)
<LOD 0.22
(0.19 - 0.24)
0.38
(0.34 - 0.41)
0.88
(0.79 - 0.97)
3-5 years
2 572 2.80 0.59
(0.52 - 0.66)
0.30
(0.25 - 0.36)
0.60
(0.54 - 0.66)
0.78
(0.60 - 0.97)
1.5
(1.2 - 1.7)
6-11 years
2 1057 1.61 0.43
(0.40 - 0.46)
0.23
(0.21 - 0.26)
0.43
(0.40 - 0.46)
0.59
(0.54 - 0.64)
1.1
(0.91 - 1.3)
12-19 years
2 1039 3.18 0.27
(0.25 - 0.30)
0.11
(<LOD - 0.13)
0.26
(0.24 - 0.29)
0.43
(0.39 - 0.46)
0.91
(0.77 - 1.1)
20-39 years
2 1318 7.81 0.20
(0.17 - 0.22)
<LOD 0.19
(0.16 - 0.22)
0.32
(0.27 - 0.38)
0.77
(0.58 - 0.96)
40-59 years
2 1220 11.15 0.19
(0.17 - 0.22)
<LOD 0.19
(0.16 - 0.22)
0.30
(0.26 - 0.34)
0.82
(0.67 - 0.97)
60-79 years
2 1079 11.86 0.21
(0.18 - 0.24)
<LOD 0.21
(0.18 - 0.23)
0.32
(0.26 - 0.38)
0.76
(0.57 - 0.94)
 
Table 8.5.6: Cobalt (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a51 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a51 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a51 footnotes

Table a51 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a51 footnote a referrer

Table a51 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a51 footnote b referrer

Males, Total 3-79 years
2 3028 7.36 0.17
(0.16 - 0.20)
<LOD 0.17
(0.14 - 0.19)
0.28
(0.24 - 0.31)
0.68
(0.61 - 0.75)
Males, 6-11 years
2 530 1.51 0.43
(0.38 - 0.49)
0.23
(0.21 - 0.26)
0.44
(0.39 - 0.50)
0.60
(0.54 - 0.66)
1.1
(0.81 - 1.5)
Males, 12-19 years
2 541 3.51 0.23
(0.21 - 0.26)
0.11
(<LOD - 0.13)
0.23
(0.20 - 0.26)
0.37
(0.33 - 0.42)
0.75
(0.58 - 0.92)
Males, 20-39 years
2 550 10.36 0.14
(0.11 - 0.16)
<LOD 0.13
(0.11 - 0.16)
0.20
(0.15 - 0.26)
0.37
(0.29 - 0.46)
Males, 40-59 years
2 615 11.87 0.14
(0.13 - 0.17)
<LOD 0.15
(0.13 - 0.17)
0.21
(0.19 - 0.24)
0.43
(0.35 - 0.51)
Males, 60-79 years
2 503 11.13 0.18
(0.16 - 0.20)
<LOD 0.18
(0.15 - 0.20)
0.27
(0.23 - 0.30)
0.65
(0.48 - 0.81)
Females, Total 3-79 years
2 3257 6.45 0.28
(0.25 - 0.32)
<LOD 0.28
(0.25 - 0.31)
0.46
(0.41 - 0.52)
0.98
(0.85 - 1.1)
Females, 6-11 years
2 527 1.71 0.43
(0.39 - 0.46)
0.23
(0.20 - 0.26)
0.42
(0.38 - 0.46)
0.56
(0.48 - 0.65)
1.0
(0.85 - 1.2)
Females, 12-19 years
2 498 2.81 0.32
(0.28 - 0.36)
0.13
(<LOD - 0.15)
0.31
(0.27 - 0.35)
0.49
(0.42 - 0.55)
1.1
(0.78 - 1.5)
Females, 20-39 years
2 768 5.99 0.28
(0.25 - 0.32)
<LOD
(<LOD - 0.15)
0.27
(0.21 - 0.32)
0.47
(0.37 - 0.56)
0.89
(0.78 - 1.0)
Females, 40-59 years
2 605 10.41 0.26
(0.22 - 0.30)
<LOD 0.26
(0.21 - 0.31)
0.41
(0.32 - 0.50)
0.92
(0.67 - 1.2)
Females, 60-79 years
2 576 12.50 0.24
(0.20 - 0.29)
<LOD 0.23
(0.20 - 0.26)
0.37
(0.29 - 0.45)
0.78
(0.56 - 1.0)
 
Table 8.6.1: Copper -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 6-79 years Table a52 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a52 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a52 footnotes

Table a52 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a52 footnote a referrer

Table a52 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a52 footnote b referrer

Total, 6-79 years
1 5318 0 910
(900 - 930)
750
(740 - 760)
890
(870 - 900)
990
(980 - 1000)
1200
(1200 - 1300)
2 5575 0 900
(890 - 910)
710
(700 - 720)
850
(840 - 860)
950
(940 - 960)
1200
(1200 - 1300)
Males, 6-79 years
1 2575 0 850
(840 - 870)
720
(710 - 740)
840
(830 - 860)
910
(890 - 930)
1000
(980 - 1100)
2 2687 0 830
(820 - 850)
680
(670 - 690)
800
(780 - 810)
870
(860 - 890)
1000
(990 - 1000)
Females, 6-79 years
1 2743 0 980
(970 - 1000)
800
(780 - 820)
960
(940 - 970)
1000
(1000 - 1100)
1400
(1300 - 1400)
2 2888 0 970
(960 - 980)
770
(760 - 780)
920
(910 - 930)
1000
(1000 - 1000)
1300
(1300 - 1400)
 
Table 8.6.2: Copper -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a53 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a53 footnotes

Table a53 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a53 footnote a referrer

Table a53 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a53 footnote b referrer

Total, 3-79 years
1Table a53 footnote b . . . . . . .
2 6070 0 900
(900 - 910)
710
(700 - 720)
860
(850 - 860)
960
(950 - 970)
1200
(1200 - 1300)
3-5 years
1Table a53 footnote b . . . . . . .
2 495 0 1000
(1000 - 1100)
860
(830 - 890)
1000
(970 - 1000)
1100
(1100 - 1200)
1300
(1200 - 1300)
6-11 years
1 909 0 970
(950 - 1000)
820
(790 - 860)
970
(950 - 980)
1000
(980 - 1000)
1200
(1100 - 1200)
2 961 0 980
(960 - 990)
800
(780 - 820)
930
(920 - 950)
1000
(1000 - 1100)
1200
(1100 - 1300)
12-19 years
1 945 0 900
(870 - 920)
720
(700 - 750)
860
(840 - 870)
970
(930 - 1000)
1300
(1100 - 1500)
2 997 0 880
(860 - 890)
680
(660 - 700)
810
(800 - 830)
920
(910 - 940)
1400
(1300 - 1400)
20-39 years
1 1165 0 920
(900 - 940)
730
(710 - 750)
870
(840 - 890)
990
(980 - 1000)
1400
(1300 - 1500)
2 1313 0 890
(880 - 910)
700
(680 - 720)
820
(810 - 840)
940
(920 - 960)
1300
(1200 - 1400)
40-59 years
1 1220 0 900
(890 - 920)
760
(740 - 770)
890
(870 - 900)
980
(960 - 1000)
1100
(1100 - 1200)
2 1222 0 900
(880 - 910)
720
(710 - 730)
860
(840 - 880)
950
(930 - 960)
1100
(1100 - 1100)
60-79 years
1 1079 0 920
(900 - 930)
770
(750 - 790)
900
(880 - 920)
990
(980 - 1000)
1100
(1100 - 1200)
2 1082 0 900
(890 - 920)
720
(710 - 730)
860
(850 - 880)
960
(940 - 970)
1100
(1100 - 1200)
 
Table 8.6.3: Copper -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a54 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a54 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a54 footnotes

Table a54 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a54 footnote a referrer

Table a54 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a54 footnote b referrer

Table a54 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a54 footnote c referrer

Males, Total 3-79 years
1Table a54 footnote c . . . . . . .
2 2940 0 840
(830 - 850)
680
(670 - 690)
800
(790 - 810)
880
(870 - 890)
1000
(1000 - 1100)
Males, 6-11 years
1 458 0 1000
(970 - 1000)
850
(820 - 870)
990
(980 - 1000)
1000
(1000 - 1100)
1200
(1100 - 1300)
2 488 0 1000
(980 - 1000)
830
(800 - 850)
960
(930 - 1000)
1100
(1000 - 1100)
1200
(1200 - 1300)
Males, 12-19 years
1 489 0 830
(820 - 850)
700
(680 - 730)
820
(800 - 840)
890
(870 - 920)
1000
(990 - 1100)
2 523 0 810
(790 - 830)
650
(630 - 680)
770
(750 - 790)
850
(820 - 890)
960
(930 - 1000)
Males, 20-39 years
1 514 0 820
(800 - 840)
700
(680 - 730)
820
(800 - 840)
880
(860 - 910)
990
(950 - 1000)
2 552 0 810
(790 - 820)
670
(660 - 690)
770
(750 - 790)
830
(810 - 850)
930
(900 - 960)
Males, 40-59 years
1 577 0 850
(830 - 870)
730
(710 - 760)
850
(830 - 860)
900
(880 - 910)
1000
(990 - 1000)
2 617 0 840
(820 - 860)
690
(660 - 710)
800
(780 - 820)
880
(850 - 910)
990
(950 - 1000)
Males, 60-79 years
1 537 0 860
(850 - 880)
740
(730 - 750)
860
(840 - 880)
920
(890 - 940)
1000
(950 - 1100)
2 507 0 840
(830 - 850)
690
(670 - 710)
810
(790 - 820)
870
(860 - 890)
1000
(970 - 1000)
Females, Total 3-79 years
1Table a54 footnote c . . . . . . .
2 3130 0 970
(960 - 980)
770
(760 - 780)
920
(910 - 930)
1000
(1000 - 1000)
1300
(1300 - 1400)
Females, 6-11 years
1 451 0 950
(930 - 980)
790
(750 - 830)
960
(940 - 980)
1000
(980 - 1000)
1200
(1100 - 1200)
2 473 0 950
(930 - 970)
780
(770 - 800)
910
(890 - 930)
990
(960 - 1000)
1200
(1000 - 1300)
Females, 12-19 years
1 456 0 970
(930 - 1000)
750
(740 - 770)
920
(890 - 950)
1100
(980 - 1200)
1600
(1400 - 1700)
2 474 0 960
(930 - 980)
710
(700 - 730)
870
(850 - 900)
1100
(1000 - 1100)
1500
(1400 - 1600)
Females, 20-39 years
1 651 0 1000
(1000 - 1100)
800
(760 - 840)
980
(960 - 1000)
1100
(1100 - 1200)
1600
(1400 - 1700)
2 761 0 990
(960 - 1000)
760
(750 - 780)
920
(890 - 950)
1100
(970 - 1200)
1500
(1300 - 1600)
Females, 40-59 years
1 643 0 960
(940 - 980)
800
(770 - 840)
950
(930 - 970)
1000
(970 - 1000)
1200
(1100 - 1200)
2 605 0 960
(940 - 970)
780
(770 - 800)
920
(900 - 940)
1000
(990 - 1000)
1200
(1100 - 1200)
Females, 60-79 years
1 542 0 970
(950 - 990)
820
(800 - 830)
960
(940 - 970)
1000
(980 - 1000)
1200
(1100 - 1300)
2 575 0 970
(950 - 1000)
790
(770 - 800)
930
(910 - 950)
1000
(990 - 1000)
1200
(1100 - 1400)
 
Table 8.6.4: Copper -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a55 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a55 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a55 footnotes

Table a55 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a55 footnote a referrer

Table a55 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a55 footnote b referrer

Total, 6-79 years
1 5492 0.29 9.0
(8.2 - 9.8)
3.0
(2.5 - 3.5)
9.9
(9.5 - 10)
15
(14 - 16)
26
(25 - 28)
2 5738 0.19 11
(10 - 11)
4.0
(3.6 - 4.4)
12
(11 - 13)
17
(17 - 18)
28
(26 - 29)
Males, 6-79 years
1 2662 0.23 10
(9.3 - 11)
3.8
(3.1 - 4.5)
11
(10 - 12)
16
(15 - 17)
27
(25 - 28)
2 2746 0.18 12
(11 - 12)
4.7
(4.3 - 5.1)
13
(12 - 13)
18
(17 - 19)
28
(25 - 30)
Females, 6-79 years
1 2830 0.35 8.0
(7.3 - 8.9)
2.9
(2.4 - 3.3)
8.8
(8.0 - 9.7)
14
(13 - 15)
25
(23 - 27)
2 2992 0.20 10
(9.6 - 11)
3.7
(3.2 - 4.1)
11
(11 - 12)
17
(16 - 17)
28
(26 - 29)
 
Table 8.6.5: Copper -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a56 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a56 footnotes

Table a56 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a56 footnote a referrer

Table a56 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a56 footnote b referrer

Total, 3-79 years
1Table a56 footnote b . . . . . . .
2 6311 0.21 11
(10 - 11)
4.1
(3.7 - 4.5)
12
(11 - 13)
17
(17 - 18)
28
(27 - 29)
3-5 years
1Table a56 footnote b . . . . . . .
2 573 0.35 12
(12 - 13)
5.8
(5.2 - 6.3)
13
(12 - 14)
18
(16 - 20)
28
(24 - 31)
6-11 years
1 1034 0.29 10
(9.4 - 12)
3.8
(2.9 - 4.6)
12
(10 - 13)
17
(16 - 18)
27
(25 - 29)
2 1062 0 13
(12 - 14)
6.0
(5.4 - 6.6)
13
(13 - 14)
18
(17 - 19)
26
(24 - 28)
12-19 years
1 983 0.31 12
(11 - 14)
4.4
(3.1 - 5.6)
13
(13 - 14)
19
(18 - 20)
32
(30 - 35)
2 1041 0.10 13
(12 - 14)
5.6
(4.7 - 6.5)
14
(13 - 15)
19
(18 - 20)
31
(28 - 34)
20-39 years
1 1169 0.43 8.6
(7.5 - 9.8)
3.0
(2.3 - 3.7)
9.5
(8.5 - 10)
15
(14 - 16)
25
(23 - 28)
2 1321 0.30 11
(10 - 12)
4.1
(3.2 - 5.0)
12
(11 - 13)
18
(17 - 19)
29
(26 - 32)
40-59 years
1 1223 0.41 8.1
(7.4 - 9.0)
2.8
(2.0 - 3.6)
9.2
(8.4 - 9.9)
14
(13 - 15)
24
(22 - 26)
2 1228 0.41 10
(9.5 - 11)
3.7
(3.2 - 4.1)
11
(10 - 12)
17
(15 - 18)
27
(25 - 29)
60-79 years
1 1083 0 9.0
(8.4 - 9.7)
3.4
(2.9 - 4.0)
9.8
(9.2 - 10)
14
(13 - 15)
24
(21 - 27)
2 1086 0.09 9.9
(9.4 - 11)
3.7
(3.4 - 4.0)
11
(10 - 12)
16
(15 - 16)
29
(26 - 32)
 
Table 8.6.6: Copper -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a57 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a57 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a57 footnotes

Table a57 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a57 footnote a referrer

Table a57 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a57 footnote b referrer

Table a57 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a57 footnote c referrer

Males, Total 3-79 years
1Table a57 footnote c . . . . . . .
2 3036 0.23 12
(11 - 12)
4.7
(4.3 - 5.1)
13
(12 - 14)
18
(17 - 19)
28
(25 - 30)
Males, 6-11 years
1 524 0 11
(8.8 - 13)
3.9
(2.5 - 5.3)
12
(9.6 - 14)
17
(15 - 19)
27
(25 - 28)
2 532 0 13
(12 - 14)
6.5
(5.5 - 7.5)
14
(13 - 15)
18
(16 - 19)
25
(21 - 29)
Males, 12-19 years
1 505 0.40 12
(10 - 14)
4.8
(3.4 - 6.2)
13
(12 - 14)
17
(16 - 19)
29
(26 - 31)
2 542 0.18 13
(12 - 15)
6.2
(5.3 - 7.2)
14
(13 - 16)
18
(17 - 20)
28
(24 - 33)
Males, 20-39 years
1 514 0.19 9.4
(8.1 - 11)
3.3E
(1.6 - 5.1)
9.9
(8.9 - 11)
16
(15 - 18)
26
(23 - 29)
2 551 0.18 11
(10 - 13)
4.6
(3.7 - 5.5)
12
(11 - 13)
19
(16 - 22)
29
(26 - 33)
Males, 40-59 years
1 578 0.52 9.6
(8.6 - 11)
3.6
(2.9 - 4.3)
11
(9.9 - 12)
15
(14 - 17)
26
(23 - 30)
2 616 0.49 11
(10 - 13)
3.7
(2.5 - 4.9)
12
(10 - 14)
18
(16 - 20)
27
(25 - 29)
Males, 60-79 years
1 541 0 11
(9.9 - 12)
4.8
(4.2 - 5.3)
11
(10 - 12)
16
(14 - 17)
27
(23 - 31)
2 505 0 11
(10 - 12)
4.3
(3.2 - 5.4)
12
(11 - 12)
16
(15 - 17)
29
(25 - 33)
Females, Total 3-79 years
1Table a57 footnote c . . . . . . .
2 3275 0.18 10
(9.7 - 11)
3.7
(3.3 - 4.1)
11
(11 - 12)
17
(16 - 17)
28
(26 - 29)
Females, 6-11 years
1 510 0.59 10
(9.4 - 11)
3.5
(2.7 - 4.3)
11
(10 - 12)
17
(16 - 18)
28
(24 - 32)
2 530 0 13
(12 - 14)
5.1
(4.5 - 5.7)
13
(12 - 14)
19
(17 - 21)
27
(26 - 29)
Females, 12-19 years
1 478 0.21 13
(11 - 15)
3.8E
(2.1 - 5.4)
14
(13 - 16)
22
(19 - 25)
34
(30 - 39)
2 499 0 13
(11 - 14)
5.0
(4.1 - 5.9)
13
(12 - 15)
19
(17 - 21)
33
(26 - 39)
Females, 20-39 years
1 655 0.61 7.9
(6.9 - 9.0)
3.0
(2.6 - 3.3)
8.6
(7.2 - 10)
13
(12 - 15)
24
(20 - 28)
2 770 0.39 10
(9.3 - 12)
3.6
(2.6 - 4.6)
12
(10 - 13)
18
(16 - 20)
27
(18 - 36)
Females, 40-59 years
1 645 0.31 6.9
(6.1 - 7.9)
1.8E
(0.63 - 3.0)
7.6
(6.3 - 8.9)
12
(11 - 13)
21
(18 - 25)
2 612 0.33 9.3
(8.4 - 10)
3.5
(2.5 - 4.4)
11
(9.5 - 12)
15
(14 - 16)
25
(20 - 30)
Females, 60-79 years
1 542 0 7.6
(6.8 - 8.5)
2.9
(2.6 - 3.3)
8.1
(6.7 - 9.5)
12
(11 - 13)
22
(20 - 25)
2 581 0.17 9.1
(8.3 - 9.9)
3.5
(3.0 - 4.0)
9.9
(8.8 - 11)
15
(13 - 17)
29
(24 - 34)
 
Table 8.6.7: Copper (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 6-79 years Table a58 footnote a, Canadian Health Measures Survey Cycle 1 (2007-2009) and Cycle 2 (2009-2011).
Cycle N %<LODTable a58 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a58 footnotes

Table a58 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a58 footnote a referrer

Table a58 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a58 footnote b referrer

Total, 6-79 years
1 5479 0.29 11
(10 - 11)
7.4
(7.1 - 7.7)
10
(9.9 - 10)
13
(12 - 13)
20
(19 - 21)
2 5719 0.19 10
(9.9 - 10)
6.9
(6.7 - 7.1)
9.7
(9.5 - 10)
12
(12 - 12)
19
(18 - 20)
Males, 6-79 years
1 2653 0.23 10
(9.5 - 10)
6.9
(6.6 - 7.1)
9.6
(9.3 - 9.9)
11
(11 - 12)
18
(17 - 19)
2 2739 0.18 9.3
(9.0 - 9.5)
6.6
(6.3 - 6.8)
8.8
(8.5 - 9.1)
11
(11 - 11)
17
(15 - 18)
Females, 6-79 years
1 2826 0.35 12
(11 - 12)
8.2
(7.7 - 8.6)
11
(11 - 11)
14
(13 - 14)
22
(20 - 23)
2 2980 0.20 11
(11 - 11)
7.9
(7.6 - 8.2)
11
(10 - 11)
13
(12 - 13)
20
(19 - 21)
 
Table 8.6.8: Copper (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a59 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a59 footnotes

Table a59 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a59 footnote a referrer

Table a59 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a59 footnote b referrer

Total, 3-79 years
1Table a59 footnote b . . . . . . .
2 6291 0.21 10
(10 - 11)
7.0
(6.8 - 7.2)
9.9
(9.7 - 10)
12
(12 - 13)
21
(20 - 21)
3-5 years
1Table a59 footnote b . . . . . . .
2 572 0.35 21
(20 - 22)
16
(14 - 17)
21
(20 - 22)
25
(24 - 26)
32
(30 - 35)
6-11 years
1 1031 0.29 16
(15 - 17)
11
(10 - 12)
15
(15 - 16)
18
(18 - 19)
26
(23 - 29)
2 1058 0 14
(14 - 15)
11
(10 - 11)
14
(14 - 15)
17
(17 - 18)
22
(21 - 23)
12-19 years
1 982 0.31 11
(10 - 11)
7.4
(7.0 - 7.8)
9.9
(9.7 - 10)
12
(11 - 13)
20
(17 - 22)
2 1039 0.10 9.7
(9.3 - 10)
6.9
(6.7 - 7.1)
9.2
(8.8 - 9.6)
11
(11 - 12)
17
(15 - 19)
20-39 years
1 1165 0.43 9.6
(9.1 - 10)
6.7
(6.3 - 7.0)
9.5
(9.1 - 9.9)
11
(10 - 11)
15
(14 - 17)
2 1319 0.30 9.0
(8.7 - 9.2)
6.5
(6.1 - 6.9)
8.7
(8.3 - 9.1)
11
(10 - 11)
15
(14 - 16)
40-59 years
1 1218 0.41 10
(9.9 - 11)
7.4
(7.1 - 7.8)
10
(9.8 - 10)
12
(11 - 12)
17
(16 - 18)
2 1223 0.41 9.9
(9.5 - 10)
7.1
(6.8 - 7.4)
9.6
(9.3 - 9.9)
11
(11 - 12)
16
(14 - 18)
60-79 years
1 1083 0 13
(12 - 13)
8.6
(8.1 - 9.2)
12
(11 - 12)
14
(14 - 15)
22
(19 - 25)
2 1080 0.09 12
(11 - 12)
8.2
(7.9 - 8.5)
11
(11 - 12)
14
(13 - 15)
21
(20 - 23)
 
Table 8.6.9: Copper (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a60 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a60 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a60 footnotes

Table a60 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a60 footnote a referrer

Table a60 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a60 footnote b referrer

Table a60 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a60 footnote c referrer

Males, Total 3-79 years
1Table a60 footnote c . . . . . . .
2 3028 0.23 9.5
(9.2 - 9.8)
6.6
(6.4 - 6.9)
9.0
(8.7 - 9.2)
11
(11 - 12)
19
(18 - 20)
Males, 6-11 years
1 522 0 16
(15 - 17)
11
(11 - 12)
15
(15 - 16)
18
(17 - 19)
27
(22 - 31)
2 530 0 14
(14 - 15)
11
(10 - 11)
14
(13 - 15)
17
(16 - 18)
21
(18 - 23)
Males, 12-19 years
1 504 0.40 10
(9.3 - 11)
7.2
(6.8 - 7.6)
9.6
(9.2 - 10)
12
(11 - 13)
17
(15 - 20)
2 541 0.18 9.0
(8.5 - 9.6)
6.6
(6.2 - 7.0)
8.6
(8.2 - 9.1)
11
(9.4 - 12)
15
(13 - 16)
Males, 20-39 years
1 512 0.20 8.7
(8.2 - 9.2)
6.4
(6.1 - 6.7)
8.5
(8.0 - 9.0)
9.9
(9.6 - 10)
13
(12 - 14)
2 550 0.18 7.9
(7.6 - 8.3)
6.0
(5.6 - 6.3)
7.7
(7.3 - 8.1)
9.3
(8.8 - 9.8)
13
(11 - 15)
Males, 40-59 years
1 574 0.52 9.5
(8.8 - 10)
7.0
(6.7 - 7.4)
9.4
(9.0 - 9.9)
11
(10 - 11)
16
(13 - 19)
2 615 0.49 9.1
(8.8 - 9.5)
6.8
(6.5 - 7.0)
8.7
(8.3 - 9.1)
10
(9.9 - 11)
14
(11 - 16)
Males, 60-79 years
1 541 0 11
(11 - 12)
7.7
(7.2 - 8.3)
10
(9.8 - 11)
13
(12 - 14)
20
(17 - 24)
2 503 0 11
(10 - 11)
7.8
(7.5 - 8.1)
10
(9.7 - 11)
12
(12 - 12)
19
(16 - 21)
Females, Total 3-79 years
1Table a60 footnote c . . . . . . .
2 3263 0.18 11
(11 - 12)
7.9
(7.6 - 8.2)
11
(10 - 11)
13
(13 - 14)
22
(21 - 23)
Females, 6-11 years
1 509 0.59 16
(15 - 17)
11
(9.7 - 12)
16
(15 - 17)
19
(18 - 20)
25
(21 - 28)
2 528 0 15
(14 - 15)
11
(10 - 12)
15
(14 - 15)
17
(17 - 18)
22
(21 - 24)
Females, 12-19 years
1 478 0.21 11
(11 - 12)
7.7
(7.1 - 8.2)
10
(9.6 - 11)
12
(12 - 13)
25
(17 - 33)
2 498 0 10
(10 - 11)
7.4
(7.0 - 7.8)
9.7
(9.1 - 10)
12
(11 - 12)
20
(17 - 22)
Females, 20-39 years
1 653 0.61 11
(10 - 11)
7.7
(7.3 - 8.2)
10
(9.8 - 10)
12
(11 - 12)
18
(14 - 23)
2 769 0.39 10
(9.7 - 11)
7.3
(6.8 - 7.9)
9.6
(8.9 - 10)
11
(11 - 12)
17
(15 - 18)
Females, 40-59 years
1 644 0.31 12
(11 - 12)
8.2
(7.5 - 8.9)
11
(10 - 11)
13
(12 - 13)
20
(16 - 23)
2 608 0.33 11
(10 - 11)
8.0
(7.4 - 8.7)
10
(9.9 - 11)
12
(12 - 13)
19
(15 - 22)
Females, 60-79 years
1 542 0 14
(13 - 14)
9.9
(9.2 - 11)
13
(12 - 13)
16
(15 - 17)
24
(21 - 28)
2 577 0.17 13
(12 - 14)
9.1
(8.5 - 9.6)
12
(12 - 13)
15
(14 - 16)
23
(19 - 27)
 
Table 8.7.1: Fluoride -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a61 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a61 footnotes

Table a61 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a61 footnote a referrer

Total, 3-79 years
2 2530 0 500
(460 - 550)
190
(180 - 210)
480
(430 - 540)
840
(750 - 930)
1500
(1300 - 1800)
3-5 years
2 510 0 470
(420 - 520)
190
(140 - 230)
510
(440 - 590)
720
(620 - 820)
1300
(920 - 1700)
6-11 years
2 514 0 500
(440 - 570)
200
(170 - 240)
490
(410 - 560)
820
(720 - 910)
1500
(1100 - 1800)
12-19 years
2 507 0 410
(370 - 460)
170
(150 - 200)
440
(360 - 520)
660
(570 - 750)
1200
(990 - 1400)
20-39 years
2 354 0 530
(470 - 590)
220
(190 - 260)
500
(380 - 620)
900
(750 - 1100)
1500
(1200 - 1800)
40-59 years
2 357 0 510
(430 - 610)
190
(130 - 250)
510
(410 - 620)
880
(740 - 1000)
1800
(1400 - 2300)
60-79 years
2 288 0 490
(440 - 560)
190E
(120 - 260)
470
(410 - 540)
830
(760 - 910)
1600
(1200 - 2000)
 
Table 8.7.2: Fluoride -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a62 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a62 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a62 footnotes

Table a62 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a62 footnote a referrer

Table a62 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a62 footnote b referrer

Males, Total 3-79 years
2 1267 0 530
(470 - 600)
220
(200 - 250)
510
(420 - 600)
870
(740 - 1000)
1600
(1400 - 1900)
Males, 6-11 years
2 262 0 530
(440 - 620)
210
(170 - 260)
500
(350 - 640)
880
(730 - 1000)
1500
(1100 - 1800)
Males, 12-19 years
2 255 0 430
(370 - 480)
190
(150 - 220)
420
(310 - 520)
650
(560 - 740)
1400
(1000 - 1700)
Males, 20-39 years
2 166 0 590
(460 - 750)
260
(220 - 300)
600E
(370 - 840)
980
(720 - 1200)
X
Males, 40-59 years
2 192 0 530
(410 - 670)
210
(130 - 280)
510
(350 - 680)
880
(620 - 1100)
X
Males, 60-79 years
2 141 0 540
(470 - 600)
230
(170 - 280)
510
(390 - 630)
860
(740 - 980)
X
Females, Total 3-79 years
2 1263 0 470
(430 - 520)
180
(150 - 200)
470
(410 - 530)
800
(700 - 900)
1300
(1000 - 1600)
Females, 6-11 years
2 252 0 480
(410 - 560)
200
(140 - 250)
470
(400 - 550)
730
(540 - 910)
1200E
(660 - 1800)
Females, 12-19 years
2 252 0 400
(340 - 460)
160
(120 - 200)
450
(370 - 530)
700
(530 - 860)
1100
(1000 - 1300)
Females, 20-39 years
2 188 0 470
(410 - 540)
190
(160 - 230)
430
(310 - 560)
750
(620 - 890)
X
Females, 40-59 years
2 165 0 500
(400 - 620)
180E
(110 - 240)
510
(350 - 660)
850
(680 - 1000)
X
Females, 60-79 years
2 147 0 460
(360 - 580)
F 460
(360 - 560)
800
(610 - 1000)
X
 
Table 8.7.3: Fluoride (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a63 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a63 footnotes

Table a63 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a63 footnote a referrer

Total, 3-79 years
2 2520 0 500
(450 - 550)
210
(190 - 230)
480
(420 - 550)
800
(710 - 900)
1700
(1300 - 2000)
3-5 years
2 509 0 810
(730 - 900)
400
(340 - 470)
790
(720 - 860)
1100
(890 - 1200)
2800E
(1700 - 3900)
6-11 years
2 512 0 580
(530 - 630)
310
(290 - 330)
570
(510 - 640)
830
(700 - 960)
1600
(1100 - 2100)
12-19 years
2 505 0 320
(280 - 350)
150
(130 - 170)
330
(280 - 370)
460
(390 - 530)
760
(540 - 980)
20-39 years
2 352 0 460
(390 - 550)
210
(170 - 250)
430
(340 - 510)
670
(490 - 850)
F
40-59 years
2 355 0 530
(460 - 600)
220
(180 - 260)
550
(430 - 670)
850
(730 - 980)
1600
(1200 - 2100)
60-79 years
2 287 0 580
(500 - 680)
220
(170 - 270)
560
(440 - 680)
970
(770 - 1200)
2100
(1500 - 2600)
 
Table 8.7.4: Fluoride (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a64 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable a64 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a64 footnotes

Table a64 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a64 footnote a referrer

Table a64 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a64 footnote b referrer

Males, Total 3-79 years
2 1263 0 460
(400 - 530)
200
(170 - 240)
430
(370 - 500)
710
(610 - 810)
1300
(950 - 1700)
Males, 6-11 years
2 261 0 600
(540 - 670)
320
(290 - 360)
590
(530 - 650)
840
(680 - 1000)
1300E
(640 - 2000)
Males, 12-19 years
2 254 0 300
(270 - 340)
150
(120 - 180)
280
(240 - 330)
430
(350 - 520)
700
(550 - 850)
Males, 20-39 years
2 165 0 450
(360 - 560)
200
(140 - 260)
410
(340 - 490)
600
(430 - 780)
X
Males, 40-59 years
2 192 0 460
(400 - 540)
210
(140 - 280)
440
(340 - 550)
700
(590 - 810)
X
Males, 60-79 years
2 141 0 510
(440 - 590)
210E
(130 - 290)
490
(400 - 580)
870
(710 - 1000)
X
Females, Total 3-79 years
2 1257 0 540
(490 - 600)
210
(180 - 240)
530
(460 - 600)
900
(780 - 1000)
2000
(1500 - 2400)
Females, 6-11 years
2 251 0 560
(490 - 640)
290
(250 - 320)
510
(430 - 590)
830
(650 - 1000)
1800
(1200 - 2300)
Females, 12-19 years
2 251 0 330
(290 - 380)
150
(120 - 170)
350
(300 - 400)
480
(410 - 550)
760E
(350 - 1200)
Females, 20-39 years
2 187 0 480
(390 - 590)
220
(160 - 280)
490
(370 - 610)
750
(490 - 1000)
X
Females, 40-59 years
2 163 0 600
(490 - 730)
230E
(110 - 350)
680
(520 - 840)
990
(830 - 1200)
X
Females, 60-79 years
2 146 0 660
(510 - 840)
230
(<LOD - 300)
630
(410 - 850)
1300
(820 - 1700)
X
 
Table 8.8.1: Lead -- Geometric means and selected percentiles of whole blood concentrations (μg/dL) for the Canadian population aged 6-79 years Table a65 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a65 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a65 footnotes

Table a65 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a65 footnote a referrer

Table a65 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a65 footnote b referrer

Total, 6-79 years
1 5319 0.02 1.3
(1.2 - 1.4)
0.60
(0.56 - 0.64)
1.2
(1.2 - 1.3)
2.0
(1.8 - 2.2)
3.7
(3.3 - 4.2)
2 5575 0 1.2
(1.1 - 1.3)
0.54
(0.50 - 0.59)
1.2
(1.1 - 1.2)
1.8
(1.6 - 1.9)
3.2
(3.0 - 3.5)
Males, 6-79 years
1 2576 0 1.5
(1.4 - 1.6)
0.71
(0.65 - 0.76)
1.4
(1.3 - 1.5)
2.2
(1.9 - 2.4)
4.2
(3.6 - 4.7)
2 2687 0 1.3
(1.3 - 1.4)
0.62
(0.55 - 0.68)
1.3
(1.2 - 1.4)
1.9
(1.8 - 2.1)
3.5
(3.1 - 3.8)
Females, 6-79 years
1 2743 0.04 1.2
(1.1 - 1.3)
0.54
(0.50 - 0.59)
1.1
(0.98 - 1.2)
1.7
(1.5 - 1.9)
3.5
(3.0 - 3.9)
2 2888 0 1.1
(1.0 - 1.1)
0.50
(0.45 - 0.54)
1.1
(0.98 - 1.1)
1.5
(1.4 - 1.7)
2.8
(2.6 - 3.0)
 
Table 8.8.2: Lead -- Geometric means and selected percentiles of whole blood concentrations (μg/dL) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a66 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a66 footnotes

Table a66 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a66 footnote a referrer

Table a66 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a66 footnote b referrer

Total, 3-79 years
1Table a66 footnote b . . . . . . .
2 6070 0 1.2
(1.1 - 1.2)
0.54
(0.50 - 0.59)
1.2
(1.1 - 1.2)
1.7
(1.6 - 1.8)
3.2
(2.9 - 3.4)
3-5 years
1Table a66 footnote b . . . . . . .
2 495 0 0.93
(0.86 - 1.0)
0.51
(0.44 - 0.58)
0.93
(0.86 - 1.0)
1.2
(1.1 - 1.3)
2.1
(1.8 - 2.3)
6-11 years
1 910 0 0.89
(0.81 - 0.99)
0.53
(0.49 - 0.56)
0.87
(0.77 - 0.97)
1.1
(1.0 - 1.3)
1.9
(1.6 - 2.2)
2 961 0 0.79
(0.74 - 0.84)
0.43
(0.37 - 0.49)
0.74
(0.68 - 0.80)
1.0
(0.93 - 1.2)
1.8
(1.5 - 2.0)
12-19 years
1 945 0 0.79
(0.74 - 0.85)
0.47
(0.44 - 0.50)
0.76
(0.69 - 0.83)
1.0
(0.94 - 1.1)
1.6
(1.4 - 1.8)
2 997 0 0.71
(0.68 - 0.75)
0.39
(0.35 - 0.43)
0.68
(0.64 - 0.72)
0.94
(0.88 - 1.0)
1.6
(1.3 - 1.9)
20-39 years
1 1165 0.09 1.1
(1.0 - 1.2)
0.57
(0.52 - 0.62)
1.0
(0.94 - 1.1)
1.5
(1.3 - 1.7)
3.1
(2.7 - 3.4)
2 1313 0 0.98
(0.88 - 1.1)
0.49
(0.42 - 0.57)
0.95
(0.87 - 1.0)
1.3
(1.2 - 1.5)
2.2
(1.6 - 2.8)
40-59 years
1 1220 0 1.6
(1.5 - 1.8)
0.82
(0.69 - 0.94)
1.5
(1.4 - 1.6)
2.2
(1.9 - 2.5)
3.8
(3.1 - 4.5)
2 1222 0 1.4
(1.3 - 1.5)
0.70
(0.61 - 0.78)
1.4
(1.3 - 1.5)
2.0
(1.8 - 2.2)
3.2
(2.9 - 3.5)
60-79 years
1 1079 0 2.1
(1.9 - 2.3)
1.0
(0.92 - 1.1)
2.0
(1.8 - 2.2)
3.0
(2.6 - 3.3)
5.2
(4.2 - 6.2)
2 1082 0 1.9
(1.8 - 1.9)
1.0
(0.95 - 1.1)
1.8
(1.7 - 1.9)
2.5
(2.4 - 2.6)
4.2
(3.9 - 4.5)
 
Table 8.8.3: Lead -- Geometric means and selected percentiles of whole blood concentrations (μg/dL) for the Canadian population aged 3-79 years by sex and age group Table a67 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a67 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a67 footnotes

Table a67 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a67 footnote a referrer

Table a67 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a67 footnote b referrer

Table a67 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a67 footnote c referrer

Males, Total 3-79 years
1Table a67 footnote c . . . . . . .
2 2940 0 1.3
(1.3 - 1.4)
0.62
(0.56 - 0.68)
1.3
(1.2 - 1.4)
1.9
(1.7 - 2.1)
3.4
(3.1 - 3.7)
Males, 6-11 years
1 459 0 0.92
(0.85 - 0.99)
0.54
(0.50 - 0.58)
0.89
(0.79 - 0.99)
1.2
(1.1 - 1.3)
1.9
(1.8 - 2.1)
2 488 0 0.79
(0.73 - 0.86)
0.43
(0.35 - 0.52)
0.75
(0.67 - 0.82)
1.1
(0.96 - 1.2)
1.7
(1.4 - 1.9)
Males, 12-19 years
1 489 0 0.88
(0.81 - 0.95)
0.51
(0.46 - 0.55)
0.87
(0.79 - 0.95)
1.1
(0.99 - 1.2)
1.7
(1.3 - 2.2)
2 523 0 0.84
(0.80 - 0.87)
0.48
(0.45 - 0.52)
0.79
(0.73 - 0.84)
1.1
(1.0 - 1.1)
1.8
(1.6 - 2.1)
Males, 20-39 years
1 514 0 1.4
(1.3 - 1.5)
0.75
(0.65 - 0.85)
1.3
(1.1 - 1.4)
2.0
(1.6 - 2.3)
3.6
(2.9 - 4.3)
2 552 0 1.1
(1.0 - 1.3)
0.60
(0.44 - 0.75)
1.1
(0.95 - 1.2)
1.5
(1.4 - 1.7)
2.4E
(1.4 - 3.3)
Males, 40-59 years
1 577 0 1.7
(1.6 - 1.9)
0.98
(0.90 - 1.1)
1.6
(1.4 - 1.7)
2.3
(1.9 - 2.7)
4.0
(3.0 - 4.9)
2 617 0 1.6
(1.5 - 1.7)
0.84
(0.77 - 0.92)
1.6
(1.4 - 1.7)
2.1
(1.9 - 2.4)
3.5
(2.3 - 4.7)
Males, 60-79 years
1 537 0 2.3
(2.1 - 2.6)
1.1
(1.0 - 1.3)
2.2
(2.0 - 2.4)
3.3
(2.9 - 3.7)
6.2
(4.9 - 7.4)
2 507 0 2.0
(1.9 - 2.2)
1.1
(1.0 - 1.2)
2.0
(1.8 - 2.2)
2.7
(2.6 - 2.9)
4.2
(3.9 - 4.5)
Females, Total 3-79 years
1Table a67 footnote c . . . . . . .
2 3130 0 1.1
(1.0 - 1.1)
0.50
(0.45 - 0.54)
1.0
(0.98 - 1.1)
1.5
(1.4 - 1.6)
2.8
(2.6 - 3.0)
Females, 6-11 years
1 451 0 0.87
(0.77 - 0.99)
0.51
(0.45 - 0.57)
0.85
(0.73 - 0.96)
1.1
(0.88 - 1.3)
1.9
(1.2 - 2.5)
2 473 0 0.78
(0.72 - 0.85)
0.43
(0.37 - 0.49)
0.71
(0.63 - 0.78)
0.99
(0.84 - 1.1)
1.8
(1.5 - 2.1)
Females, 12-19 years
1 456 0 0.71
(0.66 - 0.77)
0.43
(0.37 - 0.48)
0.68
(0.61 - 0.75)
0.91
(0.80 - 1.0)
1.4
(1.2 - 1.6)
2 474 0 0.60
(0.56 - 0.65)
0.36
(0.32 - 0.39)
0.58
(0.52 - 0.63)
0.77
(0.70 - 0.84)
1.2
(1.1 - 1.4)
Females, 20-39 years
1 651 0.15 0.89
(0.81 - 0.97)
0.52
(0.46 - 0.57)
0.86
(0.77 - 0.96)
1.1
(1.0 - 1.3)
2.0
(1.7 - 2.3)
2 761 0 0.85
(0.74 - 0.98)
0.46
(0.36 - 0.56)
0.83
(0.73 - 0.93)
1.2
(1.0 - 1.4)
1.9
(1.4 - 2.4)
Females, 40-59 years
1 643 0 1.5
(1.3 - 1.6)
0.71
(0.59 - 0.82)
1.4
(1.2 - 1.6)
2.1
(1.7 - 2.4)
3.8
(3.1 - 4.5)
2 605 0 1.3
(1.2 - 1.4)
0.60
(0.52 - 0.68)
1.3
(1.2 - 1.4)
1.7
(1.5 - 2.0)
2.8
(2.5 - 3.0)
Females, 60-79 years
1 542 0 1.9
(1.7 - 2.1)
0.94
(0.82 - 1.0)
1.9
(1.6 - 2.1)
2.7
(2.3 - 3.0)
4.5
(3.8 - 5.2)
2 575 0 1.7
(1.6 - 1.8)
0.92
(0.79 - 1.1)
1.6
(1.5 - 1.8)
2.3
(2.1 - 2.5)
4.2
(3.5 - 4.8)
 
Table 8.8.4: Lead -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a68 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a68 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a68 footnotes

Table a68 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a68 footnote a referrer

Table a68 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a68 footnote b referrer

Total, 6-79 years
1 5492 7.54 0.48
(0.43 - 0.53)
<LODE
(<LOD - 0.16)
0.52
(0.47 - 0.58)
0.91
(0.83 - 1.0)
2.1
(1.8 - 2.4)
2 5738 16.23 0.52
(0.49 - 0.55)
<LOD 0.56
(0.52 - 0.60)
0.94
(0.87 - 1.0)
1.9
(1.7 - 2.0)
Males, 6-79 years
1 2662 5.86 0.54
(0.48 - 0.60)
0.14E
(<LOD - 0.22)
0.59
(0.55 - 0.64)
1.0
(0.93 - 1.1)
2.3
(1.8 - 2.7)
2 2746 13.44 0.57
(0.54 - 0.61)
<LOD 0.63
(0.58 - 0.68)
1.0
(0.91 - 1.1)
2.1
(1.9 - 2.2)
Females, 6-79 years
1 2830 9.12 0.42
(0.37 - 0.48)
<LODE
(<LOD - 0.13)
0.45
(0.39 - 0.51)
0.79
(0.69 - 0.90)
1.8
(1.5 - 2.1)
2 2992 18.78 0.47
(0.44 - 0.50)
<LOD 0.50
(0.46 - 0.54)
0.86
(0.79 - 0.92)
1.8
(1.6 - 1.9)
 
Table 8.8.5: Lead -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a69 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a69 footnotes

Table a69 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a69 footnote a referrer

Table a69 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a69 footnote b referrer

Total, 3-79 years
1Table a69 footnote b . . . . . . .
2 6311 16.43 0.52
(0.49 - 0.54)
<LOD 0.56
(0.52 - 0.60)
0.93
(0.86 - 1.0)
1.9
(1.7 - 2.0)
3-5 years
1Table a69 footnote b . . . . . . .
2 573 18.50 0.48
(0.42 - 0.54)
<LOD 0.53
(0.47 - 0.58)
0.78
(0.68 - 0.88)
1.6
(1.2 - 2.1)
6-11 years
1 1034 9.28 0.36
(0.32 - 0.39)
<LOD 0.41
(0.37 - 0.45)
0.64
(0.57 - 0.72)
1.3
(1.1 - 1.4)
2 1062 18.46 0.41
(0.37 - 0.45)
<LOD 0.46
(0.40 - 0.52)
0.70
(0.63 - 0.76)
1.3
(1.1 - 1.6)
12-19 years
1 983 10.17 0.39
(0.34 - 0.44)
<LOD 0.43
(0.40 - 0.46)
0.73
(0.64 - 0.83)
1.5
(1.2 - 1.8)
2 1041 19.02 0.41
(0.38 - 0.45)
<LOD 0.46
(0.42 - 0.50)
0.70
(0.66 - 0.75)
1.3
(1.0 - 1.5)
20-39 years
1 1169 9.50 0.40
(0.35 - 0.47)
F 0.45
(0.39 - 0.51)
0.75
(0.63 - 0.87)
1.8
(1.6 - 2.1)
2 1321 19.68 0.45
(0.41 - 0.49)
<LOD 0.46
(0.43 - 0.50)
0.79
(0.69 - 0.89)
1.7
(1.2 - 2.1)
40-59 years
1 1223 5.97 0.54
(0.47 - 0.63)
0.16E
(<LOD - 0.23)
0.61
(0.55 - 0.66)
0.99
(0.91 - 1.1)
2.3
(1.7 - 2.8)
2 1228 13.60 0.59
(0.54 - 0.66)
<LOD 0.66
(0.60 - 0.73)
1.0
(0.92 - 1.2)
2.0
(1.7 - 2.2)
60-79 years
1 1083 3.14 0.66
(0.60 - 0.73)
0.20
(0.15 - 0.24)
0.67
(0.62 - 0.73)
1.2
(1.1 - 1.4)
2.7
(2.1 - 3.3)
2 1086 10.13 0.65
(0.60 - 0.70)
<LOD 0.73
(0.65 - 0.81)
1.2
(1.1 - 1.3)
2.3
(2.0 - 2.7)
 
Table 8.8.6: Lead -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a70 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a70 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a70 footnotes

Table a70 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a70 footnote a referrer

Table a70 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a70 footnote b referrer

Table a70 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a70 footnote c referrer

Males, Total 3-79 years
1Table a70 footnote c . . . . . . .
2 3036 13.57 0.57
(0.53 - 0.61)
<LOD 0.62
(0.58 - 0.67)
1.0
(0.91 - 1.1)
2.0
(1.9 - 2.2)
Males, 6-11 years
1 524 6.87 0.37
(0.31 - 0.45)
F 0.43
(0.32 - 0.53)
0.68
(0.57 - 0.79)
1.3
(1.0 - 1.6)
2 532 17.48 0.40
(0.35 - 0.45)
<LOD 0.42
(0.36 - 0.49)
0.69
(0.62 - 0.75)
1.2
(0.99 - 1.4)
Males, 12-19 years
1 505 9.11 0.38
(0.33 - 0.44)
<LOD 0.41
(0.37 - 0.45)
0.69
(0.59 - 0.78)
1.3
(0.89 - 1.8)
2 542 16.97 0.44
(0.39 - 0.49)
<LOD 0.49
(0.42 - 0.55)
0.71
(0.64 - 0.79)
1.3
(0.89 - 1.6)
Males, 20-39 years
1 514 7.00 0.46
(0.37 - 0.57)
F 0.53
(0.42 - 0.64)
0.95
(0.78 - 1.1)
2.0
(1.5 - 2.4)
2 551 14.88 0.50
(0.45 - 0.55)
<LOD 0.53
(0.48 - 0.59)
0.85
(0.69 - 1.0)
1.6E
(0.98 - 2.1)
Males, 40-59 years
1 578 4.67 0.62
(0.54 - 0.72)
0.18
(0.12 - 0.23)
0.66
(0.60 - 0.72)
1.1
(0.94 - 1.2)
2.6
(1.8 - 3.5)
2 616 9.74 0.68
(0.61 - 0.77)
0.22
(<LOD - 0.30)
0.78
(0.66 - 0.90)
1.2
(0.98 - 1.4)
2.1
(1.8 - 2.5)
Males, 60-79 years
1 541 2.03 0.84
(0.74 - 0.95)
0.30
(0.23 - 0.38)
0.83
(0.67 - 1.0)
1.5
(1.3 - 1.7)
3.0
(2.6 - 3.5)
2 505 8.32 0.73
(0.67 - 0.80)
0.23
(<LOD - 0.31)
0.79
(0.70 - 0.89)
1.3
(1.2 - 1.5)
2.3
(2.0 - 2.6)
Females, Total 3-79 years
1Table a70 footnote c . . . . . . .
2 3275 19.08 0.47
(0.44 - 0.50)
<LOD 0.50
(0.46 - 0.54)
0.85
(0.79 - 0.92)
1.8
(1.6 - 1.9)
Females, 6-11 years
1 510 11.76 0.34
(0.31 - 0.38)
<LOD 0.40
(0.37 - 0.43)
0.61
(0.55 - 0.68)
1.2
(1.0 - 1.4)
2 530 19.43 0.43
(0.38 - 0.48)
<LOD 0.48
(0.39 - 0.56)
0.75
(0.68 - 0.83)
1.5
(1.1 - 2.0)
Females, 12-19 years
1 478 11.30 0.40
(0.35 - 0.46)
F 0.44
(0.40 - 0.47)
0.79
(0.67 - 0.91)
1.6E
(0.84 - 2.3)
2 499 21.24 0.39
(0.35 - 0.44)
<LOD 0.44
(0.38 - 0.50)
0.69
(0.62 - 0.76)
1.3
(1.0 - 1.6)
Females, 20-39 years
1 655 11.45 0.35
(0.30 - 0.40)
F 0.39
(0.34 - 0.45)
0.65
(0.55 - 0.75)
1.3
(1.1 - 1.5)
2 770 23.12 0.40
(0.35 - 0.45)
<LOD 0.40
(0.35 - 0.45)
0.70
(0.57 - 0.84)
1.7
(1.1 - 2.2)
Females, 40-59 years
1 645 7.13 0.47
(0.39 - 0.57)
0.15E
(<LOD - 0.24)
0.53
(0.41 - 0.65)
0.94
(0.85 - 1.0)
2.0
(1.5 - 2.5)
2 612 17.48 0.52
(0.45 - 0.60)
<LOD 0.60
(0.51 - 0.69)
0.97
(0.83 - 1.1)
1.6
(1.3 - 1.8)
Females, 60-79 years
1 542 4.24 0.53
(0.44 - 0.64)
0.13E
(<LOD - 0.23)
0.57
(0.45 - 0.68)
1.0
(0.83 - 1.2)
2.2E
(1.1 - 3.3)
2 581 11.70 0.59
(0.52 - 0.66)
<LOD 0.64
(0.53 - 0.75)
1.1
(0.91 - 1.3)
2.4
(1.6 - 3.2)
 
Table 8.8.7: Lead (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 6-79 years Table a71 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a71 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a71 footnotes

Table a71 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a71 footnote a referrer

Table a71 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a71 footnote b referrer

Total, 6-79 years
1 5479 7.56 0.58
(0.53 - 0.63)
<LOD
(<LOD - 0.27)
0.57
(0.51 - 0.63)
0.93
(0.85 - 1.0)
2.0
(1.7 - 2.2)
2 5719 16.28 0.48
(0.46 - 0.51)
<LOD 0.48
(0.46 - 0.51)
0.77
(0.68 - 0.86)
1.6
(1.4 - 1.8)
Males, 6-79 years
1 2653 5.88 0.54
(0.50 - 0.58)
0.23
(<LOD - 0.25)
0.53
(0.48 - 0.57)
0.86
(0.77 - 0.95)
1.8
(1.4 - 2.2)
2 2739 13.47 0.46
(0.43 - 0.48)
<LOD 0.45
(0.43 - 0.48)
0.70
(0.60 - 0.80)
1.5
(1.2 - 1.8)
Females, 6-79 years
1 2826 9.13 0.63
(0.56 - 0.70)
<LOD
(<LOD - 0.28)
0.62
(0.54 - 0.70)
1.0
(0.88 - 1.1)
2.0
(1.6 - 2.4)
2 2980 18.86 0.51
(0.48 - 0.55)
<LOD 0.52
(0.47 - 0.57)
0.83
(0.72 - 0.94)
1.7
(1.5 - 1.8)
 
Table 8.8.8: Lead (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a72 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a72 footnotes

Table a72 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a72 footnote a referrer

Table a72 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a72 footnote b referrer

Total, 3-79 years
1Table a72 footnote b . . . . . . .
2 6291 16.48 0.49
(0.47 - 0.52)
<LOD 0.49
(0.46 - 0.52)
0.79
(0.71 - 0.87)
1.6
(1.5 - 1.8)
3-5 years
1Table a72 footnote b . . . . . . .
2 572 18.53 0.81
(0.71 - 0.93)
<LOD 0.83
(0.69 - 0.97)
1.2
(1.1 - 1.3)
2.7
(2.2 - 3.2)
6-11 years
1 1031 9.31 0.56
(0.51 - 0.61)
<LOD 0.54
(0.46 - 0.61)
0.81
(0.71 - 0.90)
1.6
(1.2 - 1.9)
2 1058 18.53 0.46
(0.43 - 0.50)
<LOD 0.48
(0.45 - 0.51)
0.70
(0.65 - 0.75)
1.3
(1.1 - 1.4)
12-19 years
1 982 10.18 0.34
(0.30 - 0.38)
<LOD 0.33
(0.30 - 0.37)
0.51
(0.44 - 0.57)
1.0
(0.72 - 1.3)
2 1039 19.06 0.31
(0.29 - 0.33)
<LOD 0.30
(0.28 - 0.33)
0.48
(0.43 - 0.54)
0.85
(0.68 - 1.0)
20-39 years
1 1165 9.53 0.45
(0.41 - 0.50)
<LOD
(<LOD - 0.24)
0.45
(0.42 - 0.48)
0.69
(0.62 - 0.76)
1.3
(1.0 - 1.6)
2 1319 19.71 0.37
(0.34 - 0.40)
<LOD 0.35
(0.31 - 0.39)
0.57
(0.50 - 0.65)
1.1
(0.83 - 1.3)
40-59 years
1 1218 5.99 0.70
(0.63 - 0.78)
0.30
(<LOD - 0.34)
0.69
(0.61 - 0.77)
1.1
(0.93 - 1.2)
2.0
(1.6 - 2.4)
2 1223 13.65 0.57
(0.53 - 0.61)
<LOD 0.55
(0.50 - 0.59)
0.84
(0.71 - 0.98)
1.7
(1.4 - 2.1)
60-79 years
1 1083 3.14 0.93
(0.84 - 1.0)
0.41
(0.35 - 0.47)
0.93
(0.82 - 1.0)
1.4
(1.3 - 1.5)
2.8
(2.3 - 3.3)
2 1080 10.19 0.77
(0.71 - 0.83)
<LOD 0.80
(0.71 - 0.88)
1.1
(1.1 - 1.2)
2.1
(1.8 - 2.4)
 
Table 8.8.9: Lead (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a73 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a73 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a73 footnotes

Table a73 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a73 footnote a referrer

Table a73 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a73 footnote b referrer

Table a73 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a73 footnote c referrer

Males, Total 3-79 years
1Table a73 footnote c . . . . . . .
2 3028 13.61 0.46
(0.44 - 0.49)
<LOD 0.46
(0.43 - 0.49)
0.73
(0.63 - 0.82)
1.5
(1.3 - 1.8)
Males, 6-11 years
1 522 6.90 0.57
(0.53 - 0.63)
<LOD
(<LOD - 0.30)
0.57
(0.48 - 0.65)
0.84
(0.75 - 0.94)
1.7
(1.2 - 2.1)
2 530 17.55 0.43
(0.39 - 0.48)
<LOD 0.46
(0.42 - 0.49)
0.66
(0.61 - 0.72)
1.1
(0.97 - 1.3)
Males, 12-19 years
1 504 9.13 0.32
(0.29 - 0.36)
<LOD 0.31
(0.28 - 0.35)
0.50
(0.44 - 0.57)
0.96
(0.64 - 1.3)
2 541 17.01 0.30
(0.27 - 0.32)
<LOD 0.29
(0.25 - 0.32)
0.47
(0.37 - 0.57)
0.85
(0.59 - 1.1)
Males, 20-39 years
1 512 7.03 0.43
(0.38 - 0.49)
<LOD
(<LOD - 0.26)
0.43
(0.40 - 0.47)
0.66
(0.57 - 0.75)
1.3E
(0.74 - 1.9)
2 550 14.91 0.35
(0.30 - 0.40)
<LOD 0.32
(0.24 - 0.39)
0.55
(0.44 - 0.66)
1.0E
(0.65 - 1.4)
Males, 40-59 years
1 574 4.70 0.62
(0.55 - 0.69)
0.29
(0.26 - 0.31)
0.60
(0.52 - 0.67)
0.93
(0.80 - 1.1)
1.8E
(1.1 - 2.5)
2 615 9.76 0.55
(0.51 - 0.59)
0.26
(<LOD - 0.32)
0.51
(0.45 - 0.56)
0.75
(0.61 - 0.88)
1.8
(1.2 - 2.5)
Males, 60-79 years
1 541 2.03 0.88
(0.82 - 0.96)
0.41
(0.39 - 0.44)
0.86
(0.77 - 0.96)
1.3
(1.1 - 1.5)
2.3
(1.5 - 3.1)
2 503 8.35 0.71
(0.65 - 0.77)
0.33
(<LOD - 0.40)
0.71
(0.61 - 0.81)
1.1
(1.0 - 1.1)
1.7
(1.4 - 2.0)
Females, Total 3-79 years
1Table a73 footnote c . . . . . . .
2 3263 19.15 0.52
(0.49 - 0.56)
<LOD 0.53
(0.48 - 0.58)
0.86
(0.75 - 0.96)
1.7
(1.5 - 1.9)
Females, 6-11 years
1 509 11.79 0.54
(0.47 - 0.61)
<LOD 0.53
(0.45 - 0.60)
0.79
(0.68 - 0.90)
1.5
(1.1 - 1.9)
2 528 19.51 0.50
(0.46 - 0.54)
<LOD 0.51
(0.47 - 0.54)
0.73
(0.65 - 0.81)
1.4E
(0.89 - 2.0)
Females, 12-19 years
1 478 11.30 0.36
(0.31 - 0.43)
<LOD
(<LOD - 0.21)
0.35
(0.31 - 0.38)
0.52
(0.41 - 0.63)
1.1E
(0.52 - 1.6)
2 498 21.29 0.32
(0.29 - 0.35)
<LOD 0.32
(0.28 - 0.35)
0.49
(0.43 - 0.55)
0.86
(0.70 - 1.0)
Females, 20-39 years
1 653 11.49 0.48
(0.43 - 0.54)
<LOD
(<LOD - 0.24)
0.46
(0.43 - 0.49)
0.72
(0.63 - 0.82)
1.4
(0.98 - 1.8)
2 769 23.15 0.39
(0.35 - 0.44)
<LOD 0.38
(0.32 - 0.44)
0.61
(0.51 - 0.70)
1.1
(0.84 - 1.3)
Females, 40-59 years
1 644 7.14 0.79
(0.69 - 0.90)
0.35
(<LOD - 0.43)
0.78
(0.68 - 0.88)
1.2
(0.98 - 1.4)
2.0
(1.4 - 2.7)
2 608 17.60 0.60
(0.52 - 0.68)
<LOD 0.60
(0.52 - 0.68)
0.94
(0.77 - 1.1)
1.6
(1.3 - 1.9)
Females, 60-79 years
1 542 4.24 0.97
(0.82 - 1.1)
0.41
(<LOD - 0.55)
0.99
(0.83 - 1.2)
1.5
(1.3 - 1.7)
3.0
(2.3 - 3.6)
2 577 11.79 0.83
(0.74 - 0.93)
<LOD 0.86
(0.75 - 0.96)
1.2
(1.0 - 1.4)
2.3
(1.8 - 2.8)
 
Table 8.9.1: Manganese -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 6-79 years Table a74 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a74 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a74 footnotes

Table a74 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a74 footnote a referrer

Table a74 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a74 footnote b referrer

Total, 6-79 years
1 5309 0 9.2
(9.0 - 9.5)
6.3
(6.1 - 6.5)
9.0
(8.8 - 9.3)
11
(10 - 11)
15
(15 - 16)
2 5575 0 9.8
(9.5 - 10)
6.6
(6.4 - 6.9)
9.5
(9.2 - 9.8)
11
(11 - 12)
15
(14 - 16)
Males, 6-79 years
1 2572 0 8.8
(8.5 - 9.0)
6.2
(5.8 - 6.5)
8.6
(8.4 - 8.9)
10
(9.7 - 10)
14
(13 - 15)
2 2687 0 9.3
(8.9 - 9.7)
6.3
(5.9 - 6.8)
9.1
(8.6 - 9.6)
11
(10 - 11)
14
(14 - 15)
Females, 6-79 years
1 2737 0 9.7
(9.4 - 9.9)
6.6
(6.3 - 6.8)
9.5
(9.2 - 9.8)
11
(11 - 12)
16
(15 - 17)
2 2888 0 10
(9.8 - 11)
7.0
(6.6 - 7.3)
9.8
(9.5 - 10)
12
(12 - 13)
16
(15 - 17)
 
Table 8.9.2: Manganese -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a75 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a75 footnotes

Table a75 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a75 footnote a referrer

Table a75 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a75 footnote b referrer

Total, 3-79 years
1Table a75 footnote b . . . . . . .
2 6070 0 9.8
(9.5 - 10)
6.7
(6.4 - 6.9)
9.5
(9.2 - 9.8)
12
(11 - 12)
15
(14 - 16)
3-5 years
1Table a75 footnote b . . . . . . .
2 495 0 11
(11 - 12)
7.6
(7.4 - 7.9)
11
(10 - 11)
13
(12 - 14)
18
(15 - 21)
6-11 years
1 907 0 9.9
(9.6 - 10)
6.9
(6.7 - 7.2)
9.7
(9.4 - 10)
11
(11 - 12)
16
(15 - 17)
2 961 0 11
(10 - 11)
7.7
(7.5 - 7.9)
11
(10 - 11)
12
(12 - 13)
16
(15 - 17)
12-19 years
1 942 0 10
(9.7 - 10)
6.7
(6.4 - 6.9)
9.9
(9.7 - 10)
12
(11 - 13)
16
(15 - 16)
2 997 0 10
(9.8 - 11)
7.0
(6.6 - 7.4)
9.9
(9.5 - 10)
12
(12 - 13)
16
(15 - 17)
20-39 years
1 1162 0 9.1
(8.8 - 9.5)
6.3
(6.0 - 6.5)
9.0
(8.7 - 9.3)
11
(10 - 11)
16
(15 - 17)
2 1313 0 9.8
(9.3 - 10)
6.4
(5.8 - 7.0)
9.7
(9.2 - 10)
12
(11 - 12)
16
(14 - 17)
40-59 years
1 1219 0 9.1
(8.8 - 9.5)
6.4
(6.1 - 6.7)
8.9
(8.5 - 9.3)
10
(10 - 11)
15
(13 - 16)
2 1222 0 9.7
(9.2 - 10)
6.7
(6.4 - 7.0)
9.2
(8.7 - 9.7)
11
(11 - 12)
15
(14 - 16)
60-79 years
1 1079 0 8.8
(8.6 - 9.1)
5.9
(5.5 - 6.3)
8.8
(8.4 - 9.2)
10
(10 - 11)
14
(13 - 15)
2 1082 0 9.4
(9.1 - 9.7)
6.5
(6.3 - 6.7)
8.9
(8.6 - 9.2)
11
(10 - 12)
15
(14 - 15)
 
Table 8.9.3: Manganese -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a76 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a76 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a76 footnotes

Table a76 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a76 footnote a referrer

Table a76 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a76 footnote b referrer

Table a76 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a76 footnote c referrer

Males, Total 3-79 years
1Table a76 footnote c . . . . . . .
2 2940 0 9.4
(9.0 - 9.8)
6.4
(5.9 - 6.8)
9.1
(8.6 - 9.6)
11
(11 - 11)
14
(14 - 15)
Males, 6-11 years
1 458 0 9.5
(9.1 - 9.9)
6.6
(6.0 - 7.1)
9.3
(8.9 - 9.7)
11
(11 - 12)
15
(12 - 18)
2 488 0 10
(10 - 11)
7.5
(7.1 - 7.8)
10
(9.6 - 11)
12
(11 - 13)
15
(13 - 16)
Males, 12-19 years
1 489 0 9.4
(9.0 - 9.9)
6.5
(6.2 - 6.7)
9.4
(9.0 - 9.9)
11
(9.9 - 12)
14
(14 - 15)
2 523 0 9.8
(9.4 - 10)
6.7
(6.2 - 7.2)
9.5
(9.1 - 10)
12
(11 - 12)
15
(13 - 17)
Males, 20-39 years
1 511 0 8.6
(8.3 - 8.9)
6.2
(5.9 - 6.5)
8.4
(8.0 - 8.8)
10
(9.7 - 10)
13
(12 - 14)
2 552 0 9.0
(8.3 - 9.8)
5.9
(5.1 - 6.7)
9.0
(8.0 - 10)
11
(10 - 11)
14
(13 - 15)
Males, 40-59 years
1 577 0 8.8
(8.4 - 9.2)
6.2
(5.6 - 6.9)
8.7
(8.2 - 9.1)
10
(9.7 - 10)
14
(12 - 15)
2 617 0 9.3
(8.8 - 9.9)
6.6
(6.1 - 7.2)
9.0
(8.4 - 9.5)
11
(10 - 12)
14
(13 - 15)
Males, 60-79 years
1 537 0 8.4
(8.1 - 8.8)
5.6
(5.3 - 5.9)
8.2
(7.7 - 8.7)
10
(9.6 - 10)
14
(13 - 15)
2 507 0 9.2
(9.0 - 9.5)
6.3
(6.0 - 6.6)
8.7
(8.3 - 9.0)
11
(10 - 11)
15
(14 - 16)
Females, Total 3-79 years
1Table a76 footnote c . . . . . . .
2 3130 0 10
(9.9 - 11)
7.0
(6.7 - 7.3)
9.9
(9.5 - 10)
12
(12 - 13)
16
(15 - 17)
Females, 6-11 years
1 449 0 10
(10 - 11)
7.4
(6.9 - 7.8)
10
(9.7 - 10)
12
(11 - 12)
16
(15 - 17)
2 473 0 11
(11 - 12)
8.0
(7.6 - 8.4)
11
(10 - 11)
13
(12 - 13)
16
(15 - 18)
Females, 12-19 years
1 453 0 11
(10 - 11)
7.1
(6.6 - 7.7)
10
(9.9 - 11)
13
(12 - 14)
17
(16 - 18)
2 474 0 11
(10 - 11)
7.4
(6.9 - 7.9)
10
(9.8 - 11)
12
(12 - 13)
17
(16 - 18)
Females, 20-39 years
1 651 0 9.8
(9.2 - 10)
6.5
(6.0 - 7.0)
9.5
(8.9 - 10)
12
(11 - 12)
17
(15 - 19)
2 761 0 11
(9.9 - 11)
7.2
(6.7 - 7.8)
10
(9.5 - 11)
12
(11 - 14)
16
(15 - 17)
Females, 40-59 years
1 642 0 9.5
(9.0 - 10)
6.4
(6.1 - 6.8)
9.2
(8.6 - 9.8)
11
(10 - 12)
16
(13 - 18)
2 605 0 10
(9.5 - 11)
6.8
(6.3 - 7.2)
9.6
(8.8 - 10)
12
(11 - 13)
16
(15 - 17)
Females, 60-79 years
1 542 0 9.2
(9.0 - 9.5)
6.6
(6.3 - 6.9)
9.4
(9.0 - 9.8)
11
(10 - 11)
14
(13 - 15)
2 575 0 9.5
(9.1 - 10)
6.6
(6.4 - 6.9)
9.1
(8.7 - 9.5)
11
(10 - 12)
14
(13 - 16)
 
Table 8.9.4: Manganese -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a77 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a77 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a77 footnotes

Table a77 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a77 footnote a referrer

Table a77 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a77 footnote b referrer

Total, 6-79 years
1 5431 35.54 0.081
(0.072 - 0.092)
<LOD 0.079
(0.067 - 0.091)
0.12
(0.087 - 0.15)
0.37
(0.32 - 0.43)
2 5738 70.83 -- <LOD <LOD <LOD 0.36
(0.32 - 0.40)
Males, 6-79 years
1 2639 38.16 0.078
(0.068 - 0.089)
<LOD 0.073
(0.060 - 0.087)
0.11
(0.074 - 0.14)
0.37
(0.29 - 0.46)
2 2746 75.82 -- <LOD <LOD <LOD 0.30
(0.27 - 0.33)
Females, 6-79 years
1 2792 33.06 0.085
(0.076 - 0.095)
<LOD 0.085
(0.074 - 0.095)
0.13
(0.10 - 0.16)
0.37
(0.33 - 0.41)
2 2992 66.24 -- <LOD <LOD <LOD
(<LOD - 0.20)
0.41
(0.32 - 0.50)
 
Table 8.9.5: Manganese -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a78 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a78 footnotes

Table a78 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a78 footnote a referrer

Table a78 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a78 footnote b referrer

Total, 3-79 years
1Table a78 footnote b . . . . . . .
2 6309 70.41 -- <LOD <LOD <LOD 0.36
(0.32 - 0.40)
3-5 years
1Table a78 footnote b . . . . . . .
2 571 66.20 -- <LOD <LOD <LOD
(<LOD - 0.23)
0.54E
(0.30 - 0.77)
6-11 years
1 1032 38.08 0.082
(0.073 - 0.092)
<LOD 0.077
(0.063 - 0.090)
0.12
(0.094 - 0.15)
0.41
(0.32 - 0.49)
2 1062 68.17 -- <LOD <LOD <LOD
(<LOD - 0.22)
0.42
(0.35 - 0.50)
12-19 years
1 981 32.31 0.088
(0.079 - 0.098)
<LOD 0.089
(0.082 - 0.096)
0.13
(0.10 - 0.16)
0.37
(0.30 - 0.45)
2 1041 67.63 -- <LOD <LOD <LOD
(<LOD - 0.20)
0.39
(0.31 - 0.46)
20-39 years
1 1153 38.16 0.079
(0.068 - 0.092)
<LOD 0.075
(0.060 - 0.090)
0.12
(0.081 - 0.16)
0.38
(0.30 - 0.47)
2 1321 72.90 -- <LOD <LOD <LOD 0.32
(0.28 - 0.37)
40-59 years
1 1203 35.91 0.081
(0.068 - 0.095)
<LOD 0.079
(0.063 - 0.094)
0.11
(0.076 - 0.15)
0.35
(0.28 - 0.42)
2 1228 74.02 -- <LOD <LOD <LOD 0.36
(0.29 - 0.42)
60-79 years
1 1062 32.77 0.082
(0.073 - 0.092)
<LOD 0.078
(0.065 - 0.090)
0.12
(0.087 - 0.15)
0.38
(0.29 - 0.46)
2 1086 70.35 -- <LOD <LOD <LOD 0.38
(0.33 - 0.44)
 
Table 8.9.6: Manganese -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a79 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a79 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a79 footnotes

Table a79 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a79 footnote a referrer

Table a79 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a79 footnote b referrer

Table a79 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a79 footnote c referrer

Males, Total 3-79 years
1Table a79 footnote c . . . . . . .
2 3036 75.66 -- <LOD <LOD <LOD 0.30
(0.27 - 0.33)
Males, 6-11 years
1 524 39.89 0.078
(0.070 - 0.087)
<LOD 0.073
(0.065 - 0.081)
0.10
(0.071 - 0.13)
0.39
(0.27 - 0.50)
2 532 75.38 -- <LOD <LOD <LOD 0.32
(0.24 - 0.39)
Males, 12-19 years
1 505 35.25 0.079
(0.069 - 0.091)
<LOD 0.078
(0.062 - 0.094)
0.11
(0.077 - 0.14)
0.36
(0.24 - 0.48)
2 542 73.43 -- <LOD <LOD <LOD 0.25
(<LOD - 0.31)
Males, 20-39 years
1 510 40.20 -- <LOD 0.073
(0.051 - 0.095)
0.11E
(0.056 - 0.17)
0.44E
(0.26 - 0.62)
2 551 75.86 -- <LOD <LOD <LOD 0.30
(0.24 - 0.37)
Males, 40-59 years
1 572 38.64 0.077
(0.064 - 0.094)
<LOD 0.073
(0.053 - 0.093)
0.11
(0.074 - 0.14)
0.33
(0.22 - 0.44)
2 616 77.27 -- <LOD <LOD <LOD 0.28
(0.23 - 0.32)
Males, 60-79 years
1 528 36.74 0.076
(0.061 - 0.094)
<LOD 0.072
(0.051 - 0.092)
0.10E
(0.061 - 0.14)
0.35E
(0.20 - 0.49)
2 505 77.03 -- <LOD <LOD <LOD 0.35
(0.29 - 0.42)
Females, Total 3-79 years
1Table a79 footnote c . . . . . . .
2 3273 65.54 -- <LOD <LOD <LOD
(<LOD - 0.20)
0.42
(0.32 - 0.52)
Females, 6-11 years
1 508 36.22 0.086
(0.073 - 0.10)
<LOD 0.084
(0.061 - 0.11)
0.14
(0.10 - 0.19)
0.43
(0.31 - 0.54)
2 530 60.94 -- <LOD <LOD 0.24
(0.20 - 0.28)
0.62E
(0.33 - 0.92)
Females, 12-19 years
1 476 29.2 0.098
(0.087 - 0.11)
<LOD 0.093
(0.089 - 0.096)
0.15
(0.12 - 0.17)
0.38
(0.29 - 0.48)
2 499 61.32 -- <LOD <LOD <LOD
(<LOD - 0.22)
0.49E
(0.25 - 0.73)
Females, 20-39 years
1 643 36.55 0.080
(0.068 - 0.094)
<LOD 0.077
(0.059 - 0.096)
0.12
(0.090 - 0.16)
0.35
(0.28 - 0.43)
2 770 70.78 -- <LOD <LOD <LOD 0.34
(0.29 - 0.40)
Females, 40-59 years
1 631 33.44 0.084
(0.070 - 0.10)
<LOD 0.083
(0.071 - 0.096)
0.12E
(0.071 - 0.17)
0.37
(0.28 - 0.45)
2 612 70.75 -- <LOD <LOD <LOD
(<LOD - 0.22)
0.43E
(0.24 - 0.62)
Females, 60-79 years
1 534 28.84 0.088
(0.077 - 0.10)
<LOD 0.086
(0.067 - 0.10)
0.13
(0.096 - 0.17)
0.39E
(0.22 - 0.56)
2 581 64.54 -- <LOD <LOD <LOD 0.42E
(0.22 - 0.62)
 
Table 8.9.7: Manganese (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 6-79 years Table a80 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a80 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a80 footnotes

Table a80 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a80 footnote a referrer

Table a80 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a80 footnote b referrer

Total, 6-79 years
1 5418 35.62 0.097
(0.085 - 0.11)
<LOD 0.091
(0.081 - 0.10)
0.19
(0.15 - 0.23)
0.70
(0.57 - 0.83)
2 5719 71.06 -- <LOD <LOD <LOD 0.61
(0.51 - 0.70)
Males, 6-79 years
1 2630 38.29 0.075
(0.065 - 0.087)
<LOD 0.073
(0.062 - 0.084)
0.14
(0.10 - 0.17)
0.48
(0.34 - 0.62)
2 2739 76.01 -- <LOD <LOD <LOD 0.42
(0.34 - 0.51)
Females, 6-79 years
1 2788 33.11 0.12
(0.11 - 0.14)
<LOD 0.11
(0.10 - 0.13)
0.24
(0.21 - 0.27)
0.84
(0.70 - 0.99)
2 2980 66.51 -- <LOD <LOD <LOD
(<LOD - 0.26)
0.72
(0.63 - 0.81)
 
Table 8.9.8: Manganese (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a81 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a81 footnotes

Table a81 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a81 footnote a referrer

Table a81 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a81 footnote b referrer

Total, 3-79 years
1Table a81 footnote b . . . . . . .
2 6289 70.63 -- <LOD <LOD <LOD 0.61
(0.53 - 0.68)
3-5 years
1Table a81 footnote b . . . . . . .
2 570 66.32 -- <LOD <LOD <LOD
(<LOD - 0.52)
1.2
(0.81 - 1.5)
6-11 years
1 1029 38.19 0.12
(0.11 - 0.14)
<LOD 0.11
(0.091 - 0.12)
0.23
(0.18 - 0.28)
0.82
(0.66 - 0.99)
2 1058 68.43 -- <LOD <LOD <LOD
(<LOD - 0.25)
0.69
(0.55 - 0.82)
12-19 years
1 980 32.35 0.076
(0.064 - 0.090)
<LOD 0.071
(0.055 - 0.087)
0.14
(0.10 - 0.17)
0.49E
(0.31 - 0.67)
2 1039 67.76 -- <LOD <LOD <LOD
(<LOD - 0.18)
0.39
(0.26 - 0.53)
20-39 years
1 1149 38.29 0.086
(0.075 - 0.10)
<LOD 0.081
(0.070 - 0.091)
0.17
(0.13 - 0.22)
0.61E
(0.38 - 0.85)
2 1319 73.01 -- <LOD <LOD <LOD 0.58
(0.40 - 0.76)
40-59 years
1 1198 36.06 0.10
(0.085 - 0.12)
<LOD 0.093
(0.081 - 0.10)
0.19
(0.14 - 0.24)
0.78
(0.57 - 0.99)
2 1223 74.33 -- <LOD <LOD <LOD 0.70E
(0.42 - 0.99)
60-79 years
1 1062 32.77 0.11
(0.10 - 0.13)
<LOD 0.11
(0.095 - 0.12)
0.23
(0.21 - 0.25)
0.76
(0.62 - 0.91)
2 1080 70.74 -- <LOD <LOD <LOD 0.61
(0.51 - 0.70)
 
Table 8.9.9: Manganese (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a82 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a82 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a82 footnotes

Table a82 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a82 footnote a referrer

Table a82 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a82 footnote b referrer

Table a82 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a82 footnote c referrer

Males, Total 3-79 years
1Table a82 footnote c . . . . . . .
2 3028 75.86 -- <LOD <LOD <LOD 0.44
(0.35 - 0.53)
Males, 6-11 years
1 522 40.04 -- <LOD 0.10
(0.082 - 0.12)
0.21
(0.16 - 0.26)
0.73
(0.49 - 0.98)
2 530 75.66 -- <LOD <LOD <LOD 0.38
(0.28 - 0.48)
Males, 12-19 years
1 504 35.32 0.066
(0.055 - 0.078)
<LOD 0.064
(0.051 - 0.077)
0.12
(0.097 - 0.14)
0.31E
(0.15 - 0.47)
2 541 73.57 -- <LOD <LOD <LOD 0.26
(<LOD - 0.30)
Males, 20-39 years
1 508 40.35 -- <LOD 0.070
(0.055 - 0.086)
0.13E
(0.075 - 0.19)
0.42E
(0.22 - 0.63)
2 550 76.00 -- <LOD <LOD <LOD 0.44E
(0.22 - 0.66)
Males, 40-59 years
1 568 38.91 0.076
(0.061 - 0.094)
<LOD 0.072
(0.052 - 0.091)
0.13
(0.092 - 0.17)
0.55E
(0.23 - 0.86)
2 615 77.40 -- <LOD <LOD <LOD 0.47
(0.31 - 0.63)
Males, 60-79 years
1 528 36.74 0.079
(0.064 - 0.096)
<LOD 0.074
(0.056 - 0.091)
0.15
(0.10 - 0.20)
0.44
(0.31 - 0.56)
2 503 77.34 -- <LOD <LOD <LOD 0.49
(0.34 - 0.63)
Females, Total 3-79 years
1Table a82 footnote c . . . . . . .
2 3261 65.78 -- <LOD <LOD <LOD
(<LOD - 0.27)
0.74
(0.62 - 0.86)
Females, 6-11 years
1 507 36.29 0.13
(0.11 - 0.15)
<LOD 0.12
(0.094 - 0.14)
0.26
(0.21 - 0.31)
0.85
(0.66 - 1.1)
2 528 61.17 -- <LOD <LOD 0.29
(0.26 - 0.32)
0.78
(0.57 - 1.0)
Females, 12-19 years
1 476 29.20 0.088
(0.072 - 0.11)
<LOD 0.084
(0.064 - 0.10)
0.15
(0.11 - 0.19)
0.62
(0.43 - 0.82)
2 498 61.45 -- <LOD <LOD <LOD
(<LOD - 0.24)
0.56
(0.47 - 0.65)
Females, 20-39 years
1 641 36.66 0.11
(0.088 - 0.13)
<LOD 0.10
(0.084 - 0.12)
0.21
(0.16 - 0.26)
0.73E
(0.22 - 1.2)
2 769 70.87 -- <LOD <LOD <LOD 0.61
(0.42 - 0.79)
Females, 40-59 years
1 630 33.49 0.14
(0.12 - 0.16)
<LOD 0.12
(0.095 - 0.14)
0.26
(0.20 - 0.32)
0.87
(0.70 - 1.0)
2 608 71.22 -- <LOD <LOD <LOD
(<LOD - 0.29)
0.92E
(0.52 - 1.3)
Females, 60-79 years
1 534 28.84 0.16
(0.13 - 0.19)
<LOD 0.15
(0.12 - 0.18)
0.27
(0.23 - 0.31)
1.1E
(0.56 - 1.6)
2 577 64.99 -- <LOD <LOD <LOD
(<LOD - 0.32)
0.66
(0.45 - 0.88)
 
Table 8.10.1: Mercury (total) -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 6-79 years Table a83 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a83 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a83 footnotes

Table a83 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a83 footnote a referrer

Table a83 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a83 footnote b referrer

Total, 6-79 years
1 5319 11.64 0.69
(0.55 - 0.86)
<LOD 0.81
(0.64 - 0.97)
1.5
(1.1 - 2.0)
4.6E
(2.5 - 6.7)
2 5575 14.28 0.72
(0.57 - 0.90)
<LOD 0.77
(0.57 - 0.96)
1.7
(1.3 - 2.2)
5.6E
(3.3 - 7.8)
Males, 6-79 years
1 2576 12.11 0.68
(0.55 - 0.84)
<LOD 0.79
(0.64 - 0.94)
1.6
(1.1 - 2.0)
5.1E
(2.6 - 7.5)
2 2687 14.77 0.74
(0.58 - 0.95)
<LOD 0.80
(0.56 - 1.0)
2.0
(1.5 - 2.5)
6.3E
(2.9 - 9.8)
Females, 6-79 years
1 2743 11.19 0.70
(0.56 - 0.88)
<LODE
(<LOD - 0.11)
0.82
(0.63 - 1.0)
1.5
(1.1 - 1.9)
4.4E
(2.5 - 6.3)
2 2888 13.82 0.69
(0.55 - 0.86)
<LOD 0.74
(0.56 - 0.92)
1.6
(1.2 - 2.0)
5.1E
(3.0 - 7.2)
 
Table 8.10.2: Mercury (total) -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a84 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a84 footnotes

Table a84 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a84 footnote a referrer

Table a84 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a84 footnote b referrer

Total, 3-79 years
1Table a84 footnote b . . . . . . .
2 6070 15.55 0.70
(0.56 - 0.87)
<LOD 0.74
(0.55 - 0.93)
1.7
(1.3 - 2.1)
5.5E
(3.3 - 7.6)
3-5 years
1Table a84 footnote b . . . . . . .
2 495 29.90 0.27
(0.20 - 0.37)
<LOD 0.20E
(0.11 - 0.28)
F 3.0E
(1.7 - 4.3)
6-11 years
1 910 24.84 0.26
(0.22 - 0.32)
<LOD 0.24
(0.18 - 0.29)
0.66
(0.47 - 0.85)
2.1E
(1.3 - 2.9)
2 961 29.03 0.28
(0.22 - 0.34)
<LOD 0.21E
(0.11 - 0.30)
0.62
(0.47 - 0.78)
2.0
(1.3 - 2.6)
12-19 years
1 945 20.85 0.30
(0.23 - 0.40)
<LOD 0.28
(0.20 - 0.37)
0.76E
(0.47 - 1.0)
2.2E
(0.88 - 3.5)
2 997 26.58 0.27
(0.20 - 0.35)
<LOD 0.20E
(0.10 - 0.29)
0.62
(0.48 - 0.76)
2.4E
(1.3 - 3.5)
20-39 years
1 1165 8.76 0.65
(0.52 - 0.81)
<LOD 0.76
(0.61 - 0.91)
1.4E
(0.88 - 2.0)
4.7E
(2.4 - 7.1)
2 1313 10.05 0.64
(0.47 - 0.86)
<LOD 0.65
(0.43 - 0.86)
1.6
(1.1 - 2.2)
5.2E
(2.6 - 7.8)
40-59 years
1 1220 3.52 1.0
(0.80 - 1.3)
0.21E
(0.12 - 0.30)
1.1
(0.83 - 1.3)
1.9
(1.4 - 2.3)
6.4E
(3.0 - 9.8)
2 1222 5.16 1.0
(0.79 - 1.3)
0.19
(0.17 - 0.21)
1.1
(0.86 - 1.3)
2.1
(1.6 - 2.6)
7.3E
(2.4 - 12)
60-79 years
1 1079 4.73 0.86
(0.64 - 1.2)
F 0.96
(0.75 - 1.2)
1.9
(1.2 - 2.5)
4.8E
(2.7 - 6.9)
2 1082 5.27 1.1
(0.86 - 1.5)
0.19E
(0.11 - 0.28)
1.2
(0.93 - 1.5)
2.3
(1.7 - 2.8)
6.5E
(3.9 - 9.2)
 
Table 8.10.3: Mercury (total) -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a85 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a85 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a85 footnotes

Table a85 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a85 footnote a referrer

Table a85 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a85 footnote b referrer

Table a85 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a85 footnote c referrer

Males, Total 3-79 years
1Table a85 footnote c . . . . . . .
2 2940 16.16 0.72
(0.56 - 0.92)
<LOD 0.77
(0.53 - 1.0)
1.9
(1.5 - 2.4)
6.1E
(2.7 - 9.5)
Males, 6-11 years
1 459 26.14 0.24
(0.19 - 0.32)
<LOD 0.21E
(0.12 - 0.30)
0.62
(0.40 - 0.84)
2.0E
(0.91 - 3.1)
2 488 29.71 0.24
(0.19 - 0.31)
<LOD 0.19
(0.16 - 0.23)
0.54
(0.41 - 0.68)
1.9E
(0.91 - 2.9)
Males, 12-19 years
1 489 20.65 0.28E
(0.19 - 0.41)
<LOD 0.25E
(0.15 - 0.35)
0.64E
(0.21 - 1.1)
F
2 523 26.96 0.26
(0.18 - 0.36)
<LOD 0.19E
(<LOD - 0.29)
0.62
(0.41 - 0.83)
2.6E
(1.5 - 3.8)
Males, 20-39 years
1 514 9.34 0.61
(0.47 - 0.80)
<LOD 0.72
(0.55 - 0.89)
1.5E
(0.66 - 2.2)
4.6E
(2.6 - 6.6)
2 552 10.51 0.62
(0.45 - 0.84)
<LOD 0.62
(0.43 - 0.81)
1.7E
(1.0 - 2.4)
4.7E
(2.2 - 7.1)
Males, 40-59 years
1 577 3.47 1.0
(0.82 - 1.3)
0.24E
(0.13 - 0.34)
1.0
(0.81 - 1.2)
1.8
(1.5 - 2.1)
F
2 617 4.54 1.2
(0.91 - 1.7)
0.20E
(<LOD - 0.30)
1.2
(0.99 - 1.4)
2.7E
(1.6 - 3.8)
F
Males, 60-79 years
1 537 4.28 0.97
(0.70 - 1.3)
0.17E
(<LOD - 0.26)
1.0
(0.67 - 1.3)
2.1
(1.5 - 2.7)
F
2 507 4.93 1.1
(0.84 - 1.5)
0.19E
(<LOD - 0.29)
1.3
(0.94 - 1.6)
2.3
(1.6 - 2.9)
7.0E
(3.9 - 10)
Females, Total 3-79 years
1Table a85 footnote c . . . . . . .
2 3130 14.98 0.67
(0.54 - 0.84)
<LOD 0.71
(0.54 - 0.88)
1.6
(1.2 - 2.0)
5.1E
(3.0 - 7.1)
Females, 6-11 years
1 451 23.50 0.29
(0.24 - 0.35)
<LOD 0.25
(0.20 - 0.30)
0.78
(0.54 - 1.0)
2.2E
(1.1 - 3.2)
2 473 28.33 0.32
(0.24 - 0.42)
<LOD 0.31E
(0.17 - 0.46)
0.71E
(0.44 - 0.98)
2.1
(1.4 - 2.7)
Females, 12-19 years
1 456 21.05 0.33
(0.26 - 0.41)
<LOD 0.32
(0.22 - 0.43)
0.83
(0.61 - 1.0)
2.2E
(1.3 - 3.1)
2 474 26.16 0.28
(0.21 - 0.38)
<LOD 0.21E
(<LOD - 0.34)
0.62
(0.46 - 0.78)
F
Females, 20-39 years
1 651 8.29 0.69
(0.53 - 0.91)
0.11E
(<LOD - 0.15)
0.80
(0.59 - 1.0)
1.4
(0.91 - 1.9)
4.8E
(2.0 - 7.5)
2 761 9.72 0.66
(0.47 - 0.92)
<LOD 0.69E
(0.39 - 1.0)
1.6
(1.1 - 2.1)
F
Females, 40-59 years
1 643 3.58 0.99
(0.76 - 1.3)
0.19E
(<LOD - 0.29)
1.1
(0.84 - 1.4)
2.0
(1.4 - 2.6)
5.4E
(2.1 - 8.7)
2 605 5.79 0.82
(0.65 - 1.0)
0.18
(0.18 - 0.19)
0.85
(0.62 - 1.1)
1.7
(1.2 - 2.2)
4.7E
(2.1 - 7.3)
Females, 60-79 years
1 542 5.17 0.78
(0.57 - 1.1)
F 0.91
(0.74 - 1.1)
1.6
(1.1 - 2.1)
4.4
(3.0 - 5.8)
2 575 5.57 1.1
(0.84 - 1.5)
0.19E
(<LOD - 0.32)
1.2
(0.84 - 1.5)
2.2
(1.7 - 2.8)
F
 
Table 8.11.1: Molybdenum -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 6-79 years Table a86 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a86 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a86 footnotes

Table a86 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a86 footnote a referrer

Table a86 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a86 footnote b referrer

Total, 6-79 years
1 5319 0.09 0.67
(0.66 - 0.69)
0.40
(0.38 - 0.42)
0.66
(0.64 - 0.68)
0.86
(0.82 - 0.89)
1.3
(1.3 - 1.4)
2 5575 0.18 0.65
(0.63 - 0.67)
0.38
(0.36 - 0.39)
0.64
(0.62 - 0.66)
0.85
(0.82 - 0.88)
1.4
(1.3 - 1.5)
Males, 6-79 years
1 2576 0.12 0.67
(0.65 - 0.68)
0.40
(0.39 - 0.41)
0.65
(0.63 - 0.66)
0.85
(0.81 - 0.88)
1.3
(1.2 - 1.4)
2 2687 0.22 0.63
(0.61 - 0.66)
0.37
(0.34 - 0.40)
0.62
(0.59 - 0.65)
0.83
(0.80 - 0.87)
1.4
(1.3 - 1.5)
Females, 6-79 years
1 2743 0.07 0.68
(0.66 - 0.71)
0.40
(0.36 - 0.43)
0.67
(0.64 - 0.69)
0.87
(0.83 - 0.92)
1.4
(1.3 - 1.5)
2 2888 0.14 0.67
(0.64 - 0.70)
0.39
(0.37 - 0.41)
0.64
(0.61 - 0.67)
0.86
(0.83 - 0.89)
1.5
(1.4 - 1.5)
 
Table 8.11.2: Molybdenum -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a87 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a87 footnotes

Table a87 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a87 footnote a referrer

Table a87 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a87 footnote b referrer

Total, 3-79 years
1Table a87 footnote b . . . . . . .
2 6070 0.16 0.66
(0.64 - 0.68)
0.38
(0.36 - 0.40)
0.64
(0.62 - 0.66)
0.86
(0.84 - 0.89)
1.5
(1.4 - 1.5)
3-5 years
1Table a87 footnote b . . . . . . .
2 495 0 1.0
(0.96 - 1.1)
0.61
(0.52 - 0.70)
0.95
(0.91 - 0.98)
1.2
(1.1 - 1.3)
2.7E
(1.4 - 4.0)
6-11 years
1 910 0 0.85
(0.83 - 0.87)
0.56
(0.54 - 0.58)
0.80
(0.75 - 0.84)
1.0
(0.96 - 1.0)
1.6
(1.5 - 1.7)
2 961 0.21 0.82
(0.77 - 0.87)
0.51
(0.49 - 0.54)
0.79
(0.75 - 0.84)
0.98
(0.92 - 1.0)
1.6
(1.2 - 2.1)
12-19 years
1 945 0.11 0.68
(0.63 - 0.72)
0.41
(0.38 - 0.44)
0.65
(0.60 - 0.70)
0.85
(0.79 - 0.91)
1.3
(1.1 - 1.5)
2 997 0 0.67
(0.65 - 0.71)
0.44
(0.41 - 0.47)
0.64
(0.62 - 0.67)
0.84
(0.79 - 0.90)
1.2
(1.1 - 1.3)
20-39 years
1 1165 0.09 0.65
(0.63 - 0.68)
0.40
(0.37 - 0.43)
0.63
(0.60 - 0.67)
0.82
(0.77 - 0.87)
1.3
(1.2 - 1.5)
2 1313 0.15 0.64
(0.61 - 0.67)
0.37
(0.30 - 0.44)
0.64
(0.62 - 0.66)
0.84
(0.79 - 0.89)
1.4
(1.2 - 1.6)
40-59 years
1 1220 0.08 0.64
(0.60 - 0.67)
0.37
(0.33 - 0.41)
0.63
(0.60 - 0.67)
0.81
(0.75 - 0.87)
1.2
(1.2 - 1.3)
2 1222 0.41 0.60
(0.57 - 0.63)
0.37
(0.33 - 0.40)
0.59
(0.56 - 0.61)
0.79
(0.76 - 0.82)
1.4
(1.2 - 1.5)
60-79 years
1 1079 0.19 0.73
(0.71 - 0.75)
0.41
(0.37 - 0.45)
0.72
(0.69 - 0.74)
0.93
(0.90 - 0.97)
1.6
(1.4 - 1.8)
2 1082 0.09 0.70
(0.66 - 0.75)
0.38
(0.36 - 0.41)
0.67
(0.62 - 0.72)
0.95
(0.89 - 1.0)
1.5
(1.4 - 1.7)
 
Table 8.11.3: Molybdenum -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a88 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a88 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a88 footnotes

Table a88 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a88 footnote a referrer

Table a88 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a88 footnote b referrer

Table a88 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a88 footnote c referrer

Males, Total 3-79 years
1Table a88 footnote c . . . . . . .
2 2940 0.20 0.64
(0.62 - 0.66)
0.37
(0.35 - 0.40)
0.63
(0.60 - 0.66)
0.85
(0.81 - 0.89)
1.4
(1.3 - 1.5)
Males, 6-11 years
1 459 0 0.87
(0.84 - 0.91)
0.56
(0.52 - 0.61)
0.81
(0.74 - 0.89)
1.0
(0.96 - 1.1)
1.5
(1.5 - 1.6)
2 488 0.20 0.86
(0.78 - 0.95)
0.55
(0.49 - 0.60)
0.86
(0.78 - 0.94)
1.0
(0.92 - 1.1)
1.9E
(1.2 - 2.7)
Males, 12-19 years
1 489 0 0.70
(0.65 - 0.74)
0.43
(0.39 - 0.48)
0.67
(0.62 - 0.71)
0.87
(0.81 - 0.92)
1.3
(0.92 - 1.7)
2 523 0 0.67
(0.64 - 0.70)
0.45
(0.39 - 0.50)
0.65
(0.60 - 0.70)
0.85
(0.79 - 0.91)
1.2
(1.0 - 1.4)
Males, 20-39 years
1 514 0 0.64
(0.61 - 0.67)
0.40
(0.36 - 0.45)
0.63
(0.59 - 0.66)
0.80
(0.75 - 0.85)
1.3
(1.1 - 1.5)
2 552 0.36 0.62
(0.58 - 0.66)
0.35
(0.27 - 0.43)
0.63
(0.58 - 0.68)
0.80
(0.71 - 0.90)
1.4
(1.0 - 1.7)
Males, 40-59 years
1 577 0.17 0.63
(0.60 - 0.67)
0.38
(0.32 - 0.43)
0.63
(0.59 - 0.67)
0.80
(0.73 - 0.86)
1.2
(1.1 - 1.3)
2 617 0.32 0.58
(0.55 - 0.62)
0.35
(0.27 - 0.43)
0.58
(0.54 - 0.62)
0.77
(0.72 - 0.82)
1.3
(0.99 - 1.5)
Males, 60-79 years
1 537 0.37 0.69
(0.65 - 0.74)
0.40
(0.36 - 0.44)
0.68
(0.64 - 0.72)
0.89
(0.85 - 0.94)
1.5
(1.3 - 1.7)
2 507 0.20 0.67
(0.61 - 0.73)
0.37
(0.33 - 0.42)
0.67
(0.60 - 0.73)
0.93
(0.85 - 1.0)
1.4
(1.3 - 1.5)
Females, Total 3-79 years
1Table a88 footnote c . . . . . . .
2 3130 0.13 0.68
(0.65 - 0.71)
0.39
(0.37 - 0.41)
0.65
(0.62 - 0.68)
0.88
(0.85 - 0.91)
1.5
(1.4 - 1.6)
Females, 6-11 years
1 451 0 0.83
(0.80 - 0.87)
0.56
(0.54 - 0.59)
0.77
(0.74 - 0.81)
1.0
(0.96 - 1.0)
1.6
(1.3 - 1.8)
2 473 0.21 0.78
(0.72 - 0.84)
0.50
(0.46 - 0.54)
0.75
(0.72 - 0.79)
0.95
(0.91 - 1.0)
1.4
(1.2 - 1.6)
Females, 12-19 years
1 456 0.22 0.65
(0.60 - 0.71)
0.39
(0.35 - 0.42)
0.63
(0.55 - 0.71)
0.83
(0.73 - 0.94)
1.3
(1.1 - 1.4)
2 474 0 0.68
(0.64 - 0.72)
0.43
(0.41 - 0.46)
0.64
(0.61 - 0.67)
0.83
(0.75 - 0.92)
1.2
(1.0 - 1.5)
Females, 20-39 years
1 651 0.15 0.67
(0.64 - 0.71)
0.40
(0.35 - 0.44)
0.64
(0.60 - 0.68)
0.85
(0.78 - 0.91)
1.4
(1.1 - 1.7)
2 761 0 0.66
(0.61 - 0.72)
0.38
(0.31 - 0.45)
0.64
(0.61 - 0.68)
0.85
(0.81 - 0.89)
1.5
(1.2 - 1.8)
Females, 40-59 years
1 643 0 0.64
(0.60 - 0.68)
0.37
(0.30 - 0.44)
0.63
(0.59 - 0.67)
0.82
(0.75 - 0.90)
1.2
(1.1 - 1.3)
2 605 0.50 0.62
(0.58 - 0.67)
0.38
(0.36 - 0.40)
0.60
(0.53 - 0.67)
0.80
(0.73 - 0.87)
1.4
(1.3 - 1.6)
Females, 60-79 years
1 542 0 0.77
(0.74 - 0.79)
0.44
(0.39 - 0.49)
0.74
(0.72 - 0.77)
0.99
(0.96 - 1.0)
1.6
(1.5 - 1.8)
2 575 0 0.73
(0.69 - 0.77)
0.39
(0.36 - 0.43)
0.70
(0.65 - 0.76)
0.96
(0.86 - 1.1)
1.6
(1.4 - 1.8)
 
Table 8.11.4: Molybdenum -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a89 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a89 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a89 footnotes

Table a89 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a89 footnote a referrer

Table a89 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a89 footnote b referrer

Total, 6-79 years
1 5492 0 36
(33 - 40)
9.9
(8.7 - 11)
40
(37 - 43)
70
(66 - 74)
130
(120 - 140)
2 5738 0.02 44
(41 - 47)
12
(10 - 14)
48
(45 - 51)
82
(76 - 88)
170
(150 - 190)
Males, 6-79 years
1 2662 0 42
(40 - 45)
12
(9.8 - 14)
47
(44 - 50)
76
(71 - 82)
150
(130 - 160)
2 2746 0.04 49
(45 - 52)
14
(11 - 17)
53
(49 - 56)
90
(82 - 98)
190
(160 - 210)
Females, 6-79 years
1 2830 0 31
(28 - 35)
8.6
(6.7 - 10)
34
(30 - 38)
63
(57 - 68)
120
(110 - 130)
2 2992 0 40
(37 - 43)
11
(9.5 - 12)
44
(39 - 48)
75
(67 - 84)
140
(110 - 170)
 
Table 8.11.5: Molybdenum -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a90 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a90 footnotes

Table a90 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a90 footnote a referrer

Table a90 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a90 footnote b referrer

Total, 3-79 years
1Table a90 footnote b . . . . . . .
2 6311 0.02 45
(42 - 48)
12
(11 - 14)
49
(46 - 52)
84
(78 - 89)
170
(150 - 190)
3-5 years
1Table a90 footnote b . . . . . . .
2 573 0 82
(75 - 90)
32
(27 - 36)
86
(77 - 95)
120
(120 - 130)
290
(200 - 380)
6-11 years
1 1034 0 57
(50 - 64)
19
(15 - 23)
60
(52 - 68)
100
(95 - 100)
170
(160 - 180)
2 1062 0 78
(72 - 85)
30
(27 - 34)
79
(70 - 88)
130
(110 - 140)
250
(190 - 320)
12-19 years
1 983 0 54
(47 - 62)
15
(11 - 19)
62
(55 - 70)
99
(92 - 110)
170
(150 - 190)
2 1041 0 65
(58 - 72)
20
(13 - 27)
69
(59 - 80)
100
(93 - 120)
190
(160 - 230)
20-39 years
1 1169 0 38
(33 - 43)
10
(7.2 - 13)
44
(39 - 49)
73
(67 - 79)
140
(110 - 160)
2 1321 0 49
(44 - 54)
14
(9.8 - 18)
53
(47 - 59)
87
(77 - 96)
190
(150 - 220)
40-59 years
1 1223 0 31
(28 - 33)
8.8
(7.1 - 10)
33
(31 - 36)
60
(56 - 64)
120
(100 - 130)
2 1228 0 38
(34 - 41)
9.6
(7.2 - 12)
41
(35 - 46)
73
(64 - 83)
120
(110 - 130)
60-79 years
1 1083 0 30
(28 - 33)
9.9
(8.8 - 11)
32
(29 - 35)
54
(51 - 58)
100
(95 - 110)
2 1086 0.09 32
(29 - 35)
9.4
(8.6 - 10)
35
(30 - 39)
57
(51 - 62)
110
(96 - 130)
 
Table 8.11.6: Molybdenum -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a91 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a91 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a91 footnotes

Table a91 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a91 footnote a referrer

Table a91 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a91 footnote b referrer

Table a91 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a91 footnote c referrer

Males, Total 3-79 years
1Table a91 footnote c . . . . . . .
2 3036 0.03 50
(46 - 53)
15
(12 - 17)
53
(49 - 57)
92
(84 - 100)
190
(170 - 210)
Males, 6-11 years
1 524 0 59
(48 - 72)
20
(13 - 28)
64
(52 - 77)
100
(90 - 120)
180
(160 - 210)
2 532 0 89
(77 - 100)
39
(31 - 46)
90
(72 - 110)
140
(110 - 170)
280
(200 - 360)
Males, 12-19 years
1 505 0 57
(51 - 65)
20
(15 - 25)
64
(56 - 72)
96
(87 - 110)
180
(130 - 220)
2 542 0 72
(61 - 85)
28
(19 - 36)
81
(66 - 95)
110
(93 - 130)
200
(140 - 250)
Males, 20-39 years
1 514 0 42
(37 - 47)
11
(8.3 - 14)
48
(43 - 53)
78
(71 - 86)
160
(140 - 190)
2 551 0 52
(47 - 58)
13E
(7.4 - 18)
59
(50 - 68)
98
(85 - 110)
200
(160 - 240)
Males, 40-59 years
1 578 0 38
(35 - 41)
10
(7.9 - 13)
42
(36 - 47)
69
(61 - 78)
130
(110 - 150)
2 616 0 41
(36 - 46)
13E
(7.9 - 18)
43
(36 - 51)
76
(70 - 83)
120
(99 - 150)
Males, 60-79 years
1 541 0 36
(34 - 39)
13
(11 - 14)
37
(32 - 42)
61
(55 - 67)
110
(97 - 120)
2 505 0.20 36
(31 - 41)
11
(8.9 - 13)
40
(33 - 46)
59
(48 - 69)
120
(100 - 140)
Females, Total 3-79 years
1Table a91 footnote c . . . . . . .
2 3275 0 41
(38 - 44)
11
(9.7 - 12)
44
(40 - 48)
78
(69 - 86)
140
(120 - 170)
Females, 6-11 years
1 510 0 54
(47 - 62)
17
(13 - 22)
58
(49 - 67)
99
(87 - 110)
170
(140 - 190)
2 530 0 68
(62 - 75)
26
(20 - 31)
71
(62 - 80)
110
(91 - 130)
230
(180 - 280)
Females, 12-19 years
1 478 0 50
(40 - 63)
13E
(7.5 - 18)
58
(48 - 69)
100
(89 - 110)
170
(140 - 190)
2 499 0 58
(52 - 64)
17
(12 - 23)
62
(56 - 69)
96
(89 - 100)
170
(140 - 200)
Females, 20-39 years
1 655 0 34
(28 - 41)
9.5
(6.0 - 13)
39
(31 - 46)
69
(59 - 79)
110
(89 - 130)
2 770 0 45
(39 - 53)
14
(9.4 - 19)
48
(37 - 60)
81
(68 - 95)
160E
(85 - 240)
Females, 40-59 years
1 645 0 25
(22 - 28)
6.2
(4.0 - 8.4)
27
(24 - 31)
51
(45 - 56)
98
(90 - 110)
2 612 0 35
(30 - 39)
9.2
(7.2 - 11)
38
(30 - 46)
64
(53 - 74)
110
(100 - 130)
Females, 60-79 years
1 542 0 26
(22 - 30)
8.1
(6.0 - 10)
27
(21 - 32)
49
(45 - 52)
92
(77 - 110)
2 581 0 28
(26 - 31)
8.6
(7.6 - 9.6)
30
(26 - 34)
54
(46 - 62)
100
(84 - 120)
 
Table 8.11.7: Molybdenum (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 6-79 years Table a92 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a92 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a92 footnotes

Table a92 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a92 footnote a referrer

Table a92 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a92 footnote b referrer

Total, 6-79 years
1 5479 0 44
(42 - 46)
20
(19 - 22)
43
(42 - 44)
64
(61 - 67)
120
(110 - 130)
2 5719 0.02 41
(39 - 43)
19
(17 - 20)
41
(39 - 44)
61
(57 - 65)
120
(110 - 130)
Males, 6-79 years
1 2653 0 42
(40 - 43)
19
(18 - 21)
40
(39 - 42)
61
(57 - 65)
110
(100 - 120)
2 2739 0.04 39
(37 - 41)
18
(16 - 19)
38
(35 - 41)
58
(55 - 62)
120
(100 - 130)
Females, 6-79 years
1 2826 0 46
(44 - 49)
21
(19 - 23)
46
(43 - 48)
66
(62 - 70)
120
(110 - 130)
2 2980 0 44
(41 - 47)
20
(19 - 22)
43
(40 - 46)
64
(59 - 70)
120
(100 - 140)
 
Table 8.11.8: Molybdenum (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a93 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a93 footnotes

Table a93 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a93 footnote a referrer

Table a93 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a93 footnote b referrer

Total, 3-79 years
1Table a93 footnote b . . . . . . .
2 6291 0.02 43
(41 - 45)
19
(17 - 20)
42
(40 - 45)
64
(60 - 68)
140
(120 - 160)
3-5 years
1Table a93 footnote b . . . . . . .
2 572 0 140
(130 - 150)
59
(41 - 77)
140
(130 - 150)
190
(170 - 220)
490E
(310 - 680)
6-11 years
1 1031 0 87
(84 - 91)
47
(43 - 50)
84
(79 - 89)
120
(110 - 120)
220
(190 - 240)
2 1058 0 88
(82 - 95)
42
(37 - 47)
85
(77 - 93)
130
(110 - 140)
260
(190 - 330)
12-19 years
1 982 0 47
(43 - 51)
21
(19 - 24)
46
(42 - 51)
69
(63 - 76)
110
(95 - 120)
2 1039 0 48
(45 - 51)
27
(25 - 28)
46
(41 - 50)
68
(61 - 74)
110
(85 - 140)
20-39 years
1 1165 0 42
(40 - 45)
20
(17 - 22)
42
(39 - 45)
59
(54 - 63)
110
(93 - 120)
2 1319 0 40
(37 - 42)
18
(16 - 20)
42
(39 - 45)
59
(52 - 65)
120
(85 - 160)
40-59 years
1 1218 0 39
(37 - 42)
19
(17 - 22)
39
(36 - 41)
55
(50 - 59)
100
(95 - 110)
2 1223 0 36
(34 - 39)
17
(15 - 19)
36
(33 - 38)
53
(49 - 56)
94
(78 - 110)
60-79 years
1 1083 0 43
(39 - 46)
19
(16 - 22)
43
(40 - 46)
61
(56 - 66)
110
(97 - 120)
2 1080 0.09 37
(34 - 40)
18
(15 - 21)
37
(33 - 41)
54
(49 - 59)
99
(90 - 110)
 
Table 8.11.9: Molybdenum (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a94 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a94 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a94 footnotes

Table a94 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a94 footnote a referrer

Table a94 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a94 footnote b referrer

Table a94 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a94 footnote c referrer

Males, Total 3-79 years
1Table a94 footnote c . . . . . . .
2 3028 0.03 40
(39 - 42)
18
(16 - 19)
39
(36 - 43)
61
(57 - 66)
140
(120 - 150)
Males, 6-11 years
1 522 0 90
(84 - 96)
48
(41 - 54)
88
(81 - 94)
120
(110 - 130)
220
(200 - 250)
2 530 0 97
(86 - 110)
50
(39 - 61)
92
(79 - 100)
130
(120 - 150)
290
(190 - 380)
Males, 12-19 years
1 504 0 48
(44 - 53)
23
(20 - 25)
49
(44 - 53)
72
(65 - 79)
110
(85 - 130)
2 541 0 49
(44 - 54)
26
(22 - 31)
48
(42 - 55)
70
(60 - 80)
120E
(57 - 180)
Males, 20-39 years
1 512 0 38
(36 - 41)
18
(16 - 19)
39
(36 - 42)
57
(50 - 63)
95
(76 - 110)
2 550 0 36
(34 - 39)
17
(15 - 18)
38
(33 - 44)
56
(50 - 62)
97
(66 - 130)
Males, 40-59 years
1 574 0 38
(35 - 40)
20
(18 - 22)
37
(35 - 38)
51
(47 - 55)
100
(86 - 120)
2 615 0 33
(30 - 36)
17
(14 - 19)
33
(30 - 36)
49
(44 - 54)
78
(62 - 93)
Males, 60-79 years
1 541 0 38
(35 - 42)
18
(15 - 21)
38
(34 - 42)
56
(50 - 61)
97
(88 - 110)
2 503 0.20 35
(32 - 38)
15
(13 - 18)
34
(29 - 39)
52
(45 - 60)
89
(80 - 98)
Females, Total 3-79 years
1Table a94 footnote c . . . . . . .
2 3263 0 46
(43 - 49)
21
(19 - 22)
44
(41 - 46)
67
(62 - 73)
150
(120 - 170)
Females, 6-11 years
1 509 0 85
(79 - 91)
46
(42 - 51)
81
(75 - 87)
110
(100 - 130)
200
(150 - 240)
2 528 0 80
(74 - 87)
38
(31 - 44)
79
(71 - 87)
120
(100 - 130)
220
(190 - 260)
Females, 12-19 years
1 478 0 45
(41 - 51)
20
(17 - 24)
44
(38 - 50)
67
(58 - 76)
110
(96 - 120)
2 498 0 48
(45 - 50)
27
(25 - 28)
45
(42 - 47)
67
(60 - 73)
110
(100 - 120)
Females, 20-39 years
1 653 0 46
(42 - 51)
24
(22 - 26)
45
(41 - 49)
62
(54 - 70)
120E
(75 - 170)
2 769 0 44
(40 - 49)
21
(17 - 24)
43
(40 - 47)
65
(54 - 75)
120E
(68 - 170)
Females, 40-59 years
1 644 0 41
(37 - 45)
19
(15 - 23)
41
(38 - 44)
60
(54 - 65)
100
(91 - 120)
2 608 0 40
(36 - 44)
18
(15 - 22)
40
(35 - 45)
58
(51 - 65)
110
(89 - 140)
Females, 60-79 years
1 542 0 47
(43 - 51)
20
(16 - 25)
48
(42 - 54)
69
(60 - 77)
120
(110 - 130)
2 577 0 40
(36 - 44)
20
(17 - 23)
39
(35 - 43)
56
(47 - 65)
110
(85 - 130)
 
Table 8.12.1: Nickel -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 6-79 years Table a95 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a95 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a95 footnotes

Table a95 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a95 footnote a referrer

Table a95 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a95 footnote b referrer

Total, 6-79 years
1 5319 6.69 0.63
(0.57 - 0.70)
<LOD 0.53
(0.52 - 0.55)
0.60E
(<LOD - 1.0)
1.6
(1.3 - 2.0)
2 5572 12.15 0.48
(0.45 - 0.51)
<LOD 0.49
(0.46 - 0.52)
0.56
(0.55 - 0.57)
1.1
(1.1 - 1.2)
Males, 6-79 years
1 2576 6.72 0.62
(0.56 - 0.69)
<LOD 0.53
(0.51 - 0.55)
0.59E
(<LOD - 0.95)
1.5
(1.2 - 1.8)
2 2685 10.99 0.48
(0.45 - 0.51)
<LOD 0.50
(0.47 - 0.53)
0.56
(0.55 - 0.57)
1.1
(1.0 - 1.2)
Females, 6-79 years
1 2743 6.67 0.64
(0.58 - 0.71)
<LOD 0.54
(0.52 - 0.55)
F 1.8
(1.4 - 2.2)
2 2887 13.23 0.47
(0.44 - 0.50)
<LOD 0.48
(0.44 - 0.52)
0.56
(0.55 - 0.57)
1.1
(1.1 - 1.2)
 
Table 8.12.2: Nickel -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a96 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a96 footnotes

Table a96 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a96 footnote a referrer

Table a96 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a96 footnote b referrer

Total, 3-79 years
1Table a96 footnote b . . . . . . .
2 6067 11.95 0.48
(0.45 - 0.51)
<LOD 0.49
(0.46 - 0.52)
0.56
(0.55 - 0.57)
1.1
(1.1 - 1.2)
3-5 years
1Table a96 footnote b . . . . . . .
2 495 9.70 0.51
(0.46 - 0.56)
<LOD
(<LOD - 0.33)
0.52
(0.47 - 0.57)
0.57
(0.55 - 0.58)
1.2
(0.96 - 1.4)
6-11 years
1 910 6.37 0.68
(0.61 - 0.77)
<LOD 0.54
(0.53 - 0.56)
1.0E
(0.46 - 1.6)
2.1
(1.5 - 2.8)
2 961 12.80 0.46
(0.42 - 0.50)
<LOD 0.47
(0.41 - 0.53)
0.56
(0.54 - 0.57)
1.1
(0.97 - 1.3)
12-19 years
1 945 7.20 0.64
(0.56 - 0.74)
<LOD 0.54
(0.52 - 0.56)
0.92E
(0.40 - 1.4)
1.8
(1.4 - 2.1)
2 996 13.65 0.46
(0.40 - 0.52)
<LOD 0.47
(0.40 - 0.54)
0.56
(0.54 - 0.57)
1.1
(0.75 - 1.5)
20-39 years
1 1165 6.95 0.62
(0.58 - 0.67)
<LOD 0.53
(0.52 - 0.55)
0.59E
(<LOD - 0.83)
1.6
(1.1 - 2.0)
2 1313 12.49 0.45
(0.41 - 0.51)
<LOD 0.48
(0.44 - 0.52)
0.56
(0.54 - 0.57)
1.1E
(0.71 - 1.6)
40-59 years
1 1220 6.80 0.61
(0.54 - 0.70)
<LOD 0.53
(0.51 - 0.55)
0.59E
(<LOD - 0.94)
1.6
(1.2 - 2.0)
2 1222 11.37 0.50
(0.48 - 0.53)
<LODE
(<LOD - 0.32)
0.51
(0.49 - 0.53)
0.56
(0.56 - 0.57)
1.1
(1.1 - 1.2)
60-79 years
1 1079 6.12 0.65
(0.58 - 0.71)
<LOD 0.54
(0.52 - 0.56)
0.94E
(<LOD - 1.5)
1.6
(1.0 - 2.1)
2 1080 10.65 0.48
(0.44 - 0.51)
<LOD 0.48
(0.45 - 0.52)
0.56
(0.55 - 0.57)
1.1
(1.1 - 1.2)
 
Table 8.12.3: Nickel -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a97 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a97 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a97 footnotes

Table a97 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a97 footnote a referrer

Table a97 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a97 footnote b referrer

Table a97 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a97 footnote c referrer

Males, Total 3-79 years
1Table a97 footnote c . . . . . . .
2 2938 10.96 0.48
(0.45 - 0.51)
<LOD 0.50
(0.47 - 0.53)
0.56
(0.55 - 0.57)
1.1
(1.1 - 1.2)
Males, 6-11 years
1 459 8.06 0.67
(0.60 - 0.76)
<LOD 0.54
(0.52 - 0.56)
1.0E
(0.41 - 1.6)
2.3
(1.6 - 3.0)
2 488 12.91 0.45
(0.41 - 0.50)
<LOD 0.45
(0.39 - 0.52)
0.55
(0.52 - 0.58)
1.1
(0.83 - 1.4)
Males, 12-19 years
1 489 7.98 0.64
(0.57 - 0.72)
<LOD 0.54
(0.52 - 0.56)
1.0E
(0.45 - 1.6)
1.7
(1.4 - 2.1)
2 522 11.49 0.46
(0.41 - 0.53)
<LOD 0.49
(0.41 - 0.57)
0.56
(0.54 - 0.58)
1.1E
(0.49 - 1.6)
Males, 20-39 years
1 514 5.84 0.60
(0.54 - 0.67)
<LOD 0.53
(0.51 - 0.55)
0.59
(0.46 - 0.72)
1.3
(1.1 - 1.5)
2 552 10.87 0.47
(0.43 - 0.52)
<LOD 0.49
(0.46 - 0.52)
0.56
(0.55 - 0.57)
1.1
(0.74 - 1.5)
Males, 40-59 years
1 577 6.93 0.60
(0.52 - 0.70)
<LOD 0.53
(0.50 - 0.55)
0.59E
(<LOD - 0.96)
1.5
(1.1 - 1.9)
2 617 10.53 0.49
(0.46 - 0.53)
F 0.52
(0.49 - 0.55)
0.56
(0.56 - 0.57)
1.1
(0.84 - 1.4)
Males, 60-79 years
1 537 5.03 0.64
(0.59 - 0.71)
<LOD 0.54
(0.51 - 0.56)
0.91E
(<LOD - 1.4)
1.7
(1.2 - 2.3)
2 506 9.29 0.49
(0.46 - 0.54)
<LODE
(<LOD - 0.32)
0.49
(0.45 - 0.53)
0.56
(0.55 - 0.57)
1.2
(1.1 - 1.2)
Females, Total 3-79 years
1Table a97 footnote c . . . . . . .
2 3129 12.88 0.47
(0.44 - 0.50)
<LOD 0.48
(0.45 - 0.52)
0.56
(0.55 - 0.57)
1.1
(1.1 - 1.2)
Females, 6-11 years
1 451 4.66 0.70
(0.61 - 0.80)
<LOD
(<LOD - 0.40)
0.55
(0.52 - 0.57)
1.1E
(0.60 - 1.6)
1.9E
(1.2 - 2.6)
2 473 12.68 0.47
(0.43 - 0.51)
<LOD 0.49
(0.43 - 0.54)
0.56
(0.55 - 0.58)
1.1
(0.94 - 1.3)
Females, 12-19 years
1 456 6.36 0.65
(0.55 - 0.76)
<LOD 0.54
(0.51 - 0.56)
F 1.8
(1.2 - 2.3)
2 474 16.03 0.45
(0.38 - 0.52)
<LOD 0.45
(0.39 - 0.51)
0.55
(0.54 - 0.57)
1.1E
(0.42 - 1.9)
Females, 20-39 years
1 651 7.83 0.65
(0.59 - 0.70)
<LOD 0.54
(0.52 - 0.55)
F 1.9
(1.5 - 2.4)
2 761 13.67 0.44
(0.39 - 0.50)
<LOD 0.46
(0.41 - 0.51)
0.55
(0.54 - 0.57)
1.1E
(0.62 - 1.7)
Females, 40-59 years
1 643 6.69 0.62
(0.55 - 0.71)
<LOD 0.53
(0.51 - 0.55)
0.60E
(<LOD - 0.94)
1.8
(1.3 - 2.3)
2 605 12.23 0.51
(0.48 - 0.55)
<LOD
(<LOD - 0.34)
0.50
(0.48 - 0.53)
0.56
(0.52 - 0.61)
1.2
(0.96 - 1.3)
Females, 60-79 years
1 542 7.20 0.65
(0.57 - 0.74)
<LOD 0.54
(0.52 - 0.56)
0.95E
(<LOD - 1.5)
1.6
(1.0 - 2.1)
2 574 11.85 0.46
(0.41 - 0.51)
<LOD 0.48
(0.43 - 0.53)
0.56
(0.55 - 0.57)
1.1
(0.90 - 1.2)
 
Table 8.12.4: Nickel -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a98 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a98 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a98 footnotes

Table a98 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a98 footnote a referrer

Table a98 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a98 footnote b referrer

Total, 6-79 years
1 5491 3.15 1.1
(1.0 - 1.2)
0.29E
(<LOD - 0.43)
1.1
(1.0 - 1.2)
2.0
(1.9 - 2.1)
4.4
(4.0 - 4.8)
2 5737 4.29 1.3
(1.3 - 1.4)
0.45
(0.40 - 0.50)
1.4
(1.3 - 1.5)
2.3
(2.1 - 2.4)
4.8
(4.2 - 5.4)
Males, 6-79 years
1 2662 2.85 1.1
(1.1 - 1.2)
0.40
(0.36 - 0.43)
1.1
(1.1 - 1.2)
2.0
(1.8 - 2.2)
4.5
(3.8 - 5.3)
2 2745 3.53 1.4
(1.3 - 1.5)
0.50
(0.42 - 0.57)
1.4
(1.3 - 1.5)
2.3
(2.1 - 2.6)
4.7
(4.0 - 5.5)
Females, 6-79 years
1 2829 3.43 1.1
(0.97 - 1.2)
0.27
(<LOD - 0.36)
1.1
(0.96 - 1.2)
2.0
(1.8 - 2.1)
4.3
(3.6 - 5.0)
2 2992 4.98 1.3
(1.2 - 1.4)
0.43
(0.38 - 0.47)
1.4
(1.3 - 1.5)
2.2
(2.0 - 2.4)
4.8
(3.8 - 5.8)
 
Table 8.12.5: Nickel -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a99 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a99 footnotes

Table a99 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a99 footnote a referrer

Table a99 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a99 footnote b referrer

Total, 3-79 years
1Table a99 footnote b . . . . . . .
2 6310 4.29 1.3
(1.3 - 1.4)
0.45
(0.40 - 0.50)
1.4
(1.3 - 1.5)
2.3
(2.1 - 2.4)
4.8
(4.2 - 5.3)
3-5 years
1Table a99 footnote b . . . . . . .
2 573 4.36 1.4
(1.3 - 1.6)
0.58
(0.45 - 0.72)
1.4
(1.2 - 1.6)
2.3
(2.0 - 2.6)
4.5
(3.4 - 5.6)
6-11 years
1 1034 2.80 1.3
(1.1 - 1.6)
0.40E
(0.23 - 0.57)
1.4
(1.2 - 1.6)
2.5
(2.2 - 2.9)
5.0
(4.2 - 5.8)
2 1061 2.45 1.7
(1.6 - 1.8)
0.59
(0.53 - 0.64)
1.7
(1.5 - 1.9)
2.8
(2.5 - 3.2)
5.8
(5.1 - 6.4)
12-19 years
1 983 1.73 1.5
(1.4 - 1.7)
0.48
(0.37 - 0.59)
1.6
(1.5 - 1.7)
2.5
(2.3 - 2.8)
5.3
(4.2 - 6.4)
2 1041 3.07 1.6
(1.5 - 1.8)
0.56
(0.46 - 0.67)
1.7
(1.5 - 1.8)
2.7
(2.5 - 3.0)
4.7
(4.1 - 5.3)
20-39 years
1 1168 3.68 1.0
(0.89 - 1.1)
0.26
(<LOD - 0.34)
1.0
(0.92 - 1.1)
1.7
(1.5 - 2.0)
3.7
(3.1 - 4.3)
2 1321 5.22 1.3
(1.2 - 1.4)
0.45
(0.36 - 0.54)
1.3
(1.2 - 1.5)
2.1
(1.9 - 2.3)
5.0
(3.8 - 6.2)
40-59 years
1 1223 5.07 1.0
(0.96 - 1.1)
0.27
(<LOD - 0.35)
1.0
(0.93 - 1.1)
2.0
(1.8 - 2.1)
4.6
(3.3 - 5.9)
2 1228 5.78 1.3
(1.1 - 1.4)
0.42
(0.31 - 0.53)
1.3
(1.2 - 1.4)
2.1
(1.9 - 2.4)
4.3
(3.2 - 5.4)
60-79 years
1 1083 2.03 1.1
(1.1 - 1.2)
0.40
(0.32 - 0.48)
1.1
(1.0 - 1.2)
1.9
(1.8 - 2.1)
4.7
(3.8 - 5.5)
2 1086 4.42 1.3
(1.2 - 1.4)
0.43
(0.33 - 0.53)
1.3
(1.2 - 1.4)
2.2
(1.9 - 2.4)
4.7
(4.1 - 5.3)
 
Table 8.12.6: Nickel -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a100 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a100 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a100 footnotes

Table a100 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a100 footnote a referrer

Table a100 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a100 footnote b referrer

Table a100 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a100 footnote c referrer

Males, Total 3-79 years
1Table a100 footnote c . . . . . . .
2 3035 3.66 1.4
(1.3 - 1.5)
0.50
(0.42 - 0.57)
1.4
(1.3 - 1.5)
2.3
(2.1 - 2.6)
4.7
(4.1 - 5.4)
Males, 6-11 years
1 524 3.05 1.3
(1.0 - 1.7)
F 1.4
(1.1 - 1.8)
2.6
(2.1 - 3.1)
4.6
(4.0 - 5.2)
2 531 1.69 1.9
(1.6 - 2.2)
0.66
(0.50 - 0.82)
1.9
(1.5 - 2.2)
3.0
(2.3 - 3.7)
5.9
(4.2 - 7.7)
Males, 12-19 years
1 505 1.19 1.4
(1.3 - 1.6)
0.47
(0.37 - 0.57)
1.5
(1.3 - 1.6)
2.2
(2.0 - 2.5)
4.8
(3.1 - 6.5)
2 542 2.40 1.6
(1.4 - 1.8)
0.59
(0.43 - 0.74)
1.7
(1.5 - 1.9)
2.6
(2.2 - 2.9)
4.6
(3.7 - 5.4)
Males, 20-39 years
1 514 3.89 1.0
(0.90 - 1.1)
0.26E
(<LOD - 0.40)
1.0
(0.97 - 1.1)
1.6
(1.3 - 1.9)
3.7
(3.0 - 4.5)
2 551 5.81 1.3
(1.2 - 1.4)
0.46
(0.31 - 0.62)
1.4
(1.1 - 1.6)
2.2
(1.8 - 2.6)
4.5
(3.2 - 5.7)
Males, 40-59 years
1 578 4.33 1.1
(0.99 - 1.3)
0.39
(0.27 - 0.52)
1.1
(0.91 - 1.3)
2.0
(1.7 - 2.3)
5.4
(4.5 - 6.4)
2 616 4.22 1.3
(1.2 - 1.4)
0.45
(0.32 - 0.58)
1.3
(1.2 - 1.5)
2.1
(1.7 - 2.6)
4.1
(3.2 - 5.0)
Males, 60-79 years
1 541 1.66 1.3
(1.1 - 1.4)
0.47
(0.43 - 0.50)
1.2
(1.1 - 1.4)
2.1
(1.7 - 2.5)
5.5
(3.5 - 7.5)
2 505 3.37 1.3
(1.2 - 1.5)
0.49
(0.36 - 0.61)
1.3
(1.2 - 1.4)
2.2
(1.8 - 2.6)
5.4
(3.8 - 7.0)
Females, Total 3-79 years
1Table a100 footnote c . . . . . . .
2 3275 4.89 1.3
(1.2 - 1.4)
0.43
(0.39 - 0.47)
1.4
(1.3 - 1.5)
2.2
(2.0 - 2.4)
4.8
(3.9 - 5.7)
Females, 6-11 years
1 510 2.55 1.3
(1.2 - 1.5)
0.43
(0.29 - 0.58)
1.3
(1.1 - 1.5)
2.3
(2.0 - 2.7)
5.5
(4.5 - 6.5)
2 530 3.21 1.5
(1.4 - 1.7)
0.55
(0.44 - 0.65)
1.6
(1.4 - 1.7)
2.6
(2.1 - 3.0)
5.3
(4.6 - 6.1)
Females, 12-19 years
1 478 2.30 1.6
(1.4 - 1.9)
0.49E
(<LOD - 0.78)
1.8
(1.6 - 2.0)
3.0
(2.6 - 3.3)
5.7
(4.0 - 7.5)
2 499 3.81 1.6
(1.4 - 1.8)
0.48
(0.35 - 0.60)
1.7
(1.5 - 1.9)
3.0
(2.7 - 3.3)
5.0
(4.5 - 5.5)
Females, 20-39 years
1 654 3.52 1.0
(0.82 - 1.2)
0.26E
(<LOD - 0.40)
1.0
(0.81 - 1.2)
1.8
(1.4 - 2.2)
3.3
(2.2 - 4.4)
2 770 4.81 1.3
(1.2 - 1.5)
0.45
(0.34 - 0.55)
1.3
(1.2 - 1.5)
2.0
(1.8 - 2.3)
5.3E
(2.8 - 7.8)
Females, 40-59 years
1 645 5.74 0.96
(0.85 - 1.1)
0.23
(<LOD - 0.31)
1.0
(0.85 - 1.1)
1.9
(1.7 - 2.1)
3.8E
(2.2 - 5.5)
2 612 7.35 1.2
(1.1 - 1.4)
0.33E
(<LOD - 0.50)
1.3
(1.2 - 1.5)
2.1
(1.8 - 2.4)
4.4E
(2.3 - 6.5)
Females, 60-79 years
1 542 2.40 1.0
(0.93 - 1.1)
0.30E
(<LOD - 0.43)
1.0
(0.89 - 1.1)
1.7
(1.5 - 1.9)
4.3
(3.3 - 5.3)
2 581 5.34 1.2
(1.1 - 1.4)
0.39
(<LOD - 0.49)
1.4
(1.2 - 1.6)
2.1
(1.8 - 2.4)
4.3
(3.5 - 5.1)
 
Table 8.12.7: Nickel (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 6-79 years Table a101 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a101 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a101 footnotes

Table a101 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a101 footnote a referrer

Table a101 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a101 footnote b referrer

Total, 6-79 years
1 5478 3.16 1.3
(1.3 - 1.4)
0.55
(<LOD - 0.58)
1.3
(1.2 - 1.3)
2.0
(1.9 - 2.1)
4.5
(3.9 - 5.0)
2 5718 4.30 1.2
(1.2 - 1.3)
0.56
(0.51 - 0.61)
1.2
(1.1 - 1.3)
1.9
(1.8 - 2.0)
4.0
(3.5 - 4.4)
Males, 6-79 years
1 2653 2.86 1.1
(1.1 - 1.2)
0.48
(0.45 - 0.52)
1.1
(0.99 - 1.1)
1.7
(1.6 - 1.8)
3.7
(3.2 - 4.3)
2 2738 3.54 1.1
(1.0 - 1.1)
0.49
(0.45 - 0.53)
1.0
(0.97 - 1.1)
1.6
(1.5 - 1.6)
3.2
(2.6 - 3.7)
Females, 6-79 years
1 2825 3.43 1.6
(1.5 - 1.7)
0.70
(<LOD - 0.76)
1.5
(1.4 - 1.6)
2.3
(2.1 - 2.5)
5.2
(4.3 - 6.1)
2 2980 5.00 1.4
(1.3 - 1.5)
0.67
(0.58 - 0.75)
1.4
(1.3 - 1.4)
2.2
(1.9 - 2.4)
4.6
(4.0 - 5.1)
 
Table 8.12.8: Nickel (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a102 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a102 footnotes

Table a102 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a102 footnote a referrer

Table a102 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a102 footnote b referrer

Total, 3-79 years
1Table a102 footnote b . . . . . . .
2 6290 4.31 1.3
(1.2 - 1.3)
0.57
(0.52 - 0.61)
1.2
(1.2 - 1.3)
1.9
(1.8 - 2.0)
4.2
(3.8 - 4.6)
3-5 years
1Table a102 footnote b . . . . . . .
2 572 4.37 2.4
(2.1 - 2.7)
1.0
(0.75 - 1.3)
2.4
(2.0 - 2.8)
3.5
(3.2 - 3.9)
6.1
(5.0 - 7.2)
6-11 years
1 1031 2.81 2.0
(1.8 - 2.3)
0.85
(0.69 - 1.0)
2.0
(1.7 - 2.2)
3.0
(2.7 - 3.3)
5.6
(4.6 - 6.7)
2 1057 2.46 1.9
(1.8 - 2.0)
0.93
(0.86 - 1.0)
1.9
(1.8 - 2.1)
2.7
(2.5 - 2.9)
5.7
(4.7 - 6.7)
12-19 years
1 982 1.73 1.3
(1.2 - 1.4)
0.57
(0.52 - 0.63)
1.3
(1.1 - 1.4)
2.0
(1.7 - 2.3)
3.9
(3.6 - 4.3)
2 1039 3.08 1.2
(1.1 - 1.3)
0.58
(0.51 - 0.64)
1.1
(1.1 - 1.2)
1.8
(1.6 - 2.0)
3.0
(2.7 - 3.3)
20-39 years
1 1164 3.69 1.1
(1.0 - 1.2)
0.46
(<LOD - 0.51)
1.1
(0.96 - 1.2)
1.6
(1.5 - 1.8)
3.9
(2.9 - 4.8)
2 1319 5.23 1.1
(1.0 - 1.1)
0.49
(0.44 - 0.54)
1.0
(0.94 - 1.1)
1.5
(1.3 - 1.7)
3.5
(3.0 - 3.9)
40-59 years
1 1218 5.09 1.3
(1.3 - 1.4)
0.57
(<LOD - 0.61)
1.3
(1.2 - 1.4)
2.0
(1.9 - 2.1)
4.4
(3.5 - 5.4)
2 1223 5.81 1.2
(1.1 - 1.3)
0.54
(0.47 - 0.62)
1.2
(1.1 - 1.3)
1.7
(1.5 - 1.9)
3.7
(2.9 - 4.6)
60-79 years
1 1083 2.03 1.6
(1.5 - 1.7)
0.67
(0.59 - 0.75)
1.5
(1.4 - 1.6)
2.4
(2.3 - 2.5)
5.3
(4.8 - 5.8)
2 1080 4.44 1.5
(1.4 - 1.6)
0.65
(0.57 - 0.73)
1.4
(1.3 - 1.5)
2.3
(2.1 - 2.5)
4.9
(4.4 - 5.3)
 
Table 8.12.9: Nickel (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table a103 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a103 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a103 footnotes

Table a103 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a103 footnote a referrer

Table a103 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a103 footnote b referrer

Table a103 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a103 footnote c referrer

Males, Total 3-79 years
1Table a103 footnote c . . . . . . .
2 3027 3.67 1.1
(1.0 - 1.2)
0.49
(0.45 - 0.53)
1.1
(1.0 - 1.1)
1.6
(1.5 - 1.7)
3.4
(2.9 - 4.0)
Males, 6-11 years
1 522 3.07 2.0
(1.7 - 2.3)
0.83
(<LOD - 1.0)
2.0
(1.7 - 2.4)
2.9
(2.6 - 3.1)
5.2
(3.5 - 7.0)
2 529 1.70 2.1
(1.8 - 2.3)
1.0
(0.86 - 1.1)
2.1
(1.8 - 2.3)
2.7
(2.4 - 3.1)
6.5
(4.7 - 8.3)
Males, 12-19 years
1 504 1.19 1.2
(1.1 - 1.3)
0.55
(0.47 - 0.63)
1.0
(0.92 - 1.2)
1.8
(1.6 - 2.0)
4.1
(3.4 - 4.9)
2 541 2.40 1.1
(1.0 - 1.2)
0.52
(0.42 - 0.62)
1.0
(0.96 - 1.1)
1.5
(1.3 - 1.7)
2.8
(2.4 - 3.2)
Males, 20-39 years
1 512 3.91 0.92
(0.81 - 1.1)
0.40
(<LOD - 0.45)
0.90
(0.78 - 1.0)
1.4
(1.1 - 1.7)
2.8
(2.0 - 3.6)
2 550 5.82 0.88
(0.80 - 0.97)
0.44
(0.36 - 0.51)
0.89
(0.79 - 0.99)
1.2
(1.1 - 1.4)
2.3
(1.6 - 3.0)
Males, 40-59 years
1 574 4.36 1.1
(1.0 - 1.2)
0.50
(0.43 - 0.56)
1.0
(0.94 - 1.1)
1.6
(1.4 - 1.8)
3.4
(2.5 - 4.3)
2 615 4.23 1.0
(0.93 - 1.1)
0.47
(0.40 - 0.54)
1.0
(0.88 - 1.1)
1.5
(1.3 - 1.6)
3.1
(2.0 - 4.2)
Males, 60-79 years
1 541 1.66 1.3
(1.2 - 1.4)
0.57
(0.49 - 0.64)
1.2
(1.1 - 1.3)
2.0
(1.7 - 2.3)
4.7
(3.2 - 6.3)
2 503 3.38 1.3
(1.2 - 1.4)
0.59
(0.56 - 0.63)
1.2
(1.1 - 1.3)
1.9
(1.7 - 2.1)
3.6E
(2.2 - 4.9)
Females, Total 3-79 years
1Table a103 footnote c . . . . . . .
2 3263 4.90 1.5
(1.3 - 1.6)
0.67
(0.59 - 0.75)
1.4
(1.3 - 1.5)
2.2
(2.0 - 2.5)
4.6
(4.0 - 5.1)
Females, 6-11 years
1 509 2.55 2.1
(1.8 - 2.3)
0.93
(0.78 - 1.1)
1.9
(1.7 - 2.1)
3.1
(2.6 - 3.6)
5.7
(4.5 - 6.9)
2 528 3.22 1.8
(1.6 - 1.9)
0.85
(0.69 - 1.0)
1.9
(1.7 - 2.1)
2.7
(2.4 - 3.0)
4.8
(3.8 - 5.8)
Females, 12-19 years
1 478 2.30 1.5
(1.3 - 1.7)
0.63
(<LOD - 0.80)
1.5
(1.3 - 1.6)
2.2
(1.8 - 2.6)
3.9
(3.3 - 4.5)
2 498 3.82 1.3
(1.2 - 1.4)
0.64
(0.55 - 0.72)
1.3
(1.2 - 1.4)
2.0
(1.8 - 2.2)
3.6
(2.9 - 4.2)
Females, 20-39 years
1 652 3.53 1.4
(1.2 - 1.6)
0.63
(<LOD - 0.73)
1.3
(1.1 - 1.4)
2.0
(1.8 - 2.2)
4.6
(3.7 - 5.5)
2 769 4.81 1.3
(1.1 - 1.5)
0.61
(0.52 - 0.70)
1.2
(1.1 - 1.3)
1.9
(1.4 - 2.3)
3.9
(3.0 - 4.8)
Females, 40-59 years
1 644 5.75 1.6
(1.5 - 1.7)
0.73
(<LOD - 0.80)
1.5
(1.4 - 1.6)
2.3
(2.0 - 2.5)
4.9
(3.6 - 6.3)
2 608 7.40 1.4
(1.2 - 1.6)
0.66
(<LOD - 0.74)
1.4
(1.2 - 1.5)
2.0
(1.7 - 2.4)
4.5E
(2.8 - 6.2)
Females, 60-79 years
1 542 2.40 1.9
(1.7 - 2.0)
0.81
(<LOD - 0.96)
1.8
(1.7 - 2.0)
2.7
(2.3 - 3.0)
5.9
(4.8 - 7.0)
2 577 5.37 1.7
(1.5 - 1.9)
0.76
(<LOD - 0.91)
1.6
(1.4 - 1.8)
2.8
(2.4 - 3.1)
5.2
(4.2 - 6.2)
 
Table 8.13.1: Selenium -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 6-79 years Table a104 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a104 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a104 footnotes

Table a104 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a104 footnote a referrer

Table a104 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a104 footnote b referrer

Total, 6-79 years
1 5319 0 200
(200 - 210)
160
(160 - 170)
190
(190 - 200)
210
(210 - 220)
250
(240 - 260)
2 5575 0 190
(190 - 190)
160
(150 - 160)
180
(180 - 190)
200
(200 - 210)
240
(230 - 250)
Males, 6-79 years
1 2576 0 200
(200 - 210)
170
(160 - 170)
200
(190 - 200)
220
(210 - 220)
250
(240 - 260)
2 2687 0 190
(190 - 200)
160
(160 - 160)
190
(180 - 190)
200
(200 - 210)
240
(230 - 260)
Females, 6-79 years
1 2743 0 200
(190 - 200)
160
(160 - 160)
190
(190 - 200)
210
(210 - 210)
250
(240 - 250)
2 2888 0 190
(180 - 190)
150
(150 - 160)
180
(180 - 190)
200
(200 - 210)
240
(230 - 250)
 
Table 8.13.2: Selenium -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a105 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a105 footnotes

Table a105 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a105 footnote a referrer

Table a105 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a105 footnote b referrer

Total, 3-79 years
1Table a105 footnote b . . . . . . .
2 6070 0 190
(190 - 190)
160
(150 - 160)
180
(180 - 190)
200
(200 - 210)
240
(230 - 250)
3-5 years
1Table a105 footnote b . . . . . . .
2 495 0 170
(160 - 170)
140
(140 - 150)
160
(160 - 170)
170
(170 - 180)
200
(200 - 210)
6-11 years
1 910 0 190
(180 - 190)
150
(150 - 160)
180
(180 - 180)
200
(190 - 200)
230
(220 - 230)
2 961 0 170
(170 - 180)
140
(140 - 150)
170
(160 - 170)
180
(180 - 190)
210
(200 - 220)
12-19 years
1 945 0 200
(190 - 200)
160
(160 - 170)
190
(190 - 190)
210
(200 - 210)
250
(240 - 260)
2 997 0 190
(180 - 190)
160
(150 - 160)
180
(180 - 180)
200
(190 - 200)
230
(220 - 240)
20-39 years
1 1165 0 200
(200 - 210)
160
(160 - 170)
200
(190 - 200)
210
(210 - 220)
250
(230 - 260)
2 1313 0 190
(190 - 200)
160
(150 - 160)
190
(180 - 190)
200
(200 - 210)
240
(220 - 270)
40-59 years
1 1220 0 200
(200 - 210)
170
(160 - 170)
200
(190 - 200)
220
(210 - 230)
250
(240 - 260)
2 1222 0 190
(190 - 200)
160
(150 - 160)
190
(180 - 190)
210
(210 - 210)
240
(240 - 250)
60-79 years
1 1079 0 200
(200 - 210)
170
(160 - 170)
200
(190 - 200)
220
(210 - 220)
250
(240 - 270)
2 1082 0 190
(190 - 190)
160
(150 - 160)
180
(180 - 190)
200
(200 - 210)
240
(230 - 240)
 
Table 8.13.3: Selenium -- Geometric means and selected percentiles of whole blood concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table a106 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a106 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a106 footnotes

Table a106 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table a106 footnote a referrer

Table a106 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a106 footnote b referrer

Table a106 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a106 footnote c referrer

Males, Total 3-79 years
1Table a106 footnote c . . . . . . .
2 2940 0 190
(190 - 190)
160
(160 - 160)
190
(180 - 190)
200
(200 - 210)
240
(230 - 260)
Males, 6-11 years
1 459 0 190
(180 - 190)
150
(150 - 160)
180
(180 - 180)
190
(190 - 200)
220
(210 - 240)
2 488 0 170
(170 - 180)
140
(140 - 150)
170
(160 - 170)
180
(180 - 190)
210
(200 - 220)
Males, 12-19 years
1 489 0 200
(190 - 200)
160
(160 - 170)
190
(180 - 190)
210
(200 - 220)
250
(230 - 260)
2 523 0 190
(180 - 190)
160
(150 - 160)
180
(180 - 190)
200
(190 - 200)
220
(190 - 250)
Males, 20-39 years
1 514 0 210
(200 - 210)
170
(170 - 170)
200
(190 - 200)
220
(210 - 230)
260
(240 - 290)
2 552 0 190
(190 - 200)
160
(160 - 170)
190
(180 - 190)
200
(200 - 210)
250
(220 - 280)
Males, 40-59 years
1 577 0 210
(200 - 210)
170
(160 - 180)
200
(190 - 210)
220
(220 - 230)
250
(240 - 260)
2 617 0 200
(190 - 200)
160
(160 - 170)
190
(190 - 200)
210
(210 - 210)
250
(230 - 270)
Males, 60-79 years
1 537 0 200
(200 - 210)
170
(160 - 180)
200
(190 - 210)
220
(210 - 230)
250
(240 - 270)
2 507 0 190
(190 - 190)
160
(160 - 160)
190
(180 - 190)
200
(200 - 200)
230
(220 - 240)
Females, Total 3-79 years
1Table a106 footnote c . . . . . . .
2 3130 0 190
(180 - 190)
150
(150 - 160)
180
(180 - 180)
200
(200 - 210)
240
(230 - 250)
Females, 6-11 years
1 451 0 190
(180 - 190)
150
(150 - 160)
180
(180 - 190)
200
(200 - 200)
230
(220 - 240)
2 473 0 180
(170 - 180)
140
(140 - 150)
170
(170 - 170)
190
(180 - 190)
220
(180 - 250)
Females, 12-19 years
1 456 0 190
(190 - 200)
160
(150 - 160)
190
(190 - 190)
210
(200 - 210)
250
(240 - 260)
2 474 0 180
(180 - 190)
160
(150 - 160)
180
(170 - 180)
200
(190 - 200)
230
(220 - 230)
Females, 20-39 years
1 651 0 200
(190 - 200)
160
(160 - 170)
190
(190 - 200)
210
(200 - 220)
240
(230 - 250)
2 761 0 190
(180 - 190)
150
(150 - 160)
180
(180 - 190)
200
(190 - 210)
230
(200 - 270)
Females, 40-59 years
1 643 0 200
(200 - 200)
160
(160 - 170)
190
(190 - 200)
210
(200 - 220)
250
(240 - 260)
2 605 0 190
(190 - 200)
150
(150 - 160)
190
(180 - 190)
210
(200 - 220)
240
(240 - 250)
Females, 60-79 years
1 542 0 200
(200 - 210)
160
(160 - 170)
190
(190 - 200)
220
(210 - 230)
250
(230 - 280)
2 575 0 190
(180 - 190)
150
(150 - 160)
180
(180 - 190)
200
(200 - 210)
240
(230 - 250)
 
Table 8.13.4: Selenium -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table a107 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a107 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a107 footnotes

Table a107 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table a107 footnote a referrer

Table a107 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a107 footnote b referrer

Total, 6-79 years
1 5492 0.46 49
(44 - 53)
17
(14 - 19)
53
(48 - 58)
85
(79 - 91)
140
(130 - 150)
2 5738 0.16 51
(49 - 53)
17
(15 - 20)
59
(55 - 62)
83
(78 - 87)
130
(130 - 140)
Males, 6-79 years
1 2662 0.23 57
(52 - 61)
21
(18 - 24)
62
(57 - 67)
94
(86 - 100)
150
(140 - 160)
2 2746 0.18 57
(54 - 60)
23
(21 - 25)
64
(60 - 69)
88
(81 - 96)
140
(130 - 160)
Females, 6-79 years
1 2830 0.67 42
(38 - 47)
13
(11 - 16)
44
(38 - 50)
75
(69 - 82)
130
(110 - 140)
2 2992 0.13 46
(43 - 48)
15
(13 - 17)
52
(49 - 55)
78
(76 - 80)
120
(110 - 140)
 
Table 8.13.5: Selenium -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable a108 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table a108 footnotes

Table a108 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table a108 footnote a referrer

Table a108 footnote 2

Data not availabl